EurekaMag PDF full texts Chapter 56,550
References:
Velayudhan, L.; Van Diepen, E.; Marudkar, M.; Hands, O.; Suribhatla, S.; Prettyman, R.; Murray, J.; Baillon, S.; Bhattacharyya, S. 2014: Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review. Current Pharmaceutical Design 20(13): 2218-2230
Kucerova, J.; Tabiova, K.; Drago, F.; Micale, V. 2014: Therapeutic potential of cannabinoids in schizophrenia. Recent Patents on Cns Drug Discovery 9(1): 13-25
Little, J.P.; Villanueva, E.B.; Klegeris, A. 2011: Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease. Mini Reviews in Medicinal Chemistry 11(7): 582-590
Ye, L.; Sun, P.-H.; Sanders, A.J.; Martin, T.A.; Lane, J.; Mason, M.D.; Jiang, W.G. 2014: Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour‑related angiogenesis. International Journal of Oncology 45(4): 1565-1573
Sunasee, R.; Adokoh, C.K.; Darkwa, J.; Narain, R. 2014: Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems. Expert Opinion on Drug Delivery 11(6): 867-884
Lobo, M.L.ís.; Esteves, F.; de Sousa, B.; Cardoso, F.; Cushion, M.T.; Antunes, F.; Matos, O. 2013: Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice. Plos one 8(8): E70619
Salmi, C.; Brunel, J.M. 2007: Therapeutic potential of cationic steroid antibacterials. Expert Opinion on Investigational Drugs 16(8): 1143-1157
Vasconcelos, L.ís.; Pärn, K.; Langel, U. 2013: Therapeutic potential of cell-penetrating peptides. Therapeutic Delivery 4(5): 573-591
Sahin, H.; Berres, M.-L.; Wasmuth, H.E. 2011: Therapeutic potential of chemokine receptor antagonists for liver disease. Expert Review of Clinical Pharmacology 4(4): 503-513
Lu, K.-H.; Liu, C.-T.; Raghu, R.; Sheen, L.-Y. 2012: Therapeutic potential of chinese herbal medicines in alcoholic liver disease. Journal of Traditional and Complementary Medicine 2(2): 115-122
Nagar, J.; Ranade, S.; Kamath, V.; Singh, S.; Karunanithi, P.; Subramani, S.; Venkatesh, K.; Srivastava, R.; Dudhgaonkar, S.; Vikramadithyan, R.K. 2014: Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease. International Immunopharmacology 21(2): 328-335
Patel, V.J.; Joharapurkar, A.A.; Kshirsagar, S.G.; Patel, K.N.; Shah, G.B.; Jain, M.R. 2014: Therapeutic potential of coagonists of glucagon and GLP-1. Cardiovascular and Hematological Agents in Medicinal Chemistry 12(2): 126-133
Warwick, K.; Gasson, M.N.; Spiers, A.J. 2007: Therapeutic potential of computer to cerebral cortex implantable devices. Acta Neurochirurgica. Suppl 97(Part 2): 529-535
Schroeder, C.I.; Craik, D.J. 2012: Therapeutic potential of conopeptides. Future Medicinal Chemistry 4(10): 1243-1255
Cooper, G.J.S. 2011: Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease. Drugs 71(10): 1281-1320
Phan, C.-W.; David, P.; Naidu, M.; Wong, K.-H.; Sabaratnam, V. 2015: Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism. Critical Reviews in Biotechnology 35(3): 355-368
Dulbecco, P.; Savarino, V. 2013: Therapeutic potential of curcumin in digestive diseases. World Journal of Gastroenterology 19(48): 9256-9270
Rajasekaran, S.A. 2011: Therapeutic potential of curcumin in gastrointestinal diseases. World Journal of Gastrointestinal Pathophysiology 2(1): 1-14
Liu, B. 2012: Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease. Clinical Lipidology 7(3): 289-301
Li, H.; Sheppard, D.N. 2009: Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 23(4): 203-216
Crispin, M. 2013: Therapeutic potential of deglycosylated antibodies. Proceedings of the National Academy of Sciences of the United States of America 110(25): 10059-10060
Yu, Z.; Ren, P.; Zhang, X.; Zhang, T.; Ma, B.'a. 2009: Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities. Expert Review of Anticancer Therapy 9(8): 1065-1071
Verma, K.; Bains, R.; Bains, V.K.; Rawtiya, M.; Loomba, K.; Srivastava, S.C. 2014: Therapeutic potential of dental pulp stem cells in regenerative medicine: An overview. Dental Research Journal 11(3): 302-308
Scapagnini, G.; Caruso, C.; Calabrese, V. 2010: Therapeutic potential of dietary polyphenols against brain ageing and neurodegenerative disorders. Advances in Experimental Medicine and Biology 698: 27-35
Mandal, A.; Patra, A.; Mandal, S.; Roy, S.; Mahapatra, S.D.; Mahapatra, T.D.; Paul, T.; Das, K.; Mondal, K.C.; Nandi, D.K. 2015: Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats. Clinical and Experimental Nephrology 19(2): 168-177
Moore, K.B.; Saudek, C.D. 2008: Therapeutic potential of dipeptidyl peptidase-IV inhibitors in patients with diabetes mellitus. American Journal of Therapeutics 15(5): 484-491
Shor, A.C.; Agresta, S.V.; D'Amato, G.Z.; Sondak, V.K. 2008: Therapeutic potential of directed tyrosine kinase inhibitor therapy in sarcomas. Cancer Control: Journal of the Moffitt Cancer Center 15(1): 47-54
Brooks, S.C.; Brooks, J.S.; Lee, W.H.; Lee, M.G.; Kim, S.G. 2009: Therapeutic potential of dithiolethiones for hepatic diseases. Pharmacology and Therapeutics 124(1): 31-43
Curtin, N. 2007: Therapeutic potential of drugs to modulate DNA repair in cancer. Expert Opinion on Therapeutic Targets 11(6): 783-799
Saliev, T.; Mustapova, Z.; Kulsharova, G.; Bulanin, D.; Mikhalovsky, S. 2014: Therapeutic potential of electromagnetic fields for tissue engineering and wound healing. Cell Proliferation 47(6): 485-493
Barton, M. 2010: Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans. Biochimica et Biophysica Acta 1802(12): 1203-1213
Aubert, J.-D.; Juillerat-Jeanneret, L. 2009: Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials. Expert Opinion on Therapeutic Targets 13(9): 1069-1084
Sirén, A.-L.; Fasshauer, T.; Bartels, C.; Ehrenreich, H. 2009: Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 6(1): 108-127
Westenbrink, B.D.; Voors, A.A.; Ruifrok, W.-P.T.; van Gilst, W.H.; van Veldhuisen, D.J. 2007: Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond. Current Heart Failure Reports 4(3): 127-133
Yu, J.-Z.; Ding, J.; Ma, C.-G.; Sun, C.-H.; Sun, Y.-F.; Lu, C.-Z.; Xiao, B.-G. 2010: Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor. Journal of Neuroscience Research 88(8): 1664-1672
Tu, J.; Wang, L.-P. 2009: Therapeutic potential of extracellular ATP and P2 receptors in nervous system diseases. Neuroscience Bulletin 25(1): 27-32
Smits, L.P.; Bouter, K.E.C.; de Vos, W.M.; Borody, T.J.; Nieuwdorp, M. 2013: Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145(5): 946-953
Roubelakis, M.G. 2013: Therapeutic potential of fetal mesenchymal stem cells. Current Stem Cell Research and Therapy 8(2): 115-116
Mostert, J.P.; Koch, M.W.; Heerings, M.; Heersema, D.J.; De Keyser, J. 2008: Therapeutic potential of fluoxetine in neurological disorders. Cns Neuroscience and Therapeutics 14(2): 153-164
Hosoi, T.; Baba, S.; Ozawa, K. 2014: Therapeutic potential of flurbiprofen against obesity in mice. Biochemical and Biophysical Research Communications 449(1): 132-134
Manzo-Silberman, S.ép.; Louedec, L.; Meilhac, O.; Letourneur, D.; Michel, J.-B.; Elmadbouh, I. 2011: Therapeutic potential of fucoidan in myocardial ischemia. Journal of Cardiovascular Pharmacology 58(6): 626-632
Pang, Y.J.; Tan, X.J.; Li, D.M.; Zheng, Z.H.; Lei, R.X.; Peng, X.M. 2013: Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus. Liver International: Official Journal of the International Association for the Study of the Liver 33(8): 1230-1238
Bartlett, R.S.; Thibeault, S.L.; Prestwich, G.D. 2012: Therapeutic potential of gel-based injectables for vocal fold regeneration. Biomedical Materials 7(2): 024103
Pal, S.N.; Kofidis, T. 2013: Therapeutic potential of genes in cardiac repair. Expert Review of Cardiovascular Therapy 11(8): 1015-1028
Hotta, M.; Ohwada, R.; Akamizu, T.; Shibasaki, T.; Kangawa, K. 2012: Therapeutic potential of ghrelin in restricting-type anorexia nervosa. Methods in Enzymology 514: 381-398
Hamed, M.A.; Ali, S.A.; El-Rigal, N.S. 2012: Therapeutic potential of ginger against renal injury induced by carbon tetrachloride in rats. Thescientificworldjournal 2012: 840421
Karmazyn, M.; Moey, M.; Gan, X.T. 2011: Therapeutic potential of ginseng in the management of cardiovascular disorders. Drugs 71(15): 1989-2008
Arushanian, E.B. 2009: Therapeutic potential of ginseng root preparations in treating diabetes mellitus. Eksperimental'naia i Klinicheskaia Farmakologiia 72(6): 52-56
Keshmiri-Neghab, H.; Goliaei, B. 2014: Therapeutic potential of gossypol: an overview. Pharmaceutical Biology 52(1): 124-128
Gupta, S.Kumar.; Agarwal, R.; Srivastava, S.; Mathur, R.; Galpalli, N.D.; Agrawal, S.Sunder. 2007: Therapeutic potential of green tea: a new horizon in drug discovery. Expert Opinion on Drug Discovery 2(3): 349-359
Wölnerhanssen, B.; Beglinger, C. 2010: Therapeutic potential of gut peptides. Forum of Nutrition 63: 54-63
Yokozawa, T.; Kang, K.S.; Yamabe, N.; Kim, H.Y. 2007: Therapeutic potential of heat-processed Panax ginseng with respect to oxidative tissue damage. Drug Discoveries and Therapeutics 1(1): 30-44
Ruyssers, N.E.; De Winter, B.Y.; De Man, J.G.; Loukas, A.; Pearson, M.S.; Weinstock, J.V.; Van den Bossche, R.M.; Martinet, W.; Pelckmans, P.A.; Moreels, T.G. 2009: Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflammatory Bowel Diseases 15(4): 491-500
Bouhassira, E.E. 2013: Therapeutic potential of hematopoietic cells derived from pluripotent stem cells. Expert Opinion on Biological Therapy 13(8): 1099-1102
Constantin, M.; Choi, A.J.S.; Cloonan, S.M.; Ryter, S.W. 2012: Therapeutic potential of heme oxygenase-1/carbon monoxide in lung disease. International Journal of Hypertension 2012: 859235
Gao, C.-F.; Xie, Q.; Zhang, Y.-W.; Su, Y.; Zhao, P.; Cao, B.; Furge, K.; Sun, J.; Rex, K.; Osgood, T.; Coxon, A.; Burgess, T.L.; Vande Woude, G.F. 2009: Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma. Molecular Cancer Therapeutics 8(10): 2803-2810
Gupta, Y.K.; Briyal, S.; Gulati, A. 2010: Therapeutic potential of herbal drugs in cerebral ischemia. Indian Journal of Physiology and Pharmacology 54(2): 99-122
Mimura, K.; Kamiya, T.; Shiraishi, K.; Kua, L.-F.; Shabbir, A.; So, J.; Yong, W.-P.; Suzuki, Y.; Yoshimoto, Y.; Nakano, T.; Fujii, H.; Campana, D.; Kono, K. 2014: Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer. International Journal of Cancer 135(6): 1390-1398
Chazot, P.L. 2010: Therapeutic potential of histamine H3 receptor antagonists in dementias. Drug News and Perspectives 23(2): 99-103
Martinel Lamas, D.J.; Croci, M.; Carabajal, E.; Crescenti, E.J.V.; Sambuco, L.; Massari, N.A.; Bergoc, R.M.; Rivera, E.S.; Medina, V.A. 2013: Therapeutic potential of histamine H₄ receptor agonists in triple-negative human breast cancer experimental model. British Journal of Pharmacology 170(1): 188-199
Alleva, L.; Tirelli, E.; Brabant, C. 2013: Therapeutic potential of histaminergic compounds in the treatment of addiction and drug-related cognitive disorders. Behavioural Brain Research 237: 357-368
Feng, W.; Zhang, B.; Cai, D.; Zou, X. 2014: Therapeutic potential of histone deacetylase inhibitors in pancreatic cancer. Cancer Letters 347(2): 183-190
Liu, G.; Neumeister, M.; Reichensperger, J.; Yang, R.D. 2013: Therapeutic potential of human adipose stem cells in a cancer stem cell-like gastric cancer cell model. International Journal of Oncology 43(4): 1301-1309
Hwangbo, S.; Kim, J.; Her, S.; Cho, H.; Lee, J. 2010: Therapeutic potential of human adipose stem cells in a rat myocardial infarction model. Yonsei Medical Journal 51(1): 69-76
García-Contreras, M.; Vera-Donoso, C.és.D.; Hernández-Andreu, J.é M.; García-Verdugo, J.é M.; Oltra, E. 2014: Therapeutic potential of human adipose-derived stem cells (ADSCs) from cancer patients: a pilot study. Plos one 9(11): E113288
Chang, K.-A.; Lee, J.-H.; Suh, Y.-H. 2014: Therapeutic potential of human adipose-derived stem cells in neurological disorders. Journal of Pharmacological Sciences 126(4): 293-301
Cooper, G.J. 1998: Therapeutic potential of human amylin analogues in diabetes mellitus. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 10(1): 1-9
Shaw, L.; Wiedow, O. 2011: Therapeutic potential of human elafin. Biochemical Society Transactions 39(5): 1450-1454
Moslem, M.; Valojerdi, M.R.; Pournasr, B.; Muhammadnejad, A.; Baharvand, H. 2013: Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure. Cell Transplantation 22(10): 1785-1799
Chang, D.-J.; Lee, N.; Park, I.-H.; Choi, C.; Jeon, I.; Kwon, J.; Oh, S.-H.; Shin, D.A.; Do, J.T.; Lee, D.R.; Lee, H.; Moon, H.; Hong, K.S.; Daley, G.Q.; Song, J. 2013: Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplantation 22(8): 1427-1440
Gao, P.; Ding, Q.; Wu, Z.; Jiang, H.; Fang, Z. 2010: Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Letters 290(2): 157-166
Wu, K.H.; Zhou, B.; Yu, C.T.; Cui, B.; Lu, S.H.; Han, Z.C.; Liu, Y.L. 2007: Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Annals of Thoracic Surgery 83(4): 1491-1498
Liu, Y.; Mu, R.; Wang, S.; Long, L.; Liu, X.; Li, R.; Sun, J.; Guo, J.; Zhang, X.; Guo, J.; Yu, P.; Li, C.; Liu, X.; Huang, Z.; Wang, D.; Li, H.; Gu, Z.; Liu, B.; Li, Z. 2010: Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Research and Therapy 12(6): R210
Kajal, A.; Bala, S.; Sharma, N.; Kamboj, S.; Saini, V. 2014: Therapeutic potential of hydrazones as anti-inflammatory agents. International Journal of Medicinal Chemistry 2014: 761030
Cruden, N.L.M.; Newby, D.E. 2008: Therapeutic potential of icatibant (HOE-140, JE-049). Expert Opinion on PharmacoTherapy 9(13): 2383-2390
Li, H.; Gao, F.; Ma, L.; Jiang, J.; Miao, J.; Jiang, M.; Fan, Y.; Wang, L.; Wu, D.; Liu, B.; Wang, W.; Lui, V.C.H.; Yuan, Z. 2012: Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta. Journal of Cellular and Molecular Medicine 16(7): 1606-1617
Hong, J.Y.; Lee, S.H.; Lee, S.C.; Kim, J.-W.; Kim, K.-P.; Kim, S.M.; Tapia, N.; Lim, K.T.; Kim, J.; Ahn, H.-S.; Ko, K.; Shin, C.Y.; Lee, H.T.; Schöler, H.R.; Hyun, J.K.; Han, D.W. 2014: Therapeutic potential of induced neural stem cells for spinal cord injury. Journal of Biological Chemistry 289(47): 32512-32525
Nori, S.; Tsuji, O.; Okada, Y.; Toyama, Y.; Okano, H.; Nakamura, M. 2012: Therapeutic potential of induced pluripotent stem cells for spinal cord injury. Brain and Nerve 64(1): 17-27
Richards, A.M. 2009: Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction. Heart 95(16): 1299-1300
Chopra, P.; Kanoje, V.; Semwal, A.; Ray, A. 2008: Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases. Expert Opinion on Investigational Drugs 17(10): 1411-1425
Froesch, E.R.; Guler, H.P.; Schmid, C.; Binz, K.; Zapf, J. 1990: Therapeutic potential of insulinlike growth factor i. Trends in Endocrinology and Metabolism: Tem 1(5): 254-260
Mathews, S.; Gao, B. 2013: Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease. Hepatology 57(5): 2078-2080
Yan, J.-W.; Wang, Y.-J.; Peng, W.-J.; Tao, J.-H.; Wan, Y.-N.; Li, B.-Z.; Mei, B.; Chen, B.; Yao, H.; Yang, G.-J.; Li, X.-P.; Ye, D.-Q.; Wang, J. 2014: Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases. Expert Opinion on Therapeutic Targets 18(1): 29-41
Brietzke, E.; Scheinberg, M.; Lafer, B. 2011: Therapeutic potential of interleukin-6 antagonism in bipolar disorder. Medical Hypotheses 76(1): 21-23
Navarrete-Opazo, A.; Mitchell, G.S. 2014: Therapeutic potential of intermittent hypoxia: a matter of dose. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 307(10): R1181-R1197
Kollar, K.; Seifried, E.; Henschler, R. 2011: Therapeutic potential of intravenously administered human mesenchymal stromal cells. Hamostaseologie 31(4): 269-274
Shahsuvaryan, M.L. 2012: Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion. International Journal of Ophthalmology 5(6): 759-770
Hershko, C.; Link, G.; Tzahor, M.; Pinson, A. 1994: Therapeutic potential of iron chelating therapy: modification of disease by iron depletion. Metal-Based Drugs 1(2-3): 83-86
Yu, Z.; Zhang, X.; Ren, P.; Zhang, M.; Qian, J. 2012: Therapeutic potential of irreversible electroporation in sarcoma. Expert Review of Anticancer Therapy 12(2): 177-184
Weïwer, M.; Lewis, M.C.; Wagner, F.F.; Holson, E.B. 2013: Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia. Future Medicinal Chemistry 5(13): 1491-1508
Matute, C. 2011: Therapeutic potential of kainate receptors. Cns Neuroscience and Therapeutics 17(6): 661-669
O'Sullivan, M. 2011: Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum. Gut 60(3): 423; Author Rpely 423
Razzaque, M.S. 2010: Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372. Expert Opinion on Therapeutic Patents 20(7): 981-985
Campanha-Rodrigues, A.L.; Grazioli, G.; Oliveira, T.C.; Campos-Lisbôa, A.C.V.; Mares-Guia, T.R.; Sogayar, M.C. 2015: Therapeutic potential of laminin-biodritin microcapsules for type 1 diabetes mellitus. Cell Transplantation 24(2): 247-261
Ebner, F.; Hepworth, M.R.; Rausch, S.; Janek, K.; Niewienda, A.; Kühl, A.; Henklein, P.; Lucius, R.; Hamelmann, E.; Hartmann, S. 2014: Therapeutic potential of larval excretory/secretory proteins of the pig whipworm Trichuris suis in allergic disease. Allergy 69(11): 1489-1497
Leggio, A.; Catalano, S.; De Marco, R.; Barone, I.; Andò, S.; Liguori, A. 2014: Therapeutic potential of leptin receptor modulators. European Journal of Medicinal Chemistry 78: 97-105
Du, J.; Wang, Z. 2009: Therapeutic potential of lipase inhibitor orlistat in Alzheimer's disease. Medical Hypotheses 73(5): 662-663
Wetsel, R.A.; Wang, D.; Calame, D.G. 2011: Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells. Annual Review of Medicine 62: 95-105
Rennel, E.S.; Harper, S.J.; Bates, D.O. 2009: Therapeutic potential of manipulating VEGF splice isoforms in oncology. Future Oncology 5(5): 703-712
Dev, R.; Srivastava, P.K.; Iyer, J.P.; Dastidar, S.G.; Ray, A. 2010: Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain. Expert Opinion on Investigational Drugs 19(4): 455-468
Ogura, Y.; Tajrishi, M.M.; Sato, S.; Hindi, S.M.; Kumar, A. 2014: Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy. Frontiers in Cell and Developmental Biology 2: 11
Arushanian, É B.; Karakov, K.G.; Él'bek'ian, K.S. 2012: Therapeutic potential of melatonin in oral cavity diseases. Eksperimental'naia i Klinicheskaia Farmakologiia 75(6): 48-52
Samantaray, S.; Das, A.; Thakore, N.P.; Matzelle, D.D.; Reiter, R.J.; Ray, S.K.; Banik, N.L. 2009: Therapeutic potential of melatonin in traumatic central nervous system injury. Journal of Pineal Research 47(2): 134-142
Yuniartha, R.; Alatas, F.S.; Nagata, K.; Kuda, M.; Yanagi, Y.; Esumi, G.; Yamaza, T.; Kinoshita, Y.; Taguchi, T. 2014: Therapeutic potential of mesenchymal stem cell transplantation in a nitrofen-induced congenital diaphragmatic hernia rat model. Pediatric Surgery International 30(9): 907-914
Kim, R.H.; Mehrazarin, S.; Kang, M.K. 2012: Therapeutic potential of mesenchymal stem cells for oral and systemic diseases. Dental Clinics of North America 56(3): 651-675
Matthay, M.A.; Thompson, B.T.; Read, E.J.; McKenna, D.H.; Liu, K.D.; Calfee, C.S.; Lee, J.W. 2010: Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 138(4): 965-972
Patel, D.M.; Shah, J.; Srivastava, A.S. 2013: Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells International 2013: 496218
Cho, J.-W.; Lee, C.-Y.; Ko, Y. 2012: Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues. Journal of Gastroenterology and Hepatology 27(8): 1362-1370
Ren, C.; Kumar, S.; Chanda, D.; Chen, J.; Mountz, J.D.; Ponnazhagan, S. 2008: Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells 26(9): 2332-2338
Sun, H.; Bénardais, K.; Stanslowsky, N.; Thau-Habermann, N.; Hensel, N.; Huang, D.; Claus, P.; Dengler, R.; Stangel, M.; Petri, S. 2013: Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia. Plos one 8(9): E72926
Dube, A.; Chaudhary, S.; Mengawade, T.; Upasani, C.D. 2014: Therapeutic potential of metabotropic glutamate receptor 4-positive allosteric modulator TAS-4 in rodent models of movement disorders. Journal of the Neurological Sciences 2014
Cho, S.W.; Yi, K.H.; Han, S.K.; Sun, H.J.; Kim, Y.A.; Oh, B.-C.; Park, Y.J.; Park, D.J. 2014: Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo. Molecular and Cellular Endocrinology 393(1-2): 24-29
Chiu, S.-C.; Chung, H.-Y.; Cho, D.-Y.; Chan, T.-M.; Liu, M.-C.; Huang, H.-M.; Li, T.-Y.; Lin, J.-Y.; Chou, P.-C.; Fu, R.-H.; Yang, W.-K.; Harn, H.-J.; Lin, S.-Z. 2014: Therapeutic potential of microRNA let-7: tumor suppression or impeding normal stemness. Cell Transplantation 23(4-5): 459-469
Guo, C.-J.; Pan, Q.; Xiong, H.; Qiao, Y.-Q.; Bian, Z.-L.; Zhong, W.; Sheng, L.; Li, H.; Shen, L.; Hua, J.; Ma, X. 2014: Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?. Biomed Research International 2014: 797898
Dorn, G.W. 2010: Therapeutic potential of micro RNAs in heart failure. Current Cardiology Reports 12(3): 209-215
Kadomatsu, K.; Bencsik, P.ét.; Görbe, A.ó; Csonka, C.; Sakamoto, K.; Kishida, S.; Ferdinandy, P.ét. 2014: Therapeutic potential of midkine in cardiovascular disease. British Journal of Pharmacology 171(4): 936-944
Gelsinger, C.; Steinhagen-Thiessen, E.; Kassner, U. 2012: Therapeutic potential of mipomersen in the management of familial hypercholesterolaemia. Drugs 72(11): 1445-1455
Schimmer, A.D.; Skrtić, M. 2012: Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia. Expert Review of Hematology 5(2): 117-119
Heeba, G.H.; Mahmoud, M.E. 2014: Therapeutic potential of morin against liver fibrosis in rats: modulation of oxidative stress, cytokine production and nuclear factor kappa B. Environmental Toxicology and Pharmacology 37(2): 662-671
Basyoni, M.M.A.; El-Sabaa, A.-A.A. 2013: Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice. Korean Journal of Parasitology 51(3): 297-304
Fetterman, J.W.; Zdanowicz, M.M. 2009: Therapeutic potential of n-3 polyunsaturated fatty acids in disease. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 66(13): 1169-1179
Kaur, V.; Garg, T.; Rath, G.; Goyal, A.K. 2014: Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. Journal of Drug Targeting 22(10): 859-870
Mythri, R.B.; Harish, G.; Bharath, M.M. 2012: Therapeutic potential of natural products in Parkinson's disease. Recent Patents on Endocrine Metabolic and Immune Drug Discovery 6(3): 181-200
Sahebkar, A. 2015: Therapeutic potential of negatively charged liposomes for atherosclerotic vascular disease: reverse delivery of cholesterol cargo from atheroma to liver. Journal of Liposome Research 25(2): 174
Merrill, D.A.; Blesch, A.; Tuszynski, M.H. 2002: Therapeutic potential of nervous system growth factors for neurodegenerative disease. Expert Review of Neurotherapeutics 2(1): 89-96
Cattaneo, E.; Bonfanti, L. 2014: Therapeutic potential of neural stem cells: greater in people's perception than in their brains?. Frontiers in Neuroscience 8: 79
Mathie, A.; Veale, E.L. 2007: Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Current Opinion in Investigational Drugs 8(7): 555-562
Brothers, S.P.; Wahlestedt, C. 2010: Therapeutic potential of neuropeptide y (NPY) receptor ligands. Embo Molecular Medicine 2(11): 429-439
Urbinati, G.; Audisio, D.; Marsaud, V.ér.; Plassat, V.; Arpicco, S.; Sola, B.; Fattal, E.; Renoir, J.-M. 2010: Therapeutic potential of new 4-hydroxy-tamoxifen-loaded pH-gradient liposomes in a multiple myeloma experimental model. Pharmaceutical Research 27(2): 327-339
Sparatore, A.; Santus, G.; Giustarini, D.; Rossi, R.; Del Soldato, P. 2011: Therapeutic potential of new hydrogen sulfide-releasing hybrids. Expert Review of Clinical Pharmacology 4(1): 109-121
McElroy, S.L.; Guerdjikova, A.; Mori, N.; Keck, P.E. 2010: Therapeutic potential of new second generation antipsychotics for major depressive disorder. Expert Opinion on Investigational Drugs 19(12): 1527-1544
Mizoguchi, H.; Arai, S.; Koike, H.; Ibi, D.; Kamei, H.; Nabeshima, T.; Kim, H.-C.; Takuma, K.; Yamada, K. 2009: Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons. Psychopharmacology 207(2): 235-243
Nakajima, N.; Ueda, M.; Higashi, N.; Katayama, Y. 2013: Therapeutic potential of nicotinic acid in erythromelalgia associated with Clitocybe acromelalga intoxication. Clinical Toxicology 51(8): 815
Drago, F.; Bucolo, C. 2010: Therapeutic potential of nitric oxide modulation in ocular diseases. Drug News and Perspectives 23(7): 430-437
Andreou, A.P.; Goadsby, P.J. 2009: Therapeutic potential of novel glutamate receptor antagonists in migraine. Expert Opinion on Investigational Drugs 18(6): 789-803
Rahman, S.; Patel, Y.M.; Wijelath, E.S.; Sobel, M.S. 2008: Therapeutic potential of novel modulators of neovascularization. Future Cardiology 4(4): 409-426
Lorusso, P.M.; Eder, J.P. 2008: Therapeutic potential of novel selective-spectrum kinase inhibitors in oncology. Expert Opinion on Investigational Drugs 17(7): 1013-1028
Grassi, G.; Scaggiante, B.; Dapas, B.; Farra, R.; Tonon, F.; Lamberti, G.; Barba, A.; Fiorentino, S.; Fiotti, N.; Zanconati, F.; Abrami, M.; Grassi, M. 2013: Therapeutic potential of nucleic acid-based drugs in coronary hyper- proliferative vascular diseases. Current Medicinal Chemistry 20(28): 3515-3538
Bhadra, K.; Kumar, G.S. 2011: Therapeutic potential of nucleic acid-binding isoquinoline alkaloids: binding aspects and implications for drug design. Medicinal Research Reviews 31(6): 821-862
Latha, R.C.R.; Daisy, P. 2013: Therapeutic potential of octyl gallate isolated from fruits of Terminalia bellerica in streptozotocin-induced diabetic rats. Pharmaceutical Biology 51(6): 798-805
Chiu, S.-C.; Hung, H.-S.; Lin, S.-Z.; Chiang, E.; Liu, D.D. 2009: Therapeutic potential of olfactory ensheathing cells in neurodegenerative diseases. Journal of Molecular Medicine 87(12): 1179-1189
Hylek, E.M. 2010: Therapeutic potential of oral factor Xa inhibitors. New England Journal of Medicine 363(26): 2559-2561
Fisk, M.; Gajendragadkar, P.R.; Mäki-Petäjä, K.M.; Wilkinson, I.B.; Cheriyan, J. 2014: Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 14(3): 155-165
Kim, D.; Lee, M-S.; Jo, K.; Lee, K-E.; Hwang, J-K. 2011: Therapeutic potential of panduratin A, LKB1-dependent AMP-activated protein kinase stimulator, with activation of PPARα/δ for the treatment of obesity. Diabetes Obesity and Metabolism 13(7): 584-593
Sharma, A.; Khuller, G.K.; Kanwar, A.J.; Sharma, S. 2010: Therapeutic potential of peptide deformylase inhibitors against experimental tuberculosis. Journal of Infection 60(6): 498-501
Hervé, J.-C. 2009: Therapeutic potential of peptide motifs--part Ii. Current Pharmaceutical Design 15(21): 2375-2376
Beraud, E.; Chandy, K.G. 2011: Therapeutic potential of peptide toxins that target ion channels. Inflammation and Allergy Drug Targets 10(5): 322-342
Wu, Y.; Tang, K.; Huang, R.-Q.; Zhuang, Z.; Cheng, H.-L.; Yin, H.-X.; Shi, J.-X. 2011: Therapeutic potential of peroxisome proliferator-activated receptor γ agonist rosiglitazone in cerebral vasospasm after a rat experimental subarachnoid hemorrhage model. Journal of the Neurological Sciences 305(1-2): 85-91
Wang, D.; DuBois, R.N. 2010: Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer. Gastroenterology Clinics of North America 39(3): 697-707
Han, K.L.; Choi, J.S.; Lee, J.Y.; Song, J.; Joe, M.K.; Jung, M.H.; Hwang, J.-K. 2008: Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes. Diabetes 57(3): 737-745
Hill, M.A.; Meininger, G.A.; Davis, M.J.; Laher, I. 2009: Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends in Pharmacological Sciences 30(7): 363-374
Shakur, Y.; de Koning, H.P.; Ke, H.; Kambayashi, J.; Seebeck, T. 2011: Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases. Handbook of Experimental Pharmacology 204: 487-510
Agrawal, A. 2008: Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis. Future Lipidology 3(6)
Tamura, N.; Haruta, K. 2007: Therapeutic potential of phosphoinositide 3-kinase inhibitors in rheumatoid arthritis. Nihon Rinsho Men'eki Gakkai Kaishi 30(5): 369-374
Rau, S.; Zheng, S. 2012: Therapeutic potential of photochemically active metal complexes based on interaction with enzymes. Current Topics in Medicinal Chemistry 12(3): 197-209
Miki, T.; Grubbs, B. 2014: Therapeutic potential of placenta-derived stem cells for liver diseases: current status and perspectives. Journal of Obstetrics and Gynaecology Research 40(2): 360-368
Cohen, T.S.; Bucki, R.; Byfield, F.J.; Ciccarelli, N.J.; Rosenberg, B.; DiNubile, M.J.; Janmey, P.A.; Margulies, S.S. 2011: Therapeutic potential of plasma gelsolin administration in a rat model of sepsis. Cytokine 54(3): 235-238
Benameur, T.; Andriantsitohaina, R.; Martínez, M.Carmen. 2009: Therapeutic potential of plasma membrane-derived microparticles. Pharmacological Reports: Pr 61(1): 49-57
Brown, N.J. 2010: Therapeutic potential of plasminogen activator inhibitor-1 inhibitors. Therapeutic Advances in Cardiovascular Disease 4(5): 315-324
González-Iglesias, J. 2013: Therapeutic potential of platelet rich plasma. Reflections on its research and development. Revista Espanola de Cirugia Ortopedica y Traumatologia 57(4): 237-239
Drew, Y.; Mulligan, E.A.; Vong, W.-T.; Thomas, H.D.; Kahn, S.; Kyle, S.; Mukhopadhyay, A.; Los, G.; Hostomsky, Z.; Plummer, E.R.; Edmondson, R.J.; Curtin, N.J. 2011: Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2. Journal of the National Cancer Institute 103(4): 334-346
Suzuki, S.; Nakasato, M.; Shibue, T.; Koshima, I.; Taniguchi, T. 2009: Therapeutic potential of proapoptotic molecule Noxa in the selective elimination of tumor cells. Cancer Science 100(4): 759-769
Amano, H.; Hino, H.; Tateno, C.; Emoto, K.; Imaoka, Y.; Yamasaki, C.; Itamoto, T.; Tashiro, H.; Asahara, T.; Ohdan, H.; Yoshizato, K. 2011: Therapeutic potential of propagated hepatocyte transplantation in liver failure. Journal of Surgical Research 167(1): E29-E37
Gazzerro, E.; Assereto, S.; Bonetto, A.; Sotgia, F.; Scarfì, S.; Pistorio, A.; Bonuccelli, G.; Cilli, M.; Bruno, C.; Zara, F.; Lisanti, M.P.; Minetti, C. 2010: Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies. American Journal of Pathology 176(4): 1863-1877
Blouin, J.-M.; Duchartre, Y.; Costet, P.; Lalanne, M.; Ged, C.éc.; Lain, A.; Millet, O.; de Verneuil, H.; Richard, E. 2013: Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria. Proceedings of the National Academy of Sciences of the United States of America 110(45): 18238-18243
Bhakkiyalakshmi, E.; Shalini, D.; Sekar, T.V.; Rajaguru, P.; Paulmurugan, R.; Ramkumar, K.M. 2014: Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2. British Journal of Pharmacology 171(7): 1747-1757
Burnstock, G. 2011: Therapeutic potential of purinergic signalling for diseases of the urinary tract. Bju International 107(2): 192-204
Larson, A.J.; Symons, J.David.; Jalili, T. 2012: Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Advances in Nutrition 3(1): 39-46
Böhm, M.; Ewen, S.; Linz, D.; Reil, J.-C.; Schirmer, S.H.; Ukena, C.; Mahfoud, F. 2013: Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 9 Suppl R: R122-R126
Fumal, A.; Schoenen, J.; de Noordhout, A.M.; Pitchot, W. 2008: Therapeutic potential of repetitive transcranial magnetic stimulation in brain disorders. Revue Medicale de Liege 63(5-6): 330-337
Peerlinck, I.; Amini-Nik, S.; Phillips, R.K.; Iggo, R.; Lemoine, N.R.; Tejpar, S.; Vassaux, G. 2008: Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(19): 6187-6192
Lee, H-Na.; Surh, Y-Joon. 2012: Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. Biochemical Pharmacology 84(10): 1340-1350
Vingtdeux, V.ér.; Dreses-Werringloer, U.; Zhao, H.; Davies, P.; Marambaud, P. 2008: Therapeutic potential of resveratrol in Alzheimer's disease. Bmc Neuroscience 9(Suppl 2): S6
Ciddi, V.; Dodda, D. 2014: Therapeutic potential of resveratrol in diabetic complications: in vitro and in vivo studies. Pharmacological Reports: Pr 66(5): 799-803
Pinaire, J.A.; Reifel-Miller, A. 2007: Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome. Ppar Research 2007: 94156
Kwong, L.M. 2011: Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data. Vascular Health and Risk Management 7: 461-466
Tiekink, E.R.T. 2012: Therapeutic potential of selenium and tellurium compounds: opportunities yet unrealised. Dalton Transactions 41(21): 6390-6395
Suda, K.; Guo, C.; Oishi, A.; Ikeda, S.; Uemura, A.; Yoshimura, N. 2014: Therapeutic potential of semaphorin 3E for the treatment of choroidal neovascularization. Investigative Ophthalmology and Visual Science 55(8): 4700-4706
Lutz, M.B. 2012: Therapeutic potential of semi-mature dendritic cells for tolerance induction. Frontiers in Immunology 3: 123
Huang, Y.T.; Cheng, C.C.; Lin, T.C.; Chiu, T.H.; Lai, P.C. 2014: Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells. Oncology Reports 31(2): 771-780
Lang, F.; Voelkl, J. 2013: Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opinion on Investigational Drugs 22(6): 701-714
Karnati, H.K.; Yalagala, R.S.; Undi, R.; Pasupuleti, S.R.; Gutti, R.K. 2014: Therapeutic potential of siRNA and DNAzymes in cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(10): 9505-9521
Yang, D.; Song, X.; Zhang, J.; Ye, L.; Wang, S.; Che, X.; Wang, J.; Zhang, Z.; Wang, L.; Shi, W. 2010: Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells. Acta Biochimica et Biophysica Sinica 42(2): 137-144
Gondi, C.S.; Rao, J.S. 2009: Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases. Methods in Molecular Biology 487: 267-281
Dumitrescu, D.; Seck, C.ér.; Möhle, L.; Erdmann, E.; Rosenkranz, S. 2012: Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension. International Journal of Cardiology 154(2): 205-206
Gan, L. 2007: Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease. Drug News and Perspectives 20(4): 233-239
Gurevich, E.V.; Gurevich, V.V. 2014: Therapeutic potential of small molecules and engineered proteins. Handbook of Experimental Pharmacology 219: 1-12
Pardon, M.-C. 2011: Therapeutic potential of some stress mediators in early Alzheimer's disease. Experimental Gerontology 46(2-3): 170-173
Song, G.-Q.; Sun, Y.; Foreman, R.D.; Chen, J.D.Z. 2014: Therapeutic potential of spinal cord stimulation for gastrointestinal motility disorders: a preliminary rodent study. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 26(3): 377-384
Perova, T.; Grandal, I.; Nutter, L.M.J.; Papp, E.; Matei, I.R.; Beyene, J.; Kowalski, P.E.; Hitzler, J.K.; Minden, M.D.; Guidos, C.J.; Danska, J.S. 2014: Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia. Science Translational Medicine 6(236): 236ra62
Bauman, J.; Jearawiriyapaisarn, N.; Kole, R. 2009: Therapeutic potential of splice-switching oligonucleotides. Oligonucleotides 19(1): 1-13
Ramma, W.; Ahmed, A. 2014: Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia. Journal of Reproductive Immunology 101-102: 153-160
Markovic-Plese, S.; Singh, A.K.; Singh, I. 2008: Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair. Future Neurology 3(2): 153
Li, J.; Li, M.; Niu, B.; Gong, J. 2011: Therapeutic potential of stem cell in liver regeneration. Frontiers of Medicine 5(1): 26-32
Yi, B.-R.; Choi, K.J.; Kim, S.U.; Choi, K.-C. 2012: Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review). International Journal of Oncology 41(3): 798-804
Bahney, C.S.; Miclau, T. 2012: Therapeutic potential of stem cells in orthopedics. Indian Journal of Orthopaedics 46(1): 4-9
Zhang, C.-p.; Fu, X.-b. 2008: Therapeutic potential of stem cells in skin repair and regeneration. Chinese Journal of Traumatology 11(4): 209-221
Annapurna, A.; Challa, S.R.; Prakash, G.J.; Viswanath, R.K. 2008: Therapeutic potential of sulindac against ischemia-reperfusion-induced myocardial infarction in diabetic and nondiabetic rats. Experimental and Clinical Cardiology 13(2): 66-70
Fogli, S.; Banti, I.; Stefanelli, F.; Picchianti, L.; Digiacomo, M.; Macchia, M.; Breschi, M.C.; Lapucci, A. 2010: Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells. European Journal of Medicinal Chemistry 45(11): 5100-5107
Chua, T.C.; Morris, D.L. 2012: Therapeutic potential of surgery for metastatic colorectal cancer. Scandinavian Journal of Gastroenterology 47(3): 258-268
Sun, S.-Y. 2008: Therapeutic potential of synthetic triterpenoids in neuroblastoma. Cancer Biology and Therapy 7(5): 718-720
Ko, S.-F.; Yip, H.-K.; Leu, S.; Lee, C.-C.; Sheu, J.-J.; Lee, C.-C.; Ng, S.-H.; Huang, C.-C.; Chen, M.-C.; Sun, C.-K. 2014: Therapeutic potential of tacrolimus on acute myocardial infarction in minipigs: analysis with serial cardiac magnetic resonance and changes at histological and protein levels. Biomed Research International 2014: 524078
Alshaker, H.; Sauer, L.; Monteil, D.; Ottaviani, S.; Srivats, S.; Böhler, T.; Pchejetski, D. 2013: Therapeutic potential of targeting SK1 in human cancers. Advances in Cancer Research 117: 143-200
Doherty, T.A.; Croft, M. 2011: Therapeutic potential of targeting TNF/TNFR family members in asthma. ImmunoTherapy 3(8): 919-921
Philibert, R.A.; Gershenfeld, H.K. 2007: Therapeutic potential of targeting gene variants in schizophrenia. Expert Review of Neurotherapeutics 7(7): 757-760
Nakano, I. 2014: Therapeutic potential of targeting glucose metabolism in glioma stem cells. Expert Opinion on Therapeutic Targets 18(11): 1233-1236
Finlay, C.; Duty, S. 2014: Therapeutic potential of targeting glutamate receptors in Parkinson's disease. Journal of Neural Transmission 121(8): 861-880
Duty, S. 2010: Therapeutic potential of targeting group IIi metabotropic glutamate receptors in the treatment of Parkinson's disease. British Journal of Pharmacology 161(2): 271-287
Cheung, K.J.; Ebert, B.L. 2009: Therapeutic potential of targeting haploinsufficient genes in cancer. Pediatric Blood and Cancer 53(2): 131-132
Hamilton, J.A. 2013: Therapeutic potential of targeting inflammation. Inflammation Research: Official Journal of the European Histamine Research Society . 62(7): 653-657
McDowell, R.E.; McGeown, J.G.; Stitt, A.W.; Curtis, T.M. 2013: Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease. Future Medicinal Chemistry 5(2): 189-211
Evangelisti, C.; Evangelisti, C.; Chiarini, F.; Lonetti, A.; Buontempo, F.; Bressanin, D.; Cappellini, A.; Orsini, E.; McCubrey, J.A.; Martelli, A.M. 2014: Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (review). International Journal of Oncology 45(3): 909-918
Dickerson, J.W.; Conn, P.J. 2012: Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease. Neurodegenerative Disease Management 2(2): 221-232
Zeng, L.-F.; Zhang, R.-Y.; Yu, Z.-H.; Li, S.; Wu, L.; Gunawan, A.M.; Lane, B.S.; Mali, R.S.; Li, X.; Chan, R.J.; Kapur, R.; Wells, C.D.; Zhang, Z.-Y. 2014: Therapeutic potential of targeting the oncogenic SHP2 phosphatase. Journal of Medicinal Chemistry 57(15): 6594-6609
Herath, C.B.; Grace, J.A.; Angus, P.W. 2013: Therapeutic potential of targeting the renin angiotensin system in portal hypertension. World Journal of Gastrointestinal Pathophysiology 4(1): 1-11
Zhu, L.; Lau, G.W. 2013: Therapeutic potential of the Streptococcus pneumoniae competence regulon. Expert Review of AntI-Infective Therapy 11(3): 227-229
Yoriki, R.; Akashi, S.; Sho, M.; Nomi, T.; Yamato, I.; Hotta, K.; Takayama, T.; Matsumoto, S.; Wakatsuki, K.; Migita, K.; Yagita, H.; Nakajima, Y. 2011: Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer. Experimental and Therapeutic Medicine 2(1): 103-108
Reddi, A.; Powers, M.A.; Dellavalle, R.P. 2014: Therapeutic potential of the anti-diabetic agent metformin in targeting the skin cancer stem cell diaspora. Experimental Dermatology 23(5): 345-346
Li, S.-A.; Liu, J.; Xiang, Y.; Wang, Y.-J.; Lee, W.-H.; Zhang, Y. 2014: Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis. Antimicrobial Agents and ChemoTherapy 58(6): 3144-3150
Rogosnitzky, M.; Danks, R. 2011: Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions. Pharmacological Reports: Pr 63(2): 337-347
D'Haese, J.G.; Friess, H.; Ceyhan, Güralp.O. 2012: Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update. Expert Opinion on Therapeutic Targets 16(6): 613-618
Morrison, G.; Fu, X.; Shea, M.; Nanda, S.; Giuliano, M.; Wang, T.; Klinowska, T.; Osborne, C.K.; Rimawi, M.F.; Schiff, R. 2014: Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance. Breast Cancer Research and Treatment 144(2): 263-272
Alonso-Alconada, D.; Álvarez, A.; Álvarez-Granda, L.; Hilario, E. 2011: Therapeutic potential of the endocannabinoid system in perinatal asphyxia. Revista de Neurologia 53(12): 758-764
Mohd, S.M.A.; Abdul Manan, M.J. 2012: Therapeutic potential of the haruan (Channa striatus): from food to medicinal uses. Malaysian Journal of Nutrition 18(1): 125-136
Petrie Aronin, C.E.; Tuan, R.S. 2010: Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Research. Part C Embryo Today: Reviews 90(1): 67-74
Nelson, C.H.; Buttrick, B.R.; Isoherranen, N. 2013: Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics. Current Topics in Medicinal Chemistry 13(12): 1402-1428
Irwin, N.; Gault, V.; Flatt, P.R. 2010: Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?. Expert Opinion on Investigational Drugs 19(9): 1039-1048
Rothemund, S.; Sönnichsen, F.D.; Polte, T. 2013: Therapeutic potential of the peptide leucine arginine as a new nonplant bowman-birk-like serine protease inhibitor. Journal of Medicinal Chemistry 56(17): 6732-6744
Ihnen, M.; zu Eulenburg, C.; Kolarova, T.; Qi, J.W.; Manivong, K.; Chalukya, M.; Dering, J.; Anderson, L.; Ginther, C.; Meuter, A.; Winterhoff, B.; Jones, S.ân.; Velculescu, V.E.; Venkatesan, N.; Rong, H.-M.; Dandekar, S.; Udar, N.; Jänicke, F.; Los, G.; Slamon, D.J.; Konecny, G.E. 2013: Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer. Molecular Cancer Therapeutics 12(6): 1002-1015
Kogure, T.; Kinghorn, A.Douglas.; Yan, I.; Bolon, B.; Lucas, D.M.; Grever, M.R.; Patel, T. 2013: Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer. Plos one 8(9): E76136
Feldman, M.; Al-Quntar, A.; Polacheck, I.; Friedman, M.; Steinberg, D. 2014: Therapeutic potential of thiazolidinedione-8 as an antibiofilm agent against Candida albicans. Plos one 9(5): E93225
Stark, C.; Taimen, P.; Tarkia, M.; Pärkkä, J.; Saraste, A.; Alastalo, T.-P.; Savunen, T.; Koskenvuo, J. 2012: Therapeutic potential of thymosin β4 in myocardial infarct and heart failure. Annals of the new York Academy of Sciences 1269: 117-124
Cabezón, R.; Benítez-Ribas, D. 2013: Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application. Clinical and Developmental Immunology 2013: 789814
Tsai, W.-H.; Yang, C.-C.; Li, P.-C.; Chen, W.-C.; Chien, C.-T. 2013: Therapeutic potential of traditional chinese medicine on inflammatory diseases. Journal of Traditional and Complementary Medicine 3(3): 142-151
Rogosnitzky, M.; Danks, R.; Kardash, E. 2012: Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders. Anticancer Research 32(7): 2471-2478
Kikuchi, H.; Yagi, H.; Hasegawa, H.; Ishii, Y.; Okabayashi, K.; Tsuruta, M.; Hoshino, G.; Takayanagi, A.; Kitagawa, Y. 2014: Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer. Journal of Surgical Research 190(1): 134-143
Kitano, A.; Okada, Y.; Yamanka, O.; Shirai, K.; Mohan, R.R.; Saika, S. 2010: Therapeutic potential of trichostatin a to control inflammatory and fibrogenic disorders of the ocular surface. Molecular Vision 16: 2964-2973
Javed, Q.; Murtaza, I. 2013: Therapeutic potential of tumour necrosis factor-alpha antagonists in patients with chronic heart failure. Heart Lung and Circulation 22(5): 323-327
Liang, Y.; Zhu, Y.; Xia, Y.; Peng, H.; Yang, X.-K.; Liu, Y.-Y.; Xu, W.-D.; Pan, H.-F.; Ye, D.-Q. 2014: Therapeutic potential of tyrosine kinase 2 in autoimmunity. Expert Opinion on Therapeutic Targets 18(5): 571-580
Nikravesh, M.R.; Jalali, M.; Ghafaripoor, H.A.; Sanchooli, J.; Hamidi, D.; Mohammadi, S.; Seghatoleslam, M. 2011: Therapeutic potential of umbilical cord blood stem cells on brain damage of a model of stroke. Journal of Cardiovascular and Thoracic Research 3(4): 117-122
Sun, T.-J.; Tao, R.; Han, Y.-Q.; Xu, G.; Liu, J.; Han, Y.-F. 2014: Therapeutic potential of umbilical cord mesenchymal stem cells with Wnt/β-catenin signaling pathway pre-activated for the treatment of diabetic wounds. European Review for Medical and Pharmacological Sciences 18(17): 2460-2464
Wang, L.; Ji, H.; Zhou, J.; Xie, J.; Zhong, Z.; Li, M.; Bai, W.; Li, N.; Zhang, Z.; Wang, X.; Zhu, D.; Liu, Y.; Wu, M. 2013: Therapeutic potential of umbilical cord mesenchymal stromal cells transplantation for cerebral palsy: a case report. Case Reports in Transplantation 2013: 146347
Iwasaki, H.; Kawamoto, A.; Willwerth, C.; Horii, M.; Oyamada, A.; Akimaru, H.; Shibata, T.; Hirai, H.; Suehiro, S.; Wnendt, S.; Fodor, W.L.; Asahara, T. 2009: Therapeutic potential of unrestricted somatic stem cells isolated from placental cord blood for cardiac repair post myocardial infarction. Arteriosclerosis Thrombosis and Vascular Biology 29(11): 1830-1835
Shah, S.; Federoff, H.J. 2011: Therapeutic potential of vaccines for Alzheimer's disease. ImmunoTherapy 3(2): 287-298
Brown, M.J. 2008: Therapeutic potential of vaccines in the management of hypertension. Drugs 68(18): 2557-2560
Clemson, C.M.; Tzekov, R.; Krebs, M.; Checchi, J.M.; Bigelow, C.; Kaushal, S. 2011: Therapeutic potential of valproic acid for retinitis pigmentosa. British Journal of Ophthalmology 95(1): 89-93
Wong, G.Y.; Gavva, N.R. 2009: Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Brain Research Reviews 60(1): 267-277
Driscoll, M.; Hansen, R.; Ding, C.; Cramer, D.E.; Yan, J. 2009: Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy. Cancer Biology and Therapy 8(3): 218-225
White, C.M.; Ji, S.; Cai, H.; Maudsley, S.; Martin, B. 2010: Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. Cns and Neurological Disorders Drug Targets 9(5): 661-666
Ali, F.; Guglin, M.; Vaitkevicius, P.; Ghali, J.K. 2007: Therapeutic potential of vasopressin receptor antagonists. Drugs 67(6): 847-858
Izumi, Y.; Miura, K.; Iwao, H. 2014: Therapeutic potential of vasopressin-receptor antagonists in heart failure. Journal of Pharmacological Sciences 124(1): 1-6
Kato, T.; Node, K. 2014: Therapeutic potential of α-glucosidase inhibitors to prevent postprandial endothelial dysfunction. International Heart Journal 55(5): 386-390
Whalen, E.J.; Rajagopal, S.; Lefkowitz, R.J. 2011: Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends in Molecular Medicine 17(3): 126-139
Tanaka, T.; De Luca, L.M. 2009: Therapeutic potential of "rexinoids" in cancer prevention and treatment. Cancer Research 69(12): 4945-4947
Kakehata, J.; Yamaguchi, T.; Togashi, H.; Sakuma, I.; Otani, H.; Morimoto, Y.; Yoshioka, M. 2010: Therapeutic potentials of an artificial oxygen-carrier, liposome-encapsulated hemoglobin, for ischemia/reperfusion-induced cerebral dysfunction in rats. Journal of Pharmacological Sciences 114(2): 189-197
Al-Rashida, M.; Iqbal, J. 2014: Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors. Medicinal Research Reviews 34(4): 703-743
Deng, Y.; Wang, C.C.; Choy, K.W.; Du, Q.; Chen, J.; Wang, Q.; Li, L.; Chung, T.K.H.; Tang, T. 2014: Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Gene 538(2): 217-227
Newman, M.B.; Bakay, R.A.E. 2008: Therapeutic potentials of human embryonic stem cells in Parkinson's disease. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 5(2): 237-251
Fan, C.-G.; Zhang, Q.-j.; Zhou, J.-r. 2011: Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Reviews and Reports 7(1): 195-207
Galib; Barve, M.; Mashru, M.; Jagtap, C.; Patgiri, B.J.; Prajapati, P.K. 2011: Therapeutic potentials of metals in ancient India: a review through Charaka Samhita. Journal of Ayurveda and Integrative Medicine 2(2): 55-63
Li, N.; Xu, Z.; Wooley, P.H.; Zhang, J.; Yang, S.-Y. 2014: Therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments. Drug Design Development and Therapy 8: 1-11
Zhang, M.; Xu, Y.-J.; Mengi, S.A.; Arneja, A.S.; Dhalla, N.S. 2004: Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Experimental and Clinical Cardiology 9(2): 103-111
Nguyen, H.; Amanullah, A.M. 2014: Therapeutic potentials of phosphodiesterase-5 inhibitors in cardiovascular disease. Reviews in Cardiovascular Medicine 15(2): 158-167
Strauer, B.E.; Schannwell, C.M.; Brehm, M. 2009: Therapeutic potentials of stem cells in cardiac diseases. Minerva Cardioangiologica 57(2): 249-267
Alonso, Mía.José.; Albarracín, G.; Caminal, J.; Rodríguez, Núria. 2008: Therapeutic practice and products in complementary and alternative medicines. A regulated market or a free market?. Atencion Primaria 40(11): 571-575
Toth, P.P.; Foody, J.M.; Tomassini, J.E.; Sajjan, S.G.; Ramey, D.R.; Neff, D.R.; Tershakovec, A.M.; Hu, X.H.; Tunceli, K. 2014: Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease. Journal of Clinical Lipidology 8(1): 107-116
De Souza, A.C.êa.; Lopes, M.J.M. 2007: Therapeutic practices among elders in Porto Alegre: a qualitative approach. Revista da Escola de Enfermagem da U S P 41(1): 52-56
Marin, B. 1999: Therapeutic practices, medico-legal skills: new approaches to the history of medicine. Studi Storici 40(2): 629-641
Ito, K.; Imafuku, S.; Nakayama, J. 2013: Therapeutic preferences are different in psoriatic and atopic dermatitis patients: a questionnaire-based study. Journal of Dermatology 40(4): 292-294
Andrus, V. 2010: Therapeutic presence: bBringing comfort to our patients. Beginnings 30(4): 18-19
Meyskens, F.L. 2011: Therapeutic prevention of colorectal carcinogenesis. Journal of Carcinogenesis 10: 13
Ma, Y.-Z. 2010: Therapeutic principle and correlative problem in treating spinal tuberculosis. Zhongguo Gu Shang 23(7): 483-485
Jiang, H.-c.; Sun, B.; Lu, C.-y. 2007: Therapeutic principles in treatment of severe acute pancreatitis. Zhonghua Wai Ke Za Zhi 45(1): 6-8
Beecker, J. 2010: Therapeutic principles in vulvovaginal dermatology. Dermatologic Clinics 28(4): 639-648
Umemura, S.; Mimaki, S.; Makinoshima, H.; Tada, S.; Ishii, G.; Ohmatsu, H.; Niho, S.; Yoh, K.; Matsumoto, S.; Takahashi, A.; Morise, M.; Nakamura, Y.; Ochiai, A.; Nagai, K.; Iwakawa, R.; Kohno, T.; Yokota, J.; Ohe, Y.; Esumi, H.; Tsuchihara, K.; Goto, K. 2014: Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(9): 1324-1331
Chiodo, G.T.; Tolle, S.W. 1994: Therapeutic privilege and truth telling. General Dentistry 42(6): 504; 506-507
Richard, C.; Lajeunesse, Y.; Lussier, M.-T.ér.ès. 2010: Therapeutic privilege: between the ethics of lying and the practice of truth. Journal of Medical Ethics 36(6): 353-357
Lawson, R.B. 1949: Therapeutic problems encountered in acute poliomyelitis. Minnesota Medicine 32(7): 693-696
Zawilska, K.; Podolak-Dawidziak, M. 2012: Therapeutic problems in elderly patients with hemophilia. Polskie Archiwum Medycyny Wewnetrznej 122(11): 567-576
Fischer, E. 1949: Therapeutic problems in primary chronic polyarthritis. Arztliche Monatshefte fur berufliche Fortbildung. Cahiers mensuels de medecine 5(9): 703-765
Moujahid, M.; Tadjdine, M.T.; Achour, M.; Janati, M.I. 2010: Therapeutic problems of hydatic cyst in the liver dome: 120 cases. Revue Medicale de Liege 65(10): 556-561
Kallianos, A.; Rapti, A.; Zarogoulidis, P.; Tsakiridis, K.; Mpakas, A.; Katsikogiannis, N.; Kougioumtzi, I.; Li, Q.; Huang, H.; Zaric, B.; Perin, B.; Courcoutsakis, N.; Zarogoulidis, K. 2013: Therapeutic procedure in small cell lung cancer. Journal of Thoracic Disease 5(Suppl 4): S420-S424
Pereira, G.L.; Tavares, N.U.L.; Mengue, S.S.; Pizzol, T.d.S.D. 2013: Therapeutic procedures and use of alternating antipyretic drugs for fever management in children. Jornal de Pediatria 89(1): 25-32
Ponsaing, L.-G.; Hansen, M.-B. 2007: Therapeutic procedures for submucosal tumors in the gastrointestinal tract. World Journal of Gastroenterology 13(24): 3316-3322
Goldner, V. 2009: Therapeutic procedures in patients with acute coronary syndrome and life-threatening arrhythmias in prehospital stage. Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 63(1): 35-37
Lee, B.-O.; Kirmayer, L.J.; Groleau, D. 2010: Therapeutic processes and perceived helpfulness of dang-ki (Chinese shamanism) from the symbolic healing perspective. Culture Medicine and Psychiatry 34(1): 56-105
Foster, B.C. 2009: Therapeutic product disposition in at-risk populations. Radiation Protection Dosimetry 134(3-4): 184-190
Chaudhuri, S.; Acharya, S.; Chatterjee, S.; Kumar, P.; Singh, M.K.; Bhattacharya, D.; Basu, A.K.; Dasgupta, S.; Flora, S.J.S.; Chaudhuri, S. 2012: Therapeutic profile of T11TS vs. T11TS+MiADMSA: a hunt for a more effective therapeutic regimen for arsenic exposure. Asian Pacific Journal of Cancer Prevention: Apjcp 13(6): 2943-2948
Gaspard, U.; Dubois, M. 2007: Therapeutic progress in gynecology: functional approaches. Revue Medicale de Liege 62(5-6): 423-427
Herman, P.; Lifrange, E.; Nisolle, M.; Kridelka, F.; Nervo, P.; Gaspard, U. 2007: Therapeutic progress in gynecology: organic diseases. Revue Medicale de Liege 62(5-6): 414-422
Zhang, G.-l.; Zhang, M. 2009: Therapeutic progress of avascular osteonecrosis of the femoral head using a fibular graft by vascular anastomosis. Zhongguo Gu Shang 22(1): 76-78
Yan, M. 2011: Therapeutic promise and challenges of targeting DLL4/NOTCH1. Vascular Cell 3: 17
Maiese, K.; Chong, Z.Z.; Shang, Y.C.; Hou, J. 2008: Therapeutic promise and principles: metabotropic glutamate receptors. Oxidative Medicine and Cellular Longevity 1(1): 1-14
Green, C. 1982: Therapeutic promise maintained. Immunology Today 3(5): 121-123
Verenich, S.; Gerk, P.M. 2010: Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges. Molecular Pharmaceutics 7(6): 2030-2039
Zdziarska, J.; Chojnowski, K.; Klukowska, A.; Łetowska, M.; Mital, A.; Podolak-Dawidziak, M.; Windyga, J.; Zawilska, K. 2009: Therapeutic properties and safety of recombinant factor VIIi and factor IX. Polskie Archiwum Medycyny Wewnetrznej 119(6): 403-409
Voultsiadou, E. 2010: Therapeutic properties and uses of marine invertebrates in the ancient Greek world and early Byzantium. Journal of Ethnopharmacology 130(2): 237-247
Domingues, N.; Pelletier, J.; Ostenson, C.-G.; Castro, M.M.C.A. 2014: Therapeutic properties of VO(dmpp)2 as assessed by in vitro and in vivo studies in type 2 diabetic GK rats. Journal of Inorganic Biochemistry 131: 115-122
Jones, L.W.; Dewhirst, M.W. 2014: Therapeutic properties of aerobic training after a cancer diagnosis: more than a one-trick pony?. Journal of the National Cancer Institute 106(4): Dju042
Kundaković, T.; Kolundžić, M. 2013: Therapeutic properties of mushrooms in managing adverse effects in the metabolic syndrome. Current Topics in Medicinal Chemistry 13(21): 2734-2744
Gasparella, M.; Betalli, P.; Benetton, C.; Zanatta, C.; Ferro, M.; Marzaro, M.; Schiavon, G.; Zoppellaro, F.; Perrino, G. 2009: Therapeutic proposal for ingestion of button battery in pediatric age: our cases and review of the literature. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 31(2): 78-81
Auvin, Séphane. 2007: Therapeutic proposals for childhood status epilepticus-induced excitotoxic neuronal injury. Pediatric Neurology 37(4): 306; Author Reply 306-7
Ruzza, P.; Biondi, B.; Calderan, A. 2009: Therapeutic prospect of Syk inhibitors. Expert Opinion on Therapeutic Patents 19(10): 1361-1376
Olanow, C.W.; Schapira, A.H.V. 2013: Therapeutic prospects for Parkinson disease. Annals of Neurology 74(3): 337-347
Heightman, T.D. 2011: Therapeutic prospects for epigenetic modulation. Expert Opinion on Therapeutic Targets 15(6): 729-740
Schon, E.A.; DiMauro, S.; Hirano, M.; Gilkerson, R.W. 2010: Therapeutic prospects for mitochondrial disease. Trends in Molecular Medicine 16(6): 268-276
Kizana, E. 2007: Therapeutic prospects of cardiac gene transfer. Heart Lung and Circulation 16(3): 180-184
Betz, M.J.; Enerbäck, S. 2011: Therapeutic prospects of metabolically active brown adipose tissue in humans. Frontiers in Endocrinology 2: 86
Mohebtash, M.; Madan, R.A.; Gulley, J.L.; Arlen, P.M. 2008: Therapeutic prostate cancer vaccines: a review of the latest developments. Current Opinion in Investigational Drugs 9(12): 1296-1301
Letoha, T.ás.; Fehér, L.án.Z.; Pecze, L.ás.ó; Somlai, C.; Varga, I.; Kaszaki, J.óz.; Tóth, G.áb.; Vizler, C.; Tiszlavicz, L.ás.ó; Takács, T.ás. 2007: Therapeutic proteasome inhibition in experimental acute pancreatitis. World Journal of Gastroenterology 13(33): 4452-4457
Roberts, C.J. 2014: Therapeutic protein aggregation: mechanisms, design, and control. Trends in Biotechnology 32(7): 372-380
Kenny, J.R.; Liu, M.M.; Chow, A.T.; Earp, J.C.; Evers, R.; Slatter, J.Greg.; Wang, D.D.; Zhang, L.; Zhou, H. 2013: Therapeutic protein drug-drug interactions: navigating the knowledge gaps-highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA workshop. AAPS journal 15(4): 933-940
Pelegri-O'Day, E.M.; Lin, E.-W.; Maynard, H.D. 2014: Therapeutic protein-polymer conjugates: advancing beyond PEGylation. Journal of the American Chemical Society 136(41): 14323-14332
Dimitrov, D.S. 2012: Therapeutic proteins. Methods in Molecular Biology 899: 1-26
Lopez-Marin, L.M.; Tamariz, E.; Acosta-Torres, L.S.; Castaño, V.M. 2013: Therapeutic proteins and nanotechnology: immune response and stealth bioengineered constructs. Current Drug Metabolism 14(5): 531-539
Kesikli, S.A.; Kilickap, S. 2013: Therapeutic proteins in tumors and targeted therapeutic agents for cancer patients. Protein and Peptide Letters 20(12): 1345-1359
Ozgur, A.; Tutar, Y. 2013: Therapeutic proteins: a to Z. Protein and Peptide Letters 20(12): 1365-1372
Teodoreanu, Răzvan.Nicolae.; Popescu, S.Arghir.; Lascăr, I.; Vulturescu, V.; Grigore, A. 2014: Therapeutic protocol using growth factors in electrocution wounds--case reports and review of the literature. Romanian Journal of Morphology and Embryology 55(2): 473-482
Antolak, S.J.; Antolak, C.M. 2009: Therapeutic pudendal nerve blocks using corticosteroids cure pelvic pain after failure of sacral neuromodulation. Pain Medicine 10(1): 186-189
Vawdrey, D.B.F.; Fitzsimmons, S.; Veldtman, G.R.; Carpenter, J.-P. 2013: Therapeutic pulmonary artery stenting for metastatic bronchial carcinoid. BMJ Case Reports
Smith, M.A. 1948: Therapeutic quiet. Texas Hospitals 4(1): 7
Szelachowska, J.; Dziegiel, P.; Tarkowski, R.; Gomulkiewicz, A.; Bebenek, M.; Halon, A.; Fortuna, K.; Wojnar, A.; Kornafel, J.; Matkowski, R. 2012: Therapeutic radiation induces different changes in expression profiles of metallothionein (MT) mRNA, MT protein, Ki 67 and minichromosome maintenance protein 3 in human rectal adenocarcinoma. Anticancer Research 32(12): 5291-5297
Lougheed, M.N. 1968: Therapeutic radiologists. Canadian Medical Association Journal 98(9): 464-465
Quick, D. 1948: Therapeutic radiology. Radiology 50(3): 283-296
Holmes, G.W. 1946: Therapeutic radiology. Radiology 47(6): 602-607
Yeong, C.-H.; Cheng, M.-h.; Ng, K.-H. 2014: Therapeutic radionuclides in nuclear medicine: current and future prospects. Journal of Zhejiang University. Science. B 15(10): 845-863
Kassis, A.I. 2008: Therapeutic radionuclides: biophysical and radiobiologic principles. Seminars in Nuclear Medicine 38(5): 358-366
Eikermann, M.; Vidal Melo, M.F. 2014: Therapeutic range of spontaneous breathing during mechanical ventilation. Anesthesiology 120(3): 536-539
Goldberger, Z.D.; Goldberger, A.L. 2012: Therapeutic ranges of serum digoxin concentrations in patients with heart failure. American Journal of Cardiology 109(12): 1818-1821
Fayed, N.A.; Abdallah, A.R.; Khalil, M.K.; Marwan, I.K. 2014: Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation. Platelets 25(8): 576-586
Curtin, P.O.; Jones, W.N. 2007: Therapeutic rationale of combining therapy with gemfibrozil and simvastatin. Journal of the American Pharmacists Association: Japha 47(2): 140-146
Despert, J.L. 1949: Therapeutic readiness in child psychiatry. Psychiatry 12(2): 153-158
Shiozuka, M.; Matsuda, R. 2011: Therapeutic readthrough strategy for suppression of nonsense mutations in duchenne muscular dystrophy. Brain and Nerve 63(11): 1253-1260
Bissessur, S.W.; Geijteman, E.C.T.; Al-Dulaimy, M.; Teunissen, P.W.; Richir, M.C.; Arnold, A.E.R.; de Vries, T.P.G.M. 2009: Therapeutic reasoning: from hiatus to hypothetical model. Journal of Evaluation in Clinical Practice 15(6): 985-989
Vivaldelli, J. 2007: Therapeutic reciprocity. 'A union through pain'. American Journal of Nursing 107(7): 74-76
Schouten, M.; van 't Veer, C.; van den Boogaard, F.E.; Gerlitz, B.; Grinnell, B.W.; Roelofs, J.J.T.H.; Levi, M.; van der Poll, T. 2010: Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumonia. Journal of Infectious Diseases 202(10): 1600-1607
Juszczyk, J.; Boroń-Kaczmarska, A.; Cianciara, J.; Flisiak, R.; Gładysz, A.; Halota, W.; Kryczka, W.ła.; Małkowski, P.; Pawłowska, M.łg.; Simon, K. 2013: Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B. Przeglad Epidemiologiczny 67(2): 287-295; 383-391
Piroth, L.; Leroy, J.; Rogeaux, O.; Stahl, J.P.; Mock, M.; Garin-Bastuji, B.; Madani, N.; Brezillon, C.; Mailles, A.; May, T.H.; Spilf 2011: Therapeutic recommendations for the management of patients exposed to Bacillus anthracis in natural settings. SPILF. Société de pathologie infectieuse de langue franc¸aise. Medecine et Maladies Infectieuses 41(11): 567-578
Juszczyk, J.; Boroń-Kaczmarska, A.; Cianciara, J.; Flisiak, R.; Gładysz, A.; Halota, W.; Kryczka, W.ła.; Małkowski, P.; Pawłowska, M.łg.; Simon, K. 2010: Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection. Przeglad Epidemiologiczny 64(1): 81-82
Concia, E.; Mazzei, T.; Azzini, A.M.; Diacciati, S.; Franco, M.; Mirone, V. 2014: Therapeutic recommendations of the multidisciplinary group. Journal of ChemoTherapy 26(Suppl 1): S36-S38
Müller-Ladner, U. 2012: Therapeutic recommendations were non-specific. Deutsches Arzteblatt International 109(44): 757; Author Reply 758
Lan, P.; Zhang, C.; Han, Q.; Zhang, J.; Tian, Z. 2013: Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance. Hepatology 58(1): 73-85
Trowbridge, R. 1980: Therapeutic recreation - a conceptual criticism. Australian Journal of PhysioTherapy 26(3): 89-94
Watson, A.; Hilton, D.; Hackett, D. 2010: Therapeutic recreation camps to provide a residential experience for young people in transition to adult renal units. Pediatric Nephrology 25(4): 787-788
Walker, D.A.; Pearman, D. 2009: Therapeutic recreation camps: an effective intervention for children and young people with chronic illness?. Archives of Disease in Childhood 94(5): 401-406
Sipurzynski-Budrass, S.; Sovinz, P.; Lanzer, G.; Schallmoser, K. 2014: Therapeutic red blood cell exchange in a child with sickle cell anaemia using the Spectra Optia® apheresis system. Transfusion Medicine 24(3): 184-186
Zengin, S.; Yılmaz, M.; Al, B.; Yildirim, C.; Yavuz, E.; Akcali, A. 2013: Therapeutic red cell exchange for severe carbon monoxide poisoning. Journal of Clinical Apheresis 28(5): 337-340
Crouch, P.J.; Barnham, K.J. 2012: Therapeutic redistribution of metal ions to treat Alzheimer's disease. Accounts of Chemical Research 45(9): 1604-1611
Denewer, A.; Shahatto, F.; Elnahas, W.; Farouk, O.; Roshdy, S.; Khater, A.; Hussein, O.; Teima, S.; Hafez, M.; Zidan, S.; Shams, N.; Kotb, S. 2012: Therapeutic reduction mammoplasty in large-breasted women with cancer using superior and superomedial pedicles. Breast Cancer 4: 167-172
Yamamoto, T.; Shibata, R.; Ishii, M.; Kanemura, N.; Kito, T.; Suzuki, H.; Miyake, H.; Maeda, K.; Tanigawa, T.; Ouchi, N.; Murohara, T. 2013: Therapeutic reendothelialization by induced pluripotent stem cells after vascular injury--brief report. Arteriosclerosis Thrombosis and Vascular Biology 33(9): 2218-2221
Tomita, T.; Yasui-Furukori, N.; Nakagami, T.; Tsuchimine, S.; Ishioka, M.; Kaneda, A.; Nakamura, K.; Kaneko, S. 2014: Therapeutic reference range for plasma concentrations of paroxetine in patients with major depressive disorders. Therapeutic Drug Monitoring 36(4): 480-485
Di Ciaula, A.; Wang, D.Q.-H.; Garruti, G.; Wang, H.H.; Grattagliano, I.; de Bari, O.; Portincasa, P. 2014: Therapeutic reflections in cholesterol homeostasis and gallstone disease: a review. Current Medicinal Chemistry 21(12): 1435-1447
Song, W.-G.; Wang, Y.-F.; Wang, R.-L.; Qu, Y.-E.; Zhang, Z.; Li, G.-Z.; Xiao, Y.; Fang, F.; Chen, H. 2013: Therapeutic regimens and prognostic factors of brain metastatic cancers. Asian Pacific Journal of Cancer Prevention: Apjcp 14(2): 923-927
Bakker, J.A.; Bierau, J.; Drent, M. 2007: Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?. European Respiratory Journal 30(5): 821-822
Olsovský, J. 2007: Therapeutic regimes accompanying physical exercise for diabetics. Vnitrni Lekarstvi 53(5): 551-553
Savant, S.S. 1995: Therapeutic regional dermabrasion in papular lichen amyloidosis of shins. Indian Journal of Dermatology Venereology and Leprology 61(4): 196-201
Watts, G.F.; Ooi, E.M.M.; Chan, D.C. 2009: Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo. Pharmacology and Therapeutics 123(3): 281-291
Turner, N.A. 2011: Therapeutic regulation of cardiac fibroblast function: targeting stress-activated protein kinase pathways. Future Cardiology 7(5): 673-691
Thurman, J.M. 2012: Therapeutic regulation of complement in patients with renal disease - where is the promise?. Clinical Nephrology 77(5): 413-423
Hamilton, S.J.; Chew, G.T.; Watts, G.F. 2007: Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diabetes and Vascular Disease Research 4(2): 89-102
Maeda, Y.; Sheffield, A.M.; Smith, R.J.H. 2009: Therapeutic regulation of gene expression in the inner ear using RNA interference. Advances in Oto-Rhino-Laryngology 66: 13-36
Iclozan, C.; Antonia, S.; Chiappori, A.; Chen, D.-T.; Gabrilovich, D. 2013: Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunology Immunotherapy: Cii 62(5): 909-918
Carter, L.; Wright, S. 2013: Therapeutic relationship. Journal of Analytical Psychology 58(4): 451-453
Hausteiner-Wiehle, C.; Schaefert, R. 2014: Therapeutic relationship and communication. Attitude towards patients with functional pain syndromes. Zeitschrift für Gerontologie und Geriatrie 47(2): 165-73; Quiz 174-5
Sosnowska, M.łg.; Prot-Klinger, K.; Scattergood, M.; Paczkowska, M.; Smolicz, A.; Ochocka, M.łg. 2011: Therapeutic relationship in community psychiatry in the patient and therapist's perspective. Psychiatria Polska 45(5): 723-735
Theodoridou, A.; Schlatter, F.; Ajdacic, V.; Rössler, W.; Jäger, M. 2012: Therapeutic relationship in the context of perceived coercion in a psychiatric population. Psychiatry Research 200(2-3): 939-944
Jankovic, M.; Vallinoto, C.; Spinelli, M.; Leoni, V.; Masera, G. 2008: Therapeutic relationship with the child and the adolescent affected with leukemia. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 30(3 Suppl B): B71-B76
Wright, K.M. 2010: Therapeutic relationship: developing a new understanding for nurses and care workers within an eating disorder unit. International Journal of Mental Health Nursing 19(3): 154-161
Farrelly, S.; Lester, H. 2014: Therapeutic relationships between mental health service users with psychotic disorders and their clinicians: a critical interpretive synthesis. Health and Social Care in the Community 22(5): 449-460
Hawamdeh, S.; Fakhry, R. 2014: Therapeutic relationships from the psychiatric nurses' perspectives: an interpretative phenomenological study. Perspectives in Psychiatric Care 50(3): 178-185
O'Connell, E. 2008: Therapeutic relationships in critical care nursing: a reflection on practice. Nursing in Critical Care 13(3): 138-143
Mottram, A. 2009: Therapeutic relationships in day surgery: a grounded theory study. Journal of Clinical Nursing 18(20): 2830-2837
Priebe, S.; Mccabe, R. 2008: Therapeutic relationships in psychiatry: the basis of therapy or therapy in itself?. International Review of Psychiatry 20(6): 521-526
Canning, D.; Rosenberg, J.P.; Yates, P. 2007: Therapeutic relationships in specialist palliative care nursing practice. International Journal of Palliative Nursing 13(5): 222-229
Catty, J.; White, S.; Koletsi, M.; Becker, T.; Fioritti, A.; Kalkan, R.; Lauber, C.; Lissouba, P.; Rössler, W.; Tomov, T.; van Busschbach, J.T.; Wiersma, D.; Burns, T.; Burns, T.; Catty, J.; Geyer, C.; Kolesti, M.; Lissouba, P.; Rinaldi, M.; White, S.; Becker, T.; Ehiosun, U.; Kalkan, R.; Kilian, R.; Fioritti, A.; Manchisi, D.; Niersman, A.; van Busschbach, J.T.; Wiersma, D.; Lauber, C.; Rossler, W.; Warnke, I.; Germanov, D.; Tomov, T.; Comas, A.; Curran, C.; Knapp, M.; Patel, A. 2011: Therapeutic relationships in vocational rehabilitation: predicting good relationships for people with psychosis. Psychiatry Research 187(1-2): 68-73
Catty, J.; Koletsi, M.; White, S.; Becker, T.; Fioritti, A.; Kalkan, R.; Lauber, C.; Lissouba, P.; Rössler, W.; Tomov, T.; van Busschbach, J.T.; Wiersma, D.; Burns, T. 2010: Therapeutic relationships: their specificity in predicting outcomes for people with psychosis using clinical and vocational services. Social Psychiatry and Psychiatric Epidemiology 45(12): 1187-1193
Schmidhofer, E. 1946: Therapeutic relaxation. Journal of Nervous and Mental Disease 103: 260-275
Gluhovschi, G.; Margineanu, F.; Kaycsa, A.; Velciov, S.; Gluhovschi, C.; Bob, F.; Petrica, L.; Bozdog, G.; Dumitru, S.; Olosz, E.; Modalca, M. 2010: Therapeutic remedies based on Aristolochia clematitis in the main foci of Balkan endemic nephropathy in Romania. NEPHRON. Clinical Practice 116(1): C36-C46
Clos, A.L.; Lasagna-Reeves, C.A.; Wagner, R.; Kelly, B.; Jackson, G.R.; Kayed, R. 2010: Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra-lesional injections of anti-amyloid antibodies. Experimental Dermatology 19(10): 904-911
Janovick, J.A.; Park, B.S.; Conn, P.M. 2011: Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugs. Plos one 6(7): E22784
Smithson, D.C.; Janovick, J.A.; Conn, P.M. 2013: Therapeutic rescue of misfolded/mistrafficked mutants: automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRs. Methods in Enzymology 521: 3-16
McGee, V. 2008: Therapeutic research for depression and insomnia. Idrugs: the Investigational Drugs Journal 11(1): 10-12
Whyte, S.R. 2014: Therapeutic research in low-income countries: studying trial communities. Archives of Disease in Childhood 99(11): 1029-1032
Vasconcelos, C.; Faria, R. 2013: Therapeutic resistance in autoimmune diseases. Lupus 22(1): 3-5
Gomez, G.G.; Wykosky, J.; Zanca, C.; Furnari, F.B.; Cavenee, W.K. 2013: Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks. Cancer Biology and Medicine 10(4): 192-205
Danilov, D.S. 2008: Therapeutic resistance in schizophrenia and biological methods of its overcoming. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(10): 81-86
McCubrey, J.A.; Steelman, L.S.; Kempf, C.R.; Chappell, W.H.; Abrams, S.L.; Stivala, F.; Malaponte, G.; Nicoletti, F.; Libra, M.; Bäsecke, J.ör.; Maksimovic-Ivanic, D.; Mijatovic, S.; Montalto, G.; Cervello, M.; Cocco, L.; Martelli, A.M. 2011: Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. Journal of Cellular Physiology 226(11): 2762-2781
Futrakul, N.; Futrakul, P. 2012: Therapeutic resistance to ACEi and ARB combination in macroalbuminuric diabetic nephropathy. Clinical Nephrology 78(3): 250
Vaz, O. 1947: Therapeutic resources in the absence of the vagina. Revista Brasileira de Cirurgia 16(3): 159-178
Roumeguère, T.; Verheyden, B.; Arver, S.; Bitton, A.; Belger, M.; Schmitt, H.; Altziebler, S.; Barta, C.; Dallinger, B.; Diehl, K.; Esterbauer, B.; Färber, K.; Grubmüller, K.H.; Heidler, H.; Hermandinger, G.; Holzmann, R.M.; Hude, R.; Janetschek, G.; Jungwirth, A.E.; Köck, H.H.; Kratzik, C.; Linshalm, C.; Lintner, C.; Ludvik, G.; Lunglmayr, G.; Madersbacher, H.; Mair, M.; Moser, P.; Nöst, G.; Pleyer, P.; Sternig, P.; Strohmeyer, D.; Suster, G.; Treu, T.; Vasold, L.; Vincek, R.; Zeitelberger, A.; Baeyens, A.; Beke, P.; Biot, H.; Boudolf, P.; Bourlet, R.; Bouts, V.; Burssens, R.; Cooremans, H.; Cuypers, H.; Denier, W.; De Sutter, P.; Evaldre, C.; Geeraerts, G.; Gorissen, G.; Hoet, P.; Houthuys, C.; Houze, G.; Huysmans, J.; Jacobs, P.; Ke 2008: Therapeutic response after first month of tadalafil treatment predicts 12 months treatment continuation in patients with erectile dysfunction: results from the DETECT study. Journal of Sexual Medicine 5(7): 1708-1719
González-Rodríguez, K.Teresita.; Vargas-Ruiz, A.Gabriel.; López-Karpovitch, X. 2012: Therapeutic response and survival in patients with hairy cell leukemia in a third level institution. Gaceta Medica de Mexico 148(5): 425-429
Minami, Y.; Nishida, N.; Kudo, M. 2014: Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRi. World Journal of Gastroenterology 20(15): 4160-4166
Minami, Y.; Kudo, M. 2013: Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging. Oncology 84(Suppl 1): 58-63
Wang, X.; Jacobs, M.A.; Fayad, L. 2011: Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRi. Nmr in Biomedicine 24(6): 750-763
Barisić, V.; Barisić, Z. 2009: Therapeutic response in outpatient opioid substitution treatment. Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 63(4): 279-283
Hasumi, K.; Aoki, Y.; Watanabe, R.; Hankey, K.G.; Mann, D.L. 2011: Therapeutic response in patients with advanced malignancies treated with combined dendritic cell-activated T cell based immunotherapy and intensity-modulated radiotherapy. Cancers 3(2): 2223-2242
Añez, A.; Navarro-Costa, D.; Yucra, O.; Garnica, C.; Melgar, V.; Moscoso, M.; Arteaga, R.; Nakao, G. 2012: Therapeutic response of Plasmodium vivax to chloroquine in Bolivia. Biomedica: Revista del Instituto Nacional de Salud 32(4): 527-535
Suematsu, R.; Ohta, A.; Matsuura, E.; Takahashi, H.; Fujii, T.; Horiuchi, T.; Minota, S.; Ishigatsubo, Y.; Ota, T.; Takei, S.; Soejima, S.; Inoue, H.; Koarada, S.; Tada, Y.; Nagasawa, K. 2012: Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan. Modern Rheumatology 22(5): 712-719
Tomov, B.; Popov, D.; Tomova, R.; Vladov, N.; Den Otter, W.; Krastev, Z. 2013: Therapeutic response of untreatable hepatocellular carcinoma after application of the immune modulators IL-2, BCG and melatonin. Anticancer Research 33(10): 4531-4535
Dean, J.L.; McClendon, A.K.; Hickey, T.E.; Butler, L.M.; Tilley, W.D.; Witkiewicz, A.K.; Knudsen, E.S. 2012: Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle 11(14): 2756-2761
Cano Megias, M.; Iglesias Lozano, P.; Ley Urzaiz, L. 2012: Therapeutic response to medical treatment in cystic giant prolactinoma. Medicina Clinica 139(9): 416-417
Al-Ozairi, E.; Quinton, R.; Advani, A. 2008: Therapeutic response to metformin in an underweight patient with polycystic ovarian syndrome. Fertility and Sterility 90(4): 1197.E1-4
Cai, S-Jyun.; Li, C-Wen.; Weihs, D.; Wang, G-Jen. 2017: Control of cell proliferation by a porous chitosan scaffold with multiple releasing capabilities. Science and Technology of Advanced Materials 18(1): 987-996
Beşiroğlu, L.üt.; Ağargün, M.Y.üc.; Ozbebit, O.ür.; Sözen, M.; Dilek, I.; Güleç, M. 2007: Therapeutic response to plasmapheresis in four cases with obsessive-compulsive disorder and tic disorder triggered by streptococcal infections. Turk Psikiyatri Dergisi 18(3): 270-276
Ueda, M.; Nakajima, N.; Nagayama, H.; Nishiyama, Y.; Ishii, K.; Katayama, Y. 2013: Therapeutic response to pramipexole in a patient with multiple system atrophy with predominant parkinsonism: positron emission tomography and pharmacokinetic assessments. Internal Medicine 52(15): 1731-1735
Purandare, N.C.; Rangarajan, V.; Shah, S.A.; Sharma, A.R.; Kulkarni, S.S.; Kulkarni, A.V.; Dua, S.G. 2011: Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings. Radiographics: a Review Publication of the Radiological Society of North America Inc 31(1): 201-213
Velez, J.Carlos.Q.; Nietert, P.J. 2011: Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 58(6): 928-938
Kim, H.-A.; Sung, J.-M.; Suh, C.-H. 2012: Therapeutic responses and prognosis in adult-onset Still's disease. Rheumatology International 32(5): 1291-1298
Olver, M.E.; Wong, S.C.P. 2009: Therapeutic responses of psychopathic sexual offenders: treatment attrition, therapeutic change, and long-term recidivism. Journal of Consulting and Clinical Psychology 77(2): 328-336
Caldas, S.ér.; Caldas, I.S.; Cecílio, A.B.; Diniz, L.ív.D.F.; Talvani, A.é; Ribeiro, I.; Bahia, M.T. 2014: Therapeutic responses to different anti-Trypanosoma cruzi drugs in experimental infection by benznidazole-resistant parasite stock. Parasitology 2014: 1-10
Jin, D.P.; An, A.; Liu, J.; Nakamura, K.; Rockson, S.G. 2009: Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization. Lymphatic Research and Biology 7(1): 47-57
Mitrione, S. 2008: Therapeutic responses to natural environments: using gardens to improve health care. Minnesota Medicine 91(3): 31-34
Iijima, M. 2011: Therapeutic responsiveness in chronic inflammatory demyelinating polyradiculoneuropathy. Rinsho Shinkeigaku 51(11): 1012-1014
De Panfilis, G.; Ficarelli, E. 2008: Therapeutic restoration of cytolytic and suicidal cell molecular machineries favours disease healing. Expert Opinion on Biological Therapy 8(5): 555-560
Kahle, K.T.; Khanna, A.; Clapham, D.E.; Woolf, C.J. 2014: Therapeutic restoration of spinal inhibition via druggable enhancement of potassium-chloride cotransporter KCC2-mediated chloride extrusion in peripheral neuropathic pain. JAMA Neurology 71(5): 640-645
Koffi, G.; Kouakou, B.; Ndiaye, F.S.D.; Ndathz, E.; Sanogo, I.; Sangare, A. 2007: Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience. Bulletin du Cancer 94(10): 902-906
Kim, J.; Lee, S.Hoon. 2012: Therapeutic results and safety of postoperative radiotherapy for keloid after repeated Cesarean section in immediate postpartum period. Radiation Oncology Journal 30(2): 49-52
Bloomfield, S.; Kellerman, L. 1949: Therapeutic results in advanced chronic simple glaucoma with telescopic fields. American Journal of Ophthalmology 32(9): 1177-1182
Mäkitie, A.; Keski-Säntti, H.; Saarilahti, K.; Bäck, L.; Kontio, R.; Grénman, R.; Koivunen, P.; Laranne, J. 2011: Therapeutic results in oral cancer--what has been learned?. Duodecim; Laaketieteellinen Aikakauskirja 127(18): 1986-1991
Murase, K.; Iyama, S.; Sato, T.; Takimoto, R.; Kobune, M.; Kato, J. 2010: Therapeutic results in patients with biphenotypic acute leukemia at Sapporo Medical University Hospital. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 2011-2013
Kostova, P.; Chakalova, G.; Gancheva, A. 2009: Therapeutic results in patients with endometrial cancer. Akusherstvo i Ginekologiia 48(4): 17-22
Steinbrocker, O. 1946: Therapeutic results in rheumatoid arthritis. Journal of the American Medical Association 131: 189-193
Szymik-Kantorowicz, S.; Urbanowicz, Wław.; Surmiak, M.; Sulisławski, J. 2012: Therapeutic results in stage I Wilms' tumors in children - 15 years of surgical experience. Central European journal of urology 65(3): 151-155
Azulay, R.D.; Antunes, A.; Cunha, H.O. 1949: Therapeutic results obtained with streptomycin in cases of cutaneous tuberculosis, four cases treated. Hospital (Rio de Janeiro) 35(6): 855-866
Hu, X.; Cao, L.; Zhang, J.; Liang, P.; Liu, G. 2015: Therapeutic results of abdominoperineal resection in the prone jackknife position for T3-4 low rectal cancers. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 19(3): 551-557
Tezuka, M.; Hayashi, K.; Okada, Y.; Irie, T.; Ina, H. 2009: Therapeutic results of computed-tomography-guided transcatheter arterial chemoembolization for local recurrence of hepatocellular carcinoma after initial transcatheter arterial chemoembolization: the results of 85 recurrent tumors in 35 patients. Digestive Diseases and Sciences 54(3): 661-669
Gang, X.; Gao, L. 2008: Therapeutic results of glucosamine hydrochloride for knee degenerative osteoarthritis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22(1): 29-31
Murakami, H.; Ogata, Y.; Uchida, S.; Sasatomi, T.; Murakami, N.; Yamaguchi, K.; Gotanda, Y.; Akagi, Y.; Ishibashi, N.; Shirouzu, K. 2009: Therapeutic results of hepatic resection using thermal ablation for unresectable colorectal liver metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2039-2041
Yoo, D.-S.; Won, Y.-D.; Huh, P.-W.; Shin, H.-E.; Kim, K.-T.; Kang, S.-G.; Lee, S.-B.; Cho, K.-S. 2010: Therapeutic results of intra-arterial thrombolysis after full-dose intravenous tissue plasminogen activator administration. AJNR. American Journal of Neuroradiology 31(8): 1536-1540
Gousheh, J.; Arasteh, E.; Beikpour, H. 2008: Therapeutic results of sciatic nerve repair in Iran-Iraq war casualties. Plastic and Reconstructive Surgery 121(3): 878-886
Takase, K.; Shinmura, K.; Kono, R.; Kumakura, T. 2011: Therapeutic results of the modified Cadenat procedure for acromioclavicular joint separations compared with the modified Dewar procedure. West Indian Medical Journal 60(3): 303-307
Doleželová, H.; Hynková, L.; Pospíšil, P.; Kazda, T.; Slampa, P.; Coupková, I.; Siková, I.; Fardus, P.; Svoboda, T.; Garčic, J.; Vrzal, M.; Selingerová, I.; Horová, I. 2012: Therapeutic results of the treatment brain tumors using radiosurgery and stereotactic radiotherapy. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 25(6): 445-451
O'Neill, C.L.; O'Doherty, M.T.; Wilson, S.E.; Rana, A.A.; Hirst, C.E.; Stitt, A.W.; Medina, R.J. 2012: Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells. Stem Cell Research and Therapy 3(4): 31
Tong, M.; Longato, L.; Ramirez, T.; Zabala, V.; Wands, J.R.; de la Monte, S.M. 2014: Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin. International Journal of Experimental Pathology 95(1): 49-63
Scheinfeld, N.S. 2010: Therapeutic review 2009-2010. Skinmed 8(6): 348-349
Rossi, J.J. 1998: Therapeutic ribozymes: principles and applications. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 9(1): 1-10
Ungermann, C.M.; Gras, L.Z. 2011: Therapeutic riding followed by rhythmic auditory stimulation to improve balance and gait in a subject with orthopedic pathologies. Journal of Alternative and Complementary Medicine 17(12): 1191-1195
Madan, K.; Agarwal, R.; Aggarwal, A.N.; Gupta, D. 2014: Therapeutic rigid bronchoscopy at a tertiary care center in North India: Initial experience and systematic review of Indian literature. Lung India: Official Organ of Indian Chest Society 31(1): 9-15
Simon, R.I.; Shuman, D.W. 2009: Therapeutic risk management of clinical-legal dilemmas: should it be a core competency?. Journal of the American Academy of Psychiatry and the Law 37(2): 155-161
Homaifar, B.; Matarazzo, B.; Wortzel, H.S. 2013: Therapeutic risk management of the suicidal patient: augmenting clinical suicide risk assessment with structured instruments. Journal of Psychiatric Practice 19(5): 406-409
Matarazzo, B.B.; Homaifar, B.Y.; Wortzel, H.S. 2014: Therapeutic risk management of the suicidal patient: safety planning. Journal of Psychiatric Practice 20(3): 220-224
Wortzel, H.S.; Homaifar, B.; Matarazzo, B.; Brenner, L.A. 2014: Therapeutic risk management of the suicidal patient: stratifying risk in terms of severity and temporality. Journal of Psychiatric Practice 20(1): 63-67
Kim, W.Shik.; Byeon, H.Kwon.; Park, Y.Min.; Ha, J.Gyun.; Kim, E.Sung.; Koh, Y.Woo.; Choi, E.Chang. 2015: Therapeutic robot-assisted neck dissection via a retroauricular or modified facelift approach in head and neck cancer: a comparative study with conventional transcervical neck dissection. Head and Neck 37(2): 249-254
Drane, J.; Safos, C.; Lathan, C.E. 2009: Therapeutic robotics for children with disabilities: a case study. Studies in Health Technology and Informatics 149: 344-356
Hara, T.; Ichimura, A.; Hirasawa, A. 2014: Therapeutic role and ligands of medium- to long-chain Fatty Acid receptors. Frontiers in Endocrinology 5: 83
Hodge, S.; Matthews, G.; Dean, M.M.; Ahern, J.; Djukic, M.; Hodge, G.; Jersmann, H.; Holmes, M.; Reynolds, P.N. 2010: Therapeutic role for mannose-binding lectin in cigarette smoke-induced lung inflammation? Evidence from a murine model. American Journal of Respiratory Cell and Molecular Biology 42(2): 235-242
Ohno, Y. 2011: Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease. Cns Neuroscience and Therapeutics 17(1): 58-65
Zhang, D.; Wang, Y.; Dong, L.; Huang, Y.; Yuan, J.; Ben, W.; Yang, Y.; Ning, N.; Lu, M.; Guan, Y. 2013: Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells. Cancer Science 104(12): 1690-1696
Tripathi, P.; Misra, M.K. 2009: Therapeutic role of L-arginine on free radical scavenging system in ischemic heart diseases. Indian Journal of Biochemistry and Biophysics 46(6): 498-502
Yuan, H.; Qian, H.; Liu, S.; Zhang, X.; Li, S.; Wang, W.; Li, Z.; Jia, J.; Zhao, W. 2012: Therapeutic role of a vaccine targeting RANKL and TNF-α on collagen-induced arthritis. Biomaterials 33(32): 8177-8185
Rajasekaran, S.; Kruse, K.; Kovey, K.; Davis, A.T.; Hassan, N.E.; Ndika, A.N.; Zuiderveen, S.; Birmingham, J. 2014: Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 15(5): 401-408
Trauner, M.; Halilbasic, E.; Kazemi-Shirazi, L.; Kienbacher, C.; Staufer, K.; Traussnigg, S.; Hofer, H. 2014: Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies. Digestive Diseases 32(5): 631-636
Ural, A.U.; Avcu, F. 2007: Therapeutic role of bisphosphonate and radiation combination in the management of myeloma bone disease. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(11): 3432
Moon, J.H.; Choi, H.J.; Ko, B.M. 2011: Therapeutic role of direct peroral cholangioscopy using an ultra-slim upper endoscope. Journal of Hepato-Biliary-Pancreatic Sciences 18(3): 350-356
Taylor, R.A.; Qureshi, A.I. 2013: Therapeutic role of endothelial progenitor cells in inhibiting carotid artery neointimal hyperplasia. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging 23(2): 165
Siniscalco, D.; Bradstreet, J.J.; Antonucci, N. 2013: Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation. Frontiers in Immunology 4: 140
Al-Khalifa, A.; Mathew, T.C.; Al-Zaid, N.S.; Mathew, E.; Dashti, H.M. 2009: Therapeutic role of low-carbohydrate ketogenic diet in diabetes. Nutrition 25(11-12): 1177-1185
Shah, M.; Lewin, S.N.; Deutsch, I.; Burke, W.M.; Sun, X.; Herzog, T.J.; Wright, J.D. 2011: Therapeutic role of lymphadenectomy for cervical cancer. Cancer 117(2): 310-317
McDaniel, S.S.; Wong, M. 2011: Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neuroscience Letters 497(3): 231-239
Forsblom, A.; Laitinen, S.; Särkämö, T.; Tervaniemi, M. 2009: Therapeutic role of music listening in stroke rehabilitation. Annals of the new York Academy of Sciences 1169: 426-430
Ganji, S.H.; Kukes, G.D.; Lambrecht, N.; Kashyap, M.L.; Kamanna, V.S. 2014: Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. American Journal of Physiology. Gastrointestinal and Liver Physiology 306(4): G320-G327
Kumar, P.; Kaman, L.; Singh, G.; Singh, R. 2009: Therapeutic role of oral water soluble iodinated contrast agent in postoperative small bowel obstruction. Singapore Medical Journal 50(4): 360-364
Das, R.R. 2012: Therapeutic role of probiotics in asthma and allergic rhinitis. Pediatric Pulmonology 47(2): 206
Khedr, E.M.; Abo-Elfetoh, N. 2010: Therapeutic role of rTMS on recovery of dysphagia in patients with lateral medullary syndrome and brainstem infarction. Journal of Neurology Neurosurgery and Psychiatry 81(5): 495-499
Funakoshi, H.; Nakamura, T. 2012: Therapeutic role of regenerative factor "HGF" in ALS and other neurodegenerative disorders. Rinsho Shinkeigaku 52(11): 942
Cheng, J.; Shah, Y.M.; Ma, X.; Pang, X.; Tanaka, T.; Kodama, T.; Krausz, K.W.; Gonzalez, F.J. 2010: Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. Journal of Pharmacology and Experimental Therapeutics 335(1): 32-41
Rangan, G.K.; Nguyen, T.; Mainra, R.; Succar, L.; Schwensen, K.G.; Burgess, J.S.; Ho, K.O. 2009: Therapeutic role of sirolimus in non-transplant kidney disease. Pharmacology and Therapeutics 123(2): 187-206
Zhang, H.; Jia, L.; Zhang, Q.; Zhang, Y.; Yang, X.; Kong, B. 2012: Therapeutic role of systematic retroperitoneal lymphadenectomy in endometrial cancer. Bulletin du Cancer 99(2): E10-E17
Wu, X.; Li, S.; Wang, X.; Song, Y.; Chen, Z.; Jiang, J.; Bai, C. 2011: Therapeutic role of terbutaline in a rat whole-lung lavage model. Experimental Lung Research 37(9): 542-548
Navi, A.; Patel, H.; Shaw, S.; Baker, D.; Tsui, J. 2013: Therapeutic role of toll-like receptor modification in cardiovascular dysfunction. Vascular Pharmacology 58(3): 231-239
Li, S.; Liao, X.; Meng, F.; Wang, Y.; Sun, Z.; Guo, F.; Li, X.; Meng, M.; Li, Y.; Sun, C. 2014: Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. Plos one 9(1): E86724
Farooq, M.U.; Moore, P.W.; Bhatt, A.; Aburashed, R.; Kassab, M.Y. 2008: Therapeutic role of zonisamide in neuropsychiatric disorders. Mini Reviews in Medicinal Chemistry 8(10): 968-975
Son, Y.; Lee, J.H.; Chung, H.-T.; Pae, H.-O. 2013: Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxidative Medicine and Cellular Longevity 2013: 639541
Ahmad, S.; Ansari, A.A. 2011: Therapeutic roles of heparin anticoagulants in cancer and related disorders. Medicinal Chemistry 7(5): 504-517
Ma, H.; Zhang, Y.; Wang, Q.; Li, Y.; He, J.; Wang, H.; Sun, J.; Pan, K.; Chen, M.; Xia, J. 2010: Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation. Cancer Biology and Therapy 9(11): 903-907
Kuo, H.-C. 2008: Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection. Urology 72(5): 1056-1060
Brunt, T.M.; van Genugten, M.; Höner-Snoeken, K.; van de Velde, M.J.; Niesink, R.J.M. 2014: Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis. Journal of Clinical Psychopharmacology 34(3): 344-349
Vladuţiu, C.; Sevan, S.; Popoviciu, S. 2009: Therapeutic schedule in ambliopia--experience of Eye Clinic Cluj. Oftalmologia 53(2): 81-87
He, H.-R.; Li, M.; Wei, D.-P.; Zhu, J.-J.; Yang, J.-B.; Feng, X.-H.; Din, W.; Zhou, R.-B.; Lu, G.-Z. 2012: Therapeutic schemes for refractory ascites of advanced schistosomiasis: a clinical control study. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 24(5): 570-572
Yamakawa, M.; Kawamoto, S.; Kouda, M.; Inaba, F.; Kindaichi, S.; Takahashi, T.; Iwase, K. 2011: Therapeutic sclerosis of a small liver cyst that caused obstructive jaundice. Journal of Vascular and Interventional Radiology: Jvir 22(5): 695-698
McCarthy, P.G.; Sebaugh, J.Genone. 2011: Therapeutic scrapbooking: a technique to promote positive coping and emotional strength in parents of pediatric oncology patients. Journal of Psychosocial Oncology 29(2): 215-230
Gomez, S.S.; Onetto, J.E.; Uribe, S.A.; Emilson, C-Göran. 2007: Therapeutic seal of approximal incipient noncavitated carious lesions: technique and case reports. Quintessence International 38(2): E99-105
Bodak, M.; Harwood, J.; Pether, M.; Birks, M. 2014: Therapeutic seals come to Townsville. Australian Nursing and Midwifery Journal 21(7): 43
Stone, J.; Hoeritzauer, I.; Brown, K.; Carson, A. 2014: Therapeutic sedation for functional (psychogenic) neurological symptoms. Journal of Psychosomatic Research 76(2): 165-168
Lim, Y.Chang.; Lee, J.Seok.; Choi, E.Chang. 2009: Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?. Acta Oto-Laryngologica 129(1): 57-61
Shepard, P.M.; Olson, J.; Harari, P.M.; Leverson, G.; Hartig, G.K. 2010: Therapeutic selective neck dissection outcomes. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 142(5): 741-746
Lehar, J.; Krueger, A.S.; Zimmermann, G.R.; Borisy, A.A. 2009: Therapeutic selectivity and the multi-node drug target. Discovery Medicine 8(43): 185-190
Wilkinson, S.M.; Gabbard, G.O. 1993: Therapeutic self-disclosure with borderline patients. Journal of PsychoTherapy Practice and Research 2(4): 282-295
Kachala, S.S.; Servais, E.L.; Park, B.J.; Rusch, V.W.; Adusumilli, P.S. 2009: Therapeutic sentinel lymph node imaging. Seminars in Thoracic and Cardiovascular Surgery 21(4): 327-338
Bahte, S.K.; Bertram, A.; Burkhardt, O.; Martens-Lobenhoffer, J.; Goedecke, V.; Bode-Böger, S.M.; Hiss, M.; Kielstein, J.T. 2010: Therapeutic serum concentrations of daptomycin after intraperitoneal administration in a patient with peritoneal dialysis-associated peritonitis. Journal of Antimicrobial ChemoTherapy 65(6): 1312-1314
Delamaide Gasper, J.A.; Barnes Heller, H.L.; Robertson, M.; Trepanier, L.A. 2015: Therapeutic serum phenobarbital concentrations obtained using chronic transdermal administration of phenobarbital in healthy cats. Journal of Feline Medicine and Surgery 17(4): 359-363
Paukstadt, W. 2010: Therapeutic services on the internet. Chat room instead of couch?. MMW Fortschritte der Medizin 152(46): 14-15
Thomas, J.M.C.; Tuddenham, E.G.; Ahrens, P.M. 2008: Therapeutic shoulder arthroscopy in patients with clotting disorders. Haemophilia: the Official Journal of the World Federation of Hemophilia 14(4): 859-861
Gavrilov, K.; Saltzman, W.M. 2012: Therapeutic siRNA: principles, challenges, and strategies. Yale Journal of Biology and Medicine 85(2): 187-200
Glebova, K.V.; Marakhonov, A.V.; Baranova, A.V.; Skoblov, M.I. 2012: Therapeutic si RNAs and non-viral systems for their delivery. Molekuliarnaia Biologiia 46(3): 371-386
Leachman, S.A.; Hickerson, R.P.; Hull, P.R.; Smith, F.J.D.; Milstone, L.M.; Lane, E.B.; Bale, S.J.; Roop, D.R.; McLean, W.H.I.; Kaspar, R.L. 2008: Therapeutic si RNAs for dominant genetic skin disorders including pachyonychia congenita. Journal of Dermatological Science 51(3): 151-157
Rammes, G.; Hasenjäger, A.; Sroka-Saidi, K.; Deussing, J.M.; Parsons, C.G. 2011: Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Neuropharmacology 60(6): 982-990
Mochizuki, S.; Yoshino, T.; Kojima, T.; Fuse, N.; Ikematsu, H.; Minashi, K.; Yano, T.; Tahara, M.; Kaneko, K.; Doi, T.; Koike, K.; Ohtsu, A. 2010: Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab. Japanese Journal of Clinical Oncology 40(10): 933-937
Verma, A.; Guha, S.; Diagaradjane, P.; Kunnumakkara, A.B.; Sanguino, A.M.; Lopez-Berestein, G.; Sood, A.K.; Aggarwal, B.B.; Krishnan, S.; Gelovani, J.G.; Mehta, K. 2008: Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(8): 2476-2483
Sareddy, G.R.; Nair, B.C.; Gonugunta, V.K.; Zhang, Q.-g.; Brenner, A.; Brann, D.W.; Tekmal, R.R.; Vadlamudi, R.K. 2012: Therapeutic significance of estrogen receptor β agonists in gliomas. Molecular Cancer Therapeutics 11(5): 1174-1182
Hemmati, A.A. 2013: Therapeutic significance of natural anti oxidants. Jundishapur Journal of Natural Pharmaceutical Products 8(3): 99
Yokoyama, M. 2010: Therapeutic significance of re-work programs. Practice in area medium-sized nuclear cities--local cooperation and the determination of the outcome. Seishin Shinkeigaku Zasshi 112(3): 246-251
Maráz, A.ó; Cserháti, A.; Uhercsák, G.; Szilágyi, E.; Varga, Z.án.; Kahán, Z. 2014: Therapeutic significance of sunitinib-induced "off-target" side effects. Magyar Onkologia 58(3): 167-172
Banati, R.; Hickie, I.B. 2009: Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Medical Journal of Australia 190(S4): S26-S32
Pecot, C.V.; Wu, S.Y.; Bellister, S.; Filant, J.; Rupaimoole, R.; Hisamatsu, T.; Bhattacharya, R.; Maharaj, A.; Azam, S.; Rodriguez-Aguayo, C.; Nagaraja, A.S.; Morelli, M.P.; Gharpure, K.M.; Waugh, T.A.; Gonzalez-Villasana, V.; Zand, B.; Dalton, H.J.; Kopetz, S.; Lopez-Berestein, G.; Ellis, L.M.; Sood, A.K. 2014: Therapeutic silencing of KRAS using systemically delivered siRNAs. Molecular Cancer Therapeutics 13(12): 2876-2885
Bernardo, B.C.; Nguyen, S.S.; Winbanks, C.E.; Gao, X-Ming.; Boey, E.J.H.; Tham, Y.Keat.; Kiriazis, H.; Ooi, J.Y.Y.; Porrello, E.R.; Igoor, S.; Thomas, C.J.; Gregorevic, P.; Lin, R.C.Y.; Du, X-Jun.; McMullen, J.R. 2014: Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 28(12): 5097-5110
Lanford, R.E.; Hildebrandt-Eriksen, E.S.; Petri, A.; Persson, R.; Lindow, M.; Munk, M.E.; Kauppinen, S.; Ørum, H. 2010: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962): 198-201
Nishiyama, A.; Koyama, H.; Miyata, T.; Watanabe, T. 2015: Therapeutic site selection is important for the successful development of collateral vessels. Journal of Vascular Surgery 62(1): 190-199
Tummey, R. 2008: Therapeutic skills in nursing: have they been lost?. Australian Nursing Journal 15(8): 28
Mann, O.; Kaifi, J.; Bloechle, C.; Schneider, C.G.; Yekebas, E.; Kluth, D.; Izbicki, J.R.; Strate, T. 2009: Therapeutic small-volume resuscitation preserves pancreatic microcirculation in acute experimental pancreatitis of graded severity in rats. Pancreatology: Official Journal of the International Association of Pancreatology . 9(5): 652-661
Hamamah, S.; Anahory, T.; Ferrière, A.; Loup, V.; Reyftmann, L.; Dechaud, H. 2009: Therapeutic solutions for male infertility. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 38 Spec no: 1-2: F58-F64
Macstravic, S. 2008: Therapeutic specificity in disease management evaluation. Disease Management: Dm 11(1): 7-11
Kothari, D.; Patel, S.; Goyal, A. 2014: Therapeutic spectrum of nondigestible oligosaccharides: overview of current state and prospect. Journal of Food Science 79(8): R1491-R1498
Savant, S.S. 1996: Therapeutic spot and regional dermabrasion in stable vitiligo. Indian Journal of Dermatology Venereology and Leprology 62(3): 139-145
Reck, M.; Rosell, R.; Tiemann, M. 2012: Therapeutic standards and perspectives for stage IV non-small cell lung cancer. Onkologie 35(Suppl 3): 10-13
Pfisterer, J.; du Bois, A. 2007: Therapeutic standards for ovarian cancer. Der Pathologe 28(3): 222-228
DiPaola, R.S.; Dvorzhinski, D.; Thalasila, A.; Garikapaty, V.; Doram, D.; May, M.; Bray, K.; Mathew, R.; Beaudoin, B.; Karp, C.; Stein, M.; Foran, D.J.; White, E. 2008: Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. Prostate 68(16): 1743-1752
Wang, M.-y. 2008: Therapeutic status of clavicular fracture. Zhongguo Gu Shang 21(7): 487-489
Fan, Q.; Su, M.; Li, L.; Li, F.; Tian, R. 2014: Therapeutic status-dependent thymic changes on 18F-FDG PET/CT in an adult patient with lymphoma who underwent 2 phases of chemotherapy. Clinical Nuclear Medicine 39(3): E243-E245
Clark, B.B.; Wolfson, S. 1948: Therapeutic stellate ganglion block using local anesthetics. American Journal of Surgery 76(1): 66-68
Moore, D.C. 2008: Therapeutic stellate ganglion block: 5 versus 10 ml of a local anesthetic. Regional Anesthesia and Pain Medicine 33(2): 191-192
Martino, G.; Bacigaluppi, M.; Peruzzotti-Jametti, L. 2011: Therapeutic stem cell plasticity orchestrates tissue plasticity. Brain: a Journal of Neurology 134(Part 6): 1585-1587
Gursel, D.B.; Berry, N.; Boockvar, J.A. 2012: Therapeutic stem cells encapsulated in a synthetic extracellular matrix selectively kill tumor cells, delay tumor growth, and increase survival in a mouse resection model of malignant glioma. Neurosurgery 70(6): N17-N19
Van de Water, J.A.J.M.; Bagci-Onder, T.; Agarwal, A.S.; Wakimoto, H.; Roovers, R.C.; Zhu, Y.; Kasmieh, R.; Bhere, D.; Van Bergen en Henegouwen, P.M.P.; Shah, K. 2012: Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects. Proceedings of the National Academy of Sciences of the United States of America 109(41): 16642-16647
Corsten, M.F.; Shah, K. 2008: Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. LANCET. Oncology 9(4): 376-384
Hariz, M.I.; Hariz, G.-M. 2013: Therapeutic stimulation versus ablation. Handbook of Clinical Neurology 116: 63-71
Bergner, R.M. 2007: Therapeutic storytelling revisited. American Journal of PsychoTherapy 61(2): 149-162
Jain, G.K.; Warsi, M.H.; Nirmal, J.; Garg, V.; Pathan, S.A.; Ahmad, F.J.; Khar, R.K. 2012: Therapeutic stratagems for vascular degenerative disorders of the posterior eye. Drug Discovery Today 17(13-14): 748-759
Sambola, A.; Ferreira-González, I.; Angel, J.; Alfonso, F.; Maristany, J.; Rodríguez, O.; Bueno, H.; López-Minguez, J.R.; Zueco, J.; Fernández-Avilés, F.; San Román, A.; Prendergast, B.; Mainar, V.; García-Dorado, D.; Tornos, P. 2009: Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study. Heart 95(18): 1483-1488
Marriott, I.; Miller, J.R.; Sahraei, M. 2007: Therapeutic strategies against inflammation and bone loss associated with osteomyelitis. Current Opinion in Investigational Drugs 8(11): 887-898
Jaeschke, H. 2012: Therapeutic strategies against ischemia-reperfusion injury: stem cell therapy and beyond. Critical Care Medicine 40(4): 1381-1382
Utsugisawa, K.; Nagane, Y. 2013: Therapeutic strategies against myasthenia gravis. Nihon Rinsho. Japanese Journal of Clinical Medicine 71(5): 881-886
Soto, C.; Martin, Z. 2009: Therapeutic strategies against protein misfolding in neurodegenerative diseases. Expert Opinion on Drug Discovery 4(1): 71-84
Stiefelhagen, P. 2007: Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it. MMW Fortschritte der Medizin 149(35-36): 12-14
Chabrier, P.-E. 2009: Therapeutic strategies and Alzheimer's disease: contribution of animal models. Annales Pharmaceutiques Francaises 67(2): 97-103
Salerno, F.; Cazzaniga, M. 2010: Therapeutic strategies and emergence of multiresistant bacterial strains. Internal and Emergency Medicine 5(Suppl 1): S45-S51
Emde, A.; Köstler, W.J.; Yarden, Y. 2012: Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer. Critical Reviews in Oncology/Hematology 84(Suppl 1): E49-E57
Durando, X.; Mansard, S.; Daste, A.; Gimbergues, P.; Brocard, L.; Magné, N.; Thivat, E. 2013: Therapeutic strategies and systemic treatment of brain melanoma metastases. Bulletin du Cancer 100(1): 23-28
Vilos, C.; Velasquez, L.A. 2012: Therapeutic strategies based on polymeric microparticles. Journal of Biomedicine and Biotechnology 2012: 672760
Fang, J.; Seki, T.; Maeda, H. 2009: Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Advanced Drug Delivery Reviews 61(4): 290-302
Sigges, J.; Biazar, C.; Landmann, A.; Ruland, V.; Patsinakidis, N.; Amler, S.; Bonsmann, G.; Kuhn, A.; Haust, M.; Nyberg, F.; Beta, Z.; Mihályi, L.; Olteanu, R.; Pujol, R.M.; Sánchez-Schmidt, J.M.; Medenica, L.; Skiljevic, D.; Reich, A.; Szepietowski, J.C.; Dalle Vedove, C.; Girolomoni, G.; Hawro, T.; Zalewska-Janowska, A.; Glaeser, R.; Huegel, R.; Jedličková, H.; Bygum, A.; Laurinaviciene, R.; Benoit, S.; Broecker, E.; Bahmer, F.A.; Aberer, E.; Wutte, N.; Lipozencic, J.; Marinovic, B.; Sárdy, M.; Bekou, V.; Ruzicka, T.; Frances, C.; Soutou, B.; Lee, H.; Worm, M.; Gruschke, A.; Hunzelmann, N.; Steinbrink, K.; Romiti, R.; Sticherling, M.; Erfurt-Berge, C.; Avgerinou, G.; Papafragkaki, D.; An 2013: Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus. Autoimmunity reviews 12(7): 694-702
Kudo, T. 2010: Therapeutic strategies for Alzheimer disease based on endoplasmic reticulum stress. Nihon Shinkei Seishin Yakurigaku Zasshi 30(4): 163-168
Barten, D.M.; Albright, C.F. 2008: Therapeutic strategies for Alzheimer's disease. Molecular Neurobiology 37(2-3): 171-186
Nakagawa, M. 2011: Therapeutic strategies for Charcot-Marie-Tooth disease. Rinsho Shinkeigaku 51(11): 1015-1018
Durrmeyer, X.; Cohen, R.; Bingen, E.; Aujard, Y. 2012: Therapeutic strategies for Escherichia coli neonatal meningitis. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 19(Suppl 3): S140-S144
Abian, O.; Alfonso, P.; Velazquez-Campoy, A.; Giraldo, P.; Pocovi, M.; Sancho, J. 2011: Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imiglucerase. Molecular Pharmaceutics 8(6): 2390-2397
Gueven, N.; Faldu, D. 2013: Therapeutic strategies for Leber's hereditary optic neuropathy: A current update. Intractable and Rare Diseases Research 2(4): 130-135
Wang, X.; Liang, X.-B.; Li, F.-Q.; Zhou, H.-F.; Liu, X.-Y.; Wang, J.-J.; Wang, X.-M. 2008: Therapeutic strategies for Parkinson's disease: the ancient meets the future--traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochemical Research 33(10): 1956-1963
Yamamoto, Y.; Yamamoto, H. 2014: Therapeutic strategies for RAGE-mediated diseases. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 143(1): 10-13
Hayashi, T. 2010: Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy. Journal of Biomedicine and Biotechnology 2010
Rogers, T.J.; Paton, J.C. 2009: Therapeutic strategies for Shiga toxin-producing Escherichia coli infections. Expert Review of AntI-Infective Therapy 7(6): 683-686
Lavers, I. 2013: Therapeutic strategies for acne vulgaris. Nursing Times 109(48): 16-18
Nashan, D.ée.; Meiss, F.; Müller, M. 2013: Therapeutic strategies for actinic keratoses--a systematic review. European Journal of Dermatology: Ejd 23(1): 14-32
Sato, Y.; Satokawa, H.; Takase, S.; Misawa, Y.; Wakamatsu, H.; Sato, Y.; Yokoyama, H. 2007: Therapeutic strategies for acute type A aortic dissection. Kyobu Geka. Japanese Journal of Thoracic Surgery 60(4): 262-266
Delacroix, S.E.; Pettaway, C.A. 2010: Therapeutic strategies for advanced penile carcinoma. Current Opinion in Supportive and Palliative Care 4(4): 285-292
Kitagawa, Y. 2008: Therapeutic strategies for advanced respectable esophageal cancer. Nihon Geka Gakkai Zasshi 109(6): 333-337
Ebihara, T. 2014: Therapeutic strategies for atopic dermatitis on skin barrier function. Arerugi 63(6): 758-763
Sekita, G.; Daida, H. 2007: Therapeutic strategies for atrial fibrillation. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 96(5): 1014-1019
Manns, M.P.; Strassburg, C.P. 2011: Therapeutic strategies for autoimmune hepatitis. Digestive Diseases 29(4): 411-415
Akiyama, F.; Horii, R. 2009: Therapeutic strategies for breast cancer based on histological type. Breast Cancer 16(3): 168-172
Pachman, D.R.; Watson, J.C.; Loprinzi, C.L. 2014: Therapeutic strategies for cancer treatment related peripheral neuropathies. Current Treatment Options in Oncology 15(4): 567-580
Kaestner, F.; Mostert, C.; Behnken, A.; Boeckermann, I.; Ternes, F.; Diedrich, M.; Zavorotnyy, M.; Arolt, V.; Weckesser, M.; Rothermundt, M. 2008: Therapeutic strategies for catatonia in paraneoplastic encephalitis. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 9(3): 236-240
Lu, X.-t. 2013: Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia. Beijing da Xue Xue Bao. Yi Xue Ban 45(2): 327-332
Khokhar, A.; Afdhal, N.H. 2008: Therapeutic strategies for chronic hepatitis B virus infection in 2008. American Journal of Medicine 121(12 Suppl): S33-S44
Van den Berg-Wolf, M.; Tedaldi, E.M. 2009: Therapeutic strategies for chronic hepatitis B virus infection in 2008-optimum dosing lamivudine challenged for HIV-1 infected patients. American Journal of Medicine 122(8): E11
Liu, K.D. 2014: Therapeutic strategies for clinical trials targeting renal recovery. Nephron. Clinical Practice 127(1-4): 113-116
Cobanoglu, U.; Sayır, F.; Sehitoğlu, A.; Bilici, S.; Melek, M. 2011: Therapeutic strategies for complications secondary to hydatid cyst rupture. International Journal of Clinical and Experimental Medicine 4(3): 220-226
Kaneda, Y. 2012: Therapeutic strategies for controlling the metastasis and recurrence of cancers: contribution of drug delivery technologies. Advanced Drug Delivery Reviews 64(8): 707-709
Sellar, R.S.; Peggs, K.S. 2014: Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update. Expert Opinion on Biological Therapy 14(8): 1121-1126
Fox, T.E.; Kester, M. 2010: Therapeutic strategies for diabetes and complications: a role for sphingolipids?. Advances in Experimental Medicine and Biology 688: 206-216
Habib, A.A.; Brannagan, T.H. 2010: Therapeutic strategies for diabetic neuropathy. Current Neurology and Neuroscience Reports 10(2): 92-100
Ha, J.-W.; Oh, J.K. 2009: Therapeutic strategies for diastolic dysfunction: a clinical perspective. Journal of Cardiovascular Ultrasound 17(3): 86-95
Deshpande, D.D.; Janero, D.R.; Amiji, M.M. 2011: Therapeutic strategies for endothelial dysfunction. Expert Opinion on Biological Therapy 11(12): 1637-1654
Nakata, S.; Imagawa, A. 2012: Therapeutic strategies for fulminant type 1 diabetes. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 549-553
Ota, I.; Okamoto, N.; Yane, K.; Takahashi, A.; Masui, T.; Hosoi, H.; Ohnishi, T. 2012: Therapeutic strategies for head and neck cancer based on p53 status. Experimental and Therapeutic Medicine 3(4): 585-591
House, A.A.; Haapio, M.; Lassus, J.; Bellomo, R.; Ronco, C. 2010: Therapeutic strategies for heart failure in cardiorenal syndromes. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 56(4): 759-773
Stasi, R. 2009: Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopenias. Seminars in Hematology 46(1 Suppl 2: S15-S25
Nozaki, K.; Kikuta, K.-i.; Takagi, Y.; Hashimoto, N. 2006: Therapeutic strategies for high grade AVMs. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 8): 680-683
Bassi, E.ão.; Park, M.; Azevedo, L.C.P. 2013: Therapeutic strategies for high-dose vasopressor-dependent shock. Critical Care Research and Practice 2013: 654708
Epaud, R.; Dubern, B.; Larroquet, M.; Tamalet, A.; Guillemot, N.; Maurage, C.; Clement, A.; Fauroux, B. 2008: Therapeutic strategies for idiopathic chylothorax. Journal of Pediatric Surgery 43(3): 461-465
Drappatz, J.; Norden, A.D.; Wen, P.Y. 2009: Therapeutic strategies for inhibiting invasion in glioblastoma. Expert Review of Neurotherapeutics 9(4): 519-534
Filioti, I.; Iosifidis, E.; Roilides, E. 2008: Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients. Expert Opinion on PharmacoTherapy 9(18): 3179-3196
Yuksel, E.S.; Vaezi, M.F. 2013: Therapeutic strategies for laryngeal manifestations of gastroesophageal reflux disease. Journal of Clinical Gastroenterology 47(3): 195-204
Ruan, Y.; Liu, N.; Napolitano, C.; Priori, S.G. 2008: Therapeutic strategies for long-QT syndrome: does the molecular substrate matter?. CIRCULATION. Arrhythmia and Electrophysiology 1(4): 290-297
Naik, R.; Obiang-Obounou, B.W.; Kim, M.; Choi, Y.; Lee, H.S.; Lee, K. 2014: Therapeutic strategies for metabolic diseases: Small-molecule diacylglycerol acyltransferase (DGAT) inhibitors. Chemmedchem 9(11): 2410-2424
Kanter, v.I.Christine.; Mäurer, M. 2008: Therapeutic strategies for multiple sclerosis--update 2008. MMW Fortschritte der Medizin 150(23): 42-45
Sunada, Y. 2006: Therapeutic strategies for muscular dystrophy by myostatin inhibition. Rinsho Shinkeigaku 46(11): 942-944
Matsuo, M.; Nonaka, I. 2014: Therapeutic strategies for muscular dystrophy: F based on the international guideline. No to Hattatsu 46(2): 87-88
Frilling, A.; Clift, A.K. 2015: Therapeutic strategies for neuroendocrine liver metastases. Cancer 121(8): 1172-1186
Bickel, A. 2009: Therapeutic strategies for neuropathic pain. MMW Fortschritte der Medizin 151(17): 40-44; Quiz 45
Bhidayasiri, R.; Truong, D.D. 2012: Therapeutic strategies for nonmotor symptoms in early Parkinson's disease: the case for a higher priority and stronger evidence. Parkinsonism and Related Disorders 18(Suppl 1): S110-S113
Mussa, A. 2008: Therapeutic strategies for obsessive-compulsive disorder refractory to treatment. Vertex 19(79): 143-155
Chen, K.-H.; Hsu, H.-M.; Hsu, G.-C.; Chen, T.-W.; Hsieh, C.-B.; Liu, Y.-C.; Chan, D.-C.; Yu, J.-C. 2008: Therapeutic strategies for pancreatic pseudocysts: experience in Taiwan. Hepato-Gastroenterology 55(85): 1470-1474
Kawabori, M.; Kuroda, S.; Terasaka, S.; Nakayama, N.; Matsui, Y.; Kubota, S.; Nakamura, M.; Nakanishi, K.; Okamoto, F.; Iwasaki, Y. 2010: Therapeutic strategies for patients with internal carotid or middle cerebral artery occlusion complicated by severe coronary artery disease. World Neurosurgery 73(4): 345-350
Boerner, R.J.; Möller, H.J. 1998: Therapeutic strategies for patients with social phobia. International Journal of Psychiatry in Clinical Practice 2(2): 107-113
Nobili, V.; Manco, M. 2007: Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers. World Journal of Gastroenterology 13(18): 2639-2641
Wozel, G. 2009: Therapeutic strategies for psoriasis and psoriatic arthritis. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 60(2): 91-99
Calabrese, M.; Gajofatto, A.; Benedetti, M.D. 2014: Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. Expert Review of Neurotherapeutics 14(12): 1417-1428
Hasegawa, S. 2009: Therapeutic strategies for resectable malignant pleural mesothelioma. Nihon Geka Gakkai Zasshi 110(6): 338-342
Diaz, J.V.; Brower, R.; Calfee, C.S.; Matthay, M.A. 2010: Therapeutic strategies for severe acute lung injury. Critical Care Medicine 38(8): 1644-1650
Li, X.-h.; Li, F.-x.; Xiao, Z.-l. 2013: Therapeutic strategies for severe acute respiratory distress syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 25(3): 186-189
Horie, Y.; Yamagishi, Y.; Ebinuma, H.; Hibi, T. 2011: Therapeutic strategies for severe alcoholic hepatitis. Clinics and Research in Hepatology and Gastroenterology 35(11): 738-744
Guillevin, L.ïc.; Pagnoux, C. 2007: Therapeutic strategies for systemic necrotizing vasculitides. Allergology International: Official Journal of the Japanese Society of Allergology 56(2): 105-111
Pratilas, C.A.; Solit, D.B. 2007: Therapeutic strategies for targeting BRAF in human cancer. Reviews on Recent Clinical Trials 2(2): 121-134
Fisher, J.P.; Fadel, P.J. 2010: Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Experimental Physiology 95(5): 572-580
Dickens, D.S.; Jubinsky, P.T. 2009: Therapeutic strategies for targeting mononuclear phagocytes in cancer. Journal of Pediatric Hematology/Oncology 31(1): 14-17
Ko, S.Y.; Naora, H. 2014: Therapeutic strategies for targeting the ovarian tumor stroma. World Journal of Clinical Cases 2(6): 194-200
Gross, G.; Hoffmann, A. 2013: Therapeutic strategies for tendon healing based on novel biomaterials, factors and cells. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 80(4): 203-210
Jones, S.A.; Scheller, J.ür.; Rose-John, S. 2011: Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. Journal of Clinical Investigation 121(9): 3375-3383
Hottinger, A.F.; Stupp, R. 2008: Therapeutic strategies for the management of gliomas. Revue Neurologique (Paris) 164(6-7): 523-530
Ng, S.C.; Kamm, M.A. 2009: Therapeutic strategies for the management of ulcerative colitis. Inflammatory Bowel Diseases 15(6): 935-950
Sellar, R.S.; Peggs, K.S. 2012: Therapeutic strategies for the prevention and treatment of cytomegalovirus infection. Expert Opinion on Biological Therapy 12(9): 1161-1172
Freier, K.; Mertens, C.; Engel, M.; Hoffmann, J. 2013: Therapeutic strategies for the reconstruction of extensive mandibular defects. Hno 61(7): 551-558
Kandulski, A.; Venerito, M.; Malfertheiner, P. 2010: Therapeutic strategies for the treatment of dyspepsia. Expert Opinion on PharmacoTherapy 11(15): 2517-2525
Saini, N.; Mahindra, A. 2013: Therapeutic strategies for the treatment of multiple myeloma. Discovery Medicine 15(83): 251-258
Cherry, J.J.; Androphy, E.J. 2012: Therapeutic strategies for the treatment of spinal muscular atrophy. Future Medicinal Chemistry 4(13): 1733-1750
Verron, E.; Schmid-Antomarchi, H.; Pascal-Mousselard, H.; Schmid-Alliana, A.; Scimeca, J.-C.; Bouler, J.-M. 2014: Therapeutic strategies for treating osteolytic bone metastases. Drug Discovery Today 19(9): 1419-1426
Tan, A.R.; Swain, S.M. 2008: Therapeutic strategies for triple-negative breast cancer. Cancer Journal 14(6): 343-351
Lee, Y.K.; Jun, H.J.; Nahm, J.H.; Lim, T.S.; Park, J.S.; Ahn, J.B.; Rha, S.Y.; Chung, H.C.; Oh, H.E.; Song, J.-S.; Yang, W.I.; Kim, H.S. 2013: Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum. Japanese Journal of Clinical Oncology 43(10): 996-1003
Lukey, M.J.; Wilson, K.F.; Cerione, R.A. 2013: Therapeutic strategies impacting cancer cell glutamine metabolism. Future Medicinal Chemistry 5(14): 1685-1700
Nakamura, T.; Nishiura, Y.; Eguchi, K. 2009: Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Central Nervous System Agents in Medicinal Chemistry 9(2): 137-149
Buerke, M.; Lemm, H.; Russ, M.; Schlitt, A.; Werdan, K. 2010: Therapeutic strategies in acute decompensated heart failure and cardiogenic shock. Der Internist 51(8): 963-974
Alase, A.; Wittmann, M. 2012: Therapeutic strategies in allergic contact dermatitis. Recent Patents on Inflammation and Allergy Drug Discovery 6(3): 210-221
Cervera, R. 2010: Therapeutic strategies in antiphospholipid syndrome. Reumatologia Clinica 6(1): 37-42
Ghezzi, A. 2010: Therapeutic strategies in childhood multiple sclerosis. Therapeutic Advances in Neurological Disorders 3(4): 217-228
Krammoh, E.K.; Bigras, J.-L.; Prsa, M.; Lapierre, C.; Miró, J.; Dahdah, N.S. 2010: Therapeutic strategies in children with an isolated unilaterally absent proximal pulmonary artery. Pediatric Cardiology 31(5): 607-610
Schara, U.; Lochmüller, H. 2008: Therapeutic strategies in congenital myasthenic syndromes. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 5(4): 542-547
Sahinbegovic, E.; Schett, G. 2011: Therapeutic strategies in erosive digital polyarthrosis. Der Internist 52(6): 682-687
Di Lernia, V. 2015: Therapeutic strategies in extrinsic atopic dermatitis: focus on inhibition of IL-4 as a new pharmacological approach. Expert Opinion on Therapeutic Targets 19(1): 87-96
Chakour, R.; Leimgruber, A.; Bart, P.-A.; Spertini, F.ço. 2009: Therapeutic strategies in idiopatic inflammatory myopathies. Revue Medicale Suisse 5(199): 812-818
Eggimann, P. 2007: Therapeutic strategies in intensive care units. Medecine et Maladies Infectieuses 37(Suppl 2): 5-8
Black, J.L.; Yin Ng, H.; Moir, L.M. 2014: Therapeutic strategies in lymphangioleiomyomatosis (LAM). Respiratory Investigation 52(1): 3-4
Schildhaus, H.-U.; Schroeder, L.; Merkelbach-Bruse, S.; Binot, E.; Büttner, R.; Kuhn, W.; Rudlowski, C. 2013: Therapeutic strategies in male breast cancer: clinical implications of chromosome 17 gene alterations and molecular subtypes. Breast 22(6): 1066-1071
Jordan, S.C.; Peng, A.; Vo, A.A. 2009: Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients. Contributions to Nephrology 162: 13-26
Finocchi, C.; Villani, V.; Casucci, G. 2010: Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 31(Suppl 1): S95-S98
Casucci, G.; Villani, V.; Finocchi, C. 2010: Therapeutic strategies in migraine patients with mood and anxiety disorders: physiopathological basis. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 31(Suppl 1): S99-101
Goldschmidt, H.; Kropff, M.; Mügge, L.-O.; Pönisch, W. 2013: Therapeutic strategies in multiple myeloma: the future role of bendamustine. Onkologie 36(Suppl 1): 19-26
Comabella, M.; Khoury, S.J. 2012: Therapeutic strategies in multiple sclerosis. Clinical Immunology 142(1): 1
Inglese, M.; Petracca, M. 2015: Therapeutic strategies in multiple sclerosis: a focus on neuroprotection and repair and relevance to schizophrenia. Schizophrenia Research 161(1): 94-101
Mariette, C.; Piessen, G.; Triboulet, J.-P. 2007: Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. LANCET. Oncology 8(6): 545-553
Zellweger, M.J.; Pfisterer, M.E. 2011: Therapeutic strategies in patients with chronic stable coronary artery disease. Cardiovascular Therapeutics 29(6): E23-E30
Gulino, G.; Palermo, G.; Antonucci, M.; Racioppi, M.; Pinto, F.; Sacco, E.; Bassi, P.F. 2013: Therapeutic strategies in penile cancer: state of the art. Urologia 80(1): 1-10
Terzis, J.K.; Karypidis, D. 2012: Therapeutic strategies in post-facial paralysis synkinesis in adult patients. Plastic and Reconstructive Surgery 129(6): 925e-939e
Fuso, L.; Baldi, F.; Di Perna, A. 2011: Therapeutic strategies in pulmonary hypertension. Frontiers in Pharmacology 2: 21
Bastian, H.; Feist, E.; Burmester, G.-R. 2011: Therapeutic strategies in rheumatoid arthritis. Der Internist 52(6): 645-656
Märker-Hermann, E.; Gross, W.L. 2011: Therapeutic strategies in rheumatology. new concepts, new agents, observance of comorbidities. Der Internist 52(6): 643-644
Bortoluzzi, A.; Padovan, M.; Farina, I.; Galuppi, E.; De Leonardis, F.; Govoni, M. 2012: Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre. Reumatismo 64(6): 350-359
Steib, S.; Schupp, W. 2012: Therapeutic strategies in stroke aftercare. Contents and effects. Der Nervenarzt 83(4): 467-475
Vibert, E.; Azoulay, D.; Aloia, T.; Pascal, G.ér.; Veilhan, L.-A.; Adam, R.é; Samuel, D.; Castaing, D. 2007: Therapeutic strategies in symptomatic portal biliopathy. Annals of Surgery 246(1): 97-104
Papatheodoridis, G.V.; Manolakopoulos, S.; Dusheiko, G.; Archimandritis, A.J. 2008: Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. Lancet. Infectious Diseases 8(3): 167-178
Veenstra, R.D. 2018: Control of Cell Proliferation by Polyamine Signaling through Gap Junctions, Feasible or Not?. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 40(6): E1800043
Jiang, W.-y.; Ma, W.-h.; Xu, R.-m. 2009: Therapeutic strategies in the surgical treatment of Hangman's fractures. Zhongguo Gu Shang 22(8): 585-588
Shah, I.M.; Mackay, S.P.; McKay, G.A. 2009: Therapeutic strategies in the treatment of diabetic nephropathy - a translational medicine approach. Current Medicinal Chemistry 16(8): 997-1016
Xiao, B.-p.; Li, M.; Mao, W.-m.; Xu, R.-m.; Zhou, L.; Zhang, J.-w. 2008: Therapeutic strategies of grade-IIi open fractures of tibia and fibula. Zhongguo Gu Shang 21(4): 289-290
Koshinaga, T.; Inoue, M.; Ohashi, K.; Sugito, K.; Ikeda, T.; Tomita, R. 2011: Therapeutic strategies of meconium obstruction of the small bowel in very-low-birthweight neonates. Pediatrics International: Official Journal of the Japan Pediatric Society 53(3): 338-344
Vecchierini, M.-F.; Laaban, J.-P.; Desjobert, M.; Gagnadoux, F.; Chabolle, F.; Meurice, J.-C.; Sapène, M.; Serrier, P.; Lévy, P. 2010: Therapeutic strategies of obstructive sleep apnea syndrome integrating combined treatments?. Revue des Maladies Respiratoires 27(Suppl 3): S166-S178
Denys, P.; Phe, V.; Even, A.; Chartier-Kastler, E. 2014: Therapeutic strategies of urinary disorders in MS. Practice and algorithms. Annals of Physical and Rehabilitation Medicine 57(5): 297-301
Toda, M. 2009: Therapeutic strategies targeting brain tumor stem cells. Brain and Nerve 61(7): 799-803
Carrasco-Garcia, E.; Sampron, N.; Aldaz, P.; Arrizabalaga, O.; Villanua, J.; Barrena, C.; Ruiz, I.; Arrazola, M.; Lawrie, C.; Matheu, A. 2013: Therapeutic strategies targeting glioblastoma stem cells. Recent Patents on Anti-Cancer Drug Discovery 8(3): 216-227
Wang, H.-D.; Lu, D.-X.; Qi, R.-B. 2009: Therapeutic strategies targeting the LPS signaling and cytokines. Pathophysiology: the Official Journal of the International Society for Pathophysiology 16(4): 291-296
Becker, B.F.; Chappell, D.; Bruegger, D.; Annecke, T.; Jacob, M. 2010: Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovascular Research 87(2): 300-310
Safo, M.K.; Kato, G.J. 2014: Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin. Hematology/Oncology Clinics of North America 28(2): 217-231
Forcelli, P.A.; Janssen, M.J.; Stamps, L.A.; Sweeney, C.; Vicini, S.; Gale, K. 2010: Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure. Epilepsia 51(Suppl 3): 18-23
Collins, M.J.; Li, X.; Lv, W.; Yang, C.; Protack, C.D.; Muto, A.; Jadlowiec, C.C.; Shu, C.; Dardik, A. 2012: Therapeutic strategies to combat neointimal hyperplasia in vascular grafts. Expert Review of Cardiovascular Therapy 10(5): 635-647
Bodas, M.; Tran, I.; Vij, N. 2012: Therapeutic strategies to correct proteostasis-imbalance in chronic obstructive lung diseases. Current Molecular Medicine 12(7): 807-814
Miller, C.P.; Singh, M.M.; Rivera-Del Valle, N.; Manton, C.A.; Chandra, J. 2011: Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors. Journal of Biomedicine and Biotechnology 2011: 514261
Armario, P.; Waeber, B. 2013: Therapeutic strategies to improve control of hypertension. Journal of Hypertension 31(Suppl 1): S9-12
Torres-Castro, R.; Monge, G.; Vera, R.; Puppo, H.; Céspedes, J.; Vilaró, J. 2014: Therapeutic strategies to increase the effectiveness of cough. Revista Medica de Chile 142(2): 238-245
McKeown, M.R.; Bradner, J.E. 2014: Therapeutic strategies to inhibit MYC. Cold Spring Harbor Perspectives in Medicine 4(10)
Berlin, I. 2009: Therapeutic strategies to optimize the efficacy of nicotine replacement therapies. Copd 6(4): 272-276
Katayama, R.; Khan, T.M.; Benes, C.; Lifshits, E.; Ebi, H.; Rivera, V.M.; Shakespeare, W.C.; Iafrate, A.J.; Engelman, J.A.; Shaw, A.T. 2011: Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK. Proceedings of the National Academy of Sciences of the United States of America 108(18): 7535-7540
Schmidt, B.M.W. 2012: Therapeutic strategies to prevent chronic kidney disease progression. Der Internist 53(7): 810-816
Quintavalle, C.; Donnarumma, E.; Fiore, D.; Briguori, C.; Condorelli, G. 2013: Therapeutic strategies to prevent contrast-induced acute kidney injury. Current Opinion in Cardiology 28(6): 676-682
Kieburtz, K. 2008: Therapeutic strategies to prevent motor complications in Parkinson's disease. Journal of Neurology 255 Suppl. 4: 42-45
Gill, R.S.; Pelletier, J-Sébastien.; LaBossiere, J.; Bigam, D.L.; Cheung, P-Yin. 2012: Therapeutic strategies to protect the immature newborn myocardium during resuscitation following asphyxia. Canadian Journal of Physiology and Pharmacology 90(6): 689-695
Buijs, J.T.; Juárez, P.; Guise, T.A. 2011: Therapeutic strategies to target TGF-β in the treatment of bone metastases. Current Pharmaceutical Biotechnology 12(12): 2121-2137
Tan, J.J.; Cong, X.J.; Hu, L.M.; Wang, C.X.; Jia, L.; Liang, X.-J. 2010: Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection. Drug Discovery Today 15(5-6): 186-197
Yu, H.A.; Riely, G.J.; Lovly, C.M. 2014: Therapeutic strategies utilized in the setting of acquired resistance to EGFR tyrosine kinase inhibitors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(23): 5898-5907
Moore, G.P.; Lawrence, S.L.; Maharajh, G.; Sumner, A.; Gaboury, I.; Barrowman, N.; Lemyre, B. 2012: Therapeutic strategies, including a high surgical ligation rate, for patent ductus arteriosus closure in extremely premature infants in a North American centre. Paediatrics and Child Health 17(4): E26-E31
Guijarro, C.; García-Díaz, J.de.Dios. 2013: Therapeutic strategies. Evolution and current status of the European Guidelines on Cardiovascular disease prevention. Clinica e Investigacion en Arteriosclerosis: Publicacion Oficial de la Sociedad Espanola de Arteriosclerosis 25(2): 92-97
Yoshiji, H.; Fukui, H. 2014: Therapeutic strategy against chronic hepatitis C without viral eradication. Nihon Shokakibyo Gakkai Zasshi 111(9): 1765-1773
Hirose, Y. 2011: Therapeutic strategy against gliomas based on their molecular biological nature. No Shinkei Geka. Neurological Surgery 39(9): 837-847
Suzumura, A. 2008: Therapeutic strategy against multiple sclerosis. Rinsho Shinkeigaku 48(11): 937-939
Matsui, T. 2012: Therapeutic strategy and long-term outcome of meningiomas located in the posterior cranial fossa. Neurologia Medico-Chirurgica 52(10): 704-713
Meng, T.; Yin, H.; Li, Z.; Li, B.; Zhou, W.; Wang, J.; Zhou, L.; Song, D.; Xiao, J. 2015: Therapeutic strategy and outcome of spine tumors in pregnancy: a report of 21 cases and literature review. Spine 40(3): E146-E153
Wang, X.-s.; Hao, Y.-h. 2012: Therapeutic strategy and prognostic factors in colorectal cancer patients with pulmonary metastasis. Zhonghua Wei Chang Wai Ke Za Zhi 15(10): 1017-1019
Nozaki, Y.; Nagare, Y.; Hino, S.; Yano, T.; Kishimoto, K.; Shimazu, H.; Ikoma, S.; Kinoshita, K.; Funauchi, M. 2010: Therapeutic strategy and significance of serum rheumatoid factor in patients with rheumatoid arthritis during infliximab treatment. Nihon Rinsho Men'eki Gakkai Kaishi 33(3): 135-141
Sakai, N.; Wada, T. 2014: Therapeutic strategy and thrombotic microangiopathy. Nihon Jinzo Gakkai Shi 56(7): 1082-1089
Iijima, M.; Koike, H.; Sobue, G. 2013: Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy). Nihon Rinsho. Japanese Journal of Clinical Medicine 71(5): 855-860
Oshitani, N.; Matsumoto, H.; Aomatsu, K.; Suwa, I. 2012: Therapeutic strategy for Crohn's disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 1): 280-285
Kurahashi, K. 2011: Therapeutic strategy for acute respiratory distress syndrome: recent understanding of the pathophysiology of the disease. Journal of Anesthesia 25(1): 155-156
Kalderon, N.; Muruganandham, M.; Koutcher, J.A.; Potuzak, M. 2007: Therapeutic strategy for acute spinal cord contusion injury: cell elimination combined with microsurgical intervention. Plos one 2(6): E565
Darius, T.; Reding, R. 2014: Therapeutic strategy for anastomotic biliary strictures after pediatric liver transplantation: two radically different approaches. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20(8): 876-878
Kamisawa, T.; Satake, K. 2008: Therapeutic strategy for autoimmune pancreatitis. Advances in Medical Sciences 53(2): 145-148
Yoshida, G.J.; Saya, H. 2012: Therapeutic strategy for breast cancer stem cells. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 243-248
Mak, R.H.; Cheung, W. 2007: Therapeutic strategy for cachexia in chronic kidney disease. Current Opinion in Nephrology and Hypertension 16(6): 542-546
Turkina, A.G.; Chelysheva, E.I. 2013: Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects. Terapevticheskii Arkhiv 85(7): 4-9
Oka, S.; Tanaka, S.; Kanao, H.; Oba, S.; Chayama, K. 2009: Therapeutic strategy for colorectal laterally spreading tumor. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society 21(Suppl 1): S43-S46
Takami, H.; Ito, Y.; Okamoto, T.; Yoshida, A. 2011: Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World journal of surgery 35(1): 111-121
Bebezov, B.K.; Nuraliev, M.A.; Kakchekeeva, T.T.; Salieva, B.R.; Chazymov, R.M. 2013: Therapeutic strategy for diffuse toxic goiter. Klinicheskaia Meditsina 91(9): 61-67
Andretta, M.; Scomersi, S.; Urbani, M.; Bortul, M. 2014: Therapeutic strategy for ductal carcinoma in situ patients according to van Nuys Prognostic Index. Annali Italiani di Chirurgia 85(3): 254-259
Kunisaki, C.; Makino, H.; Kimura, J.; Oshima, T.; Fujii, S.; Takagawa, R.; Kosaka, T.; Ono, H.; Akiyama, H.; Endo, I. 2011: Therapeutic strategy for esophageal cancer based on solitary lymph node metastasis. Hepato-Gastroenterology 58: 110-111
Ikeda, S.-i. 2009: Therapeutic strategy for familial amyloid polyneuropathy (FAP). Rinsho Shinkeigaku 49(11): 953-955
Iwasaki, Y.; Ohashi, M.; Iwanaga, T.; Oohinata, R.; Yuu, K.; Takahashi, K.; Yamaguchi, T.; Matsumoto, H.; Nakano, D. 2012: Therapeutic strategy for gastric cancer with positive peritoneal lavage cytology without peritoneal dissemination. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(13): 2451-2454
Akahane, K.; Tsunoda, N.; Kato, M.; Noda, S.; Shimoyama, Y.; Ishigakis, S.; Satake, H.; Nakamura, S.; Nagino, M. 2013: Therapeutic strategy for granulomatous lobular mastitis: a clinicopathological study of 12 patients. Nagoya Journal of Medical Science 75(3-4): 193-200
Chueh, S.-C.; Lin, S.-J.; Chen, C.-C.; Lei, M.; Wang, L.M.; Widelitz, R.; Hughes, M.W.; Jiang, T.-X.; Chuong, C.M. 2013: Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering. Expert Opinion on Biological Therapy 13(3): 377-391
Léveillard, T.; Fridlich, R.; Clérin, E.; Aït-Ali, N.; Millet-Puel, G.ér.; Jaillard, C.él.; Yang, Y.; Zack, D.; van-Dorsselaer, A.; Sahel, J.é-A. 2014: Therapeutic strategy for handling inherited retinal degenerations in a gene-independent manner using rod-derived cone viability factors. Comptes Rendus Biologies 337(3): 207-213
Kim, K.-H.; Kim, D.-I.; Kim, I.-H.; Kim, J.-Y.; Han, Y.-C.; Seol, S.-H.; Kim, U.; Yang, T.-H.; Kim, D.-K.; Kim, D.-S.; Lee, S.-H.; Park, J.-S.; Kim, Y.-J.; Shin, D.-G.; Cho, Y.-K.; Nam, C.-W.; Hur, S.-H.; Kim, K.-B. 2009: Therapeutic strategy for in-stent restenosis based on the restenosis pattern after drug-eluting stent implantation. Korean Circulation Journal 39(10): 408-413
Liu, W.-m.; Ni, M.; Jia, W.; Guan, S.-s.; Jia, G.-j. 2010: Therapeutic strategy for intrasellar cystic lesions. Zhonghua Yi Xue Za Zhi 90(41): 2932-2934
Yamashita, T.; Deguchi, K.; Sehara, Y.; Lukic-Panin, V.; Zhang, H.; Kamiya, T.; Abe, K. 2009: Therapeutic strategy for ischemic stroke. Neurochemical Research 34(4): 707-710
Kammori, M.; Fukumori, T.; Sugishita, Y.; Hoshi, M.; Yamada, T. 2014: Therapeutic strategy for low-risk thyroid cancer in Kanaji Thyroid Hospital. Endocrine Journal 61(1): 1-12
Hara, H.; Mihara, M.; Hayashi, A.; Kanemaru, M.; Todokoro, T.; Yamamoto, T.; Iida, T.; Hino, R.; Koshima, I. 2014: Therapeutic strategy for lower limb lymphedema and lymphatic fistula after resection of a malignant tumor in the hip joint region: a case report. Microsurgery 34(3): 224-228
Makino, H.; Kobayashi, M.; Sada, K. 2007: Therapeutic strategy for lupus nephritis based on the new classification. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 96(9): 2039-2045
Koyanagi, K.; Ozawa, S. 2011: Therapeutic strategy for marginally resectable esophageal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(8): 1241-1245
Kanemoto, K.; Oshima, T. 2011: Therapeutic strategy for mental symptoms and behavioral problems in people with epilepsy. Brain and Nerve 63(4): 371-377
Oshima, T.; Kato, E.; Tadokoro, Y.; Kanemoto, K. 2014: Therapeutic strategy for mental symptoms in people with epilepsy. Nihon Rinsho. Japanese Journal of Clinical Medicine 72(5): 902-906
Ohnuma, S.; Naitoh, T.; Haneda, S.; Kudoh, K.; Kohyama, A.; Nagao, M.; Tanaka, N.; Sasaki, H.; Aoki, T.; Abe, T.; Musha, H.; Morikawa, T.; Yoshida, H.; Motoi, F.; Katayose, Y.; Shibata, C.; Unno, M. 2013: Therapeutic strategy for neuroendocrine tumor of the rectum. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2077-2079
Kim, Y.H.; Nagai, H.; Ozasa, H.; Sakamori, Y.; Mishima, M. 2013: Therapeutic strategy for non-small-cell lung cancer patients with brain metastases (Review). Biomedical Reports 1(5): 691-696
Yoshino, K.; Imai, Y.; Nakazawa, M.; Chikayama, T.; Ando, S.; Sugawara, K.; Hamaoka, K.; Inao, M.; Oka, M.; Mochida, S. 2014: Therapeutic strategy for patients with bleeding rectal varices complicating liver cirrhosis. Hepatology Research: the Official Journal of the Japan Society of Hepatology 44(11): 1088-1094
Kanda, T. 2008: Therapeutic strategy for peripheral nerve regeneration; molecular permeability control at the blood-nerve barrier. Rinsho Shinkeigaku 48(11): 1028-1030
Kubota, A.; Nara, K.; Kawahara, H.; Yoneda, A.; Nakai, H.; Goda, T.; Ibuka, S.; Matsui, F.; Shimada, K. 2011: Therapeutic strategy for persistent cloaca: the efficacy of antegrade continent enema as a salvage surgery. Pediatric Surgery International 27(5): 505-508
Iihara, M. 2009: Therapeutic strategy for pheochromocytoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(10): 1623-1626
Suzuki, H. 2011: Therapeutic strategy for prevention of contrast-induced nephropathy. Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl. 7: 220-225
Asayama, M.; Yamada-Murano, T.; Hara, H.; Ooki, A.; Yoshii, T.; Yamaguchi, K. 2013: Therapeutic strategy for recurrent gastric cancer and efforts aimed at finding a cure. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(8): 976-980
Miura, H.; Nakajima, N.; Takahashi, H.; Kinoshita, M.; Ikeda, N. 2010: Therapeutic strategy for secondary lung cancer. Kyobu Geka. Japanese Journal of Thoracic Surgery 63(11): 956-961
Qian, Z.-y.; Miao, Y. 2007: Therapeutic strategy for severe acute pancreatitis and pancreatic encephalopathy. Zhonghua Wai Ke Za Zhi 45(11): 740-741
Maruyama, K.; Motoyama, S.; Anbai, A.; Usami, S.; Sato, Y.; Shibuya, K.; Yoshino, K.; Nakatsu, T.; Minamiya, Y.; Ogawa, J.-I. 2011: Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 24(3): 166-171
Hashikawa, K.; Terashi, H.; Tahara, S. 2007: Therapeutic strategy for the triad of acquired anophthalmic orbit. Plastic and Reconstructive Surgery 119(7): 2182-2188
Cao, P.; Liang, Y.; Gong, Y.-C.; Zheng, T.; Zhang, X.-K.; Wu, W.-J. 2008: Therapeutic strategy for traumatic instability of subaxial cervical spine. Chinese Medical Journal 121(15): 1364-1368
Akashi, H.; Kawamoto, S.; Saiki, Y.; Sakamoto, T.; Sawa, Y.; Tsukube, T.; Kubota, S.; Matsui, Y.; Karube, N.; Imoto, K.; Yamanaka, K.; Kondo, S.; Tobinaga, S.; Tanaka, H.; Okita, Y.; Fujita, H. 2014: Therapeutic strategy for treating aortoesophageal fistulas. General Thoracic and Cardiovascular Surgery 62(10): 573-580
Berhoune, M.; Banu, E.; Scotte, F.; Prognon, P.; Oudard, S.; Bonan, B. 2008: Therapeutic strategy for treatment of metastatic non-small cell lung cancer. Annals of PharmacoTherapy 42(11): 1640-1652
Kitano, M. 2011: Therapeutic strategy for tuberculous empyema--trends in plombage. Kekkaku: 86(2): 69-78
Sasaki, T.; Koizumi, W.; Higuchi, K.; Ishido, K.; Ae, T.; Nakatani, K.; Katada, C.; Tanabe, S.; Saigenji, K. 2007: Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(7): 988-992
Okazaki, K.; Kurishima, A.; Okazaki, T.; Matsushita, M. 2012: Therapeutic strategy for ulcerative colitis. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 1): 273-279
Kawakami, M. 2012: Therapeutic strategy in diabetes for the prevention of its complications. Nihon Rinsho. Japanese Journal of Clinical Medicine 70 Suppl. 5: 263-267
Tournadre, A. 2014: Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy). La Revue de Medecine Interne 35(7): 466-471
Tranchant, C. 2009: Therapeutic strategy in myasthenia gravis. Revue Neurologique (Paris) 165(2): 149-154
Freudenberg, F.; Wintergerst, U.; Roesen-Wolff, A.; Albert, M.H.; Prell, C.; Strahm, B.; Koletzko, S.; Ehl, S.; Roos, D.; Tommasini, A.; Ventura, A.; Belohradsky, B.H.; Seger, R.; Roesler, J.; Güngör, T. 2010: Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. Journal of Allergy and Clinical Immunology 125(4): 943-946.E1
Mei, F.; Qin, Y.; Gu, H.; Liu, Y.; Wang, H. 2013: Therapeutic strategy of Bosniak category II renal cyst: a report of 52 cases. Zhonghua Yi Xue Za Zhi 93(24): 1897-1899
Hasegawa, T.; Yoshiyama, M. 2011: Therapeutic strategy of angina pectoris. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 34-38
Nuss, P. 2010: Therapeutic strategy of depressive episodes. Prevention of relapse risk. L'Encephale 36 Suppl. 5: S145-S149
Liu, X.-B.; Wang, J.-A.; Yu, S.P.; Keogh, C.L.; Wei, L. 2008: Therapeutic strategy of erythropoietin in neurological disorders. Cns and Neurological Disorders Drug Targets 7(3): 227-234
Carangelo, B.; Cerillo, A.; Mariottini, A.; Peri, G.; Rubino, G.; Mourmouras, V.; Palma, L. 2010: Therapeutic strategy of late cerebral radionecrosis. A retrospective study of 21 cases. Journal of Neurosurgical Sciences 54(1): 21-28
Riemann, B.; Schober, O. 2009: Therapeutic strategy of papillary microcarcinoma of the thyroid gland: a nuclear medicine perspective. Minerva Endocrinologica 34(1): 81-87
Naruse, M.; Nakao, K.; Nanba, K.; Tagami, T.; Tsuiki, M. 2011: Therapeutic strategy of pheochromocytoma. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 2): 536-539
Kuroda, T.; Matsumoto, T.; Mifune, Y.; Fukui, T.; Kubo, S.; Matsushita, T.; Asahara, T.; Kurosaka, M.; Kuroda, R. 2011: Therapeutic strategy of third-generation autologous chondrocyte implantation for osteoarthritis. Upsala Journal of Medical Sciences 116(2): 107-114
Miyazawa, M.; Yasuda, M.; Fujita, M.; Kajiwara, H.; Hirabayashi, K.; Takekoshi, S.; Hirasawa, T.; Murakami, M.; Ogane, N.; Kiguchi, K.; Ishiwata, I.; Mikami, M.; Osamura, R.Y. 2009: Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. Pathology International 59(1): 19-27
Aoyama, N.; Imai, H.; Kurosawa, T.; Fukuda, N.; Moriguchi, M.; Nishinari, M.; Nishii, M.; Kono, K.; Soma, K.; Izumi, T. 2014: Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction. Journal of Artificial Organs: the Official Journal of the Japanese Society for Artificial Organs 17(1): 33-41
Duc, N.; Monnier, A.; Bergonier, J. 1960: Therapeutic study of the combination of meprobamate with current neuroleptics. Revue Medicale de France 41: 299-301
Vandoros, S. 2014: Therapeutic substitution post-patent expiry: the cases of ACE inhibitors and proton pump inhibitors. Health Economics 23(5): 621-630
Reinke, T. 2011: Therapeutic substitution. a change for the good--or the bad?. Managed Care 20(8): 22-23
Kahan, J.; Mancini, L.; Urner, M.; Friston, K.; Hariz, M.; Holl, E.; White, M.; Ruge, D.; Jahanshahi, M.; Boertien, T.; Yousry, T.; Thornton, J.S.; Limousin, P.; Zrinzo, L.; Foltynie, T. 2012: Therapeutic subthalamic nucleus deep brain stimulation reverses cortico-thalamic coupling during voluntary movements in Parkinson's disease. Plos one 7(12): E50270
Camartin, C. 2014: Therapeutic success with TARGIN in practice. Revue Medicale Suisse 10(431): 1129
Da Costa, A.F.G.; Meireles, J.; Festas, M.J.; Gomes, A.; Abreu, P. 2014: Therapeutic success with local botulinum toxin in erythromelalgia. Pain Physician 17(5): E658-E660
Schlanger, J.; Fritúz, G.áb.; Varga, K. 2013: Therapeutic suggestion helps to cut back on drug intake for mechanically ventilated patients in intensive care unit. Interventional Medicine and Applied Science 5(4): 145-152
Telling, M. 2014: Therapeutic suggestion. 1914. Practitioner 258(1770): 34
Friedman, B. 1947: Therapeutic sulfadiazine poisoning with pemphigold lesions: conjuctival signs. Archives of Ophthalmology 37(5): 694
Mifune, Y.; Matsumoto, T.; Murasawa, S.; Kawamoto, A.; Kuroda, R.; Shoji, T.; Kuroda, T.; Fukui, T.; Kawakami, Y.; Kurosaka, M.; Asahara, T. 2013: Therapeutic superiority for cartilage repair by CD271-positive marrow stromal cell transplantation. Cell Transplantation 22(7): 1201-1211
Kupferman, M.E.; Jayakumar, A.; Zhou, G.; Xie, T.; Dakak-Yazici, Y.; Zhao, M.; Ju, J.; Mandal, M.; Jasser, S.; Madden, T.; Myers, J.N.; Priebe, W. 2009: Therapeutic suppression of constitutive and inducible JAKSTAT activation in head and neck squamous cell carcinoma. Journal of Experimental Therapeutics and Oncology 8(2): 117-127
Karijolich, J.; Yu, Y.-T. 2014: Therapeutic suppression of premature termination codons: mechanisms and clinical considerations (review). International Journal of Molecular Medicine 34(2): 355-362
Bordeleau, M-Eve.; Robert, F.; Gerard, B.; Lindqvist, L.; Chen, S.M.H.; Wendel, H-Guido.; Brem, B.; Greger, H.; Lowe, S.W.; Porco, J.A.; Pelletier, J. 2008: Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. Journal of Clinical Investigation 118(7): 2651-2660
Erpenbeck, V.J.; Fischer, I.; Wiese, K.; Schaumann, F.; Schmiedl, A.; Nassenstein, C.; Krug, N.; Hohlfeld, J.M. 2009: Therapeutic surfactants modulate the viability of eosinophils and induce inflammatory mediator release. International Archives of Allergy and Immunology 149(4): 333-342
Balduyck, B.; Trousse, D.; Nakas, A.; Martin-Ucar, A.E.; Edwards, J.; Waller, D.A. 2010: Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?. Annals of Thoracic Surgery 89(3): 907-911
Ozeki, N.; Iwano, S.; Taniguchi, T.; Kawaguchi, K.; Fukui, T.; Ishiguro, F.; Fukumoto, K.; Nakamura, S.; Hirakawa, A.; Yokoi, K. 2014: Therapeutic surgery without a definitive diagnosis can be an option in selected patients with suspected lung cancer. Interactive Cardiovascular and Thoracic Surgery 19(5): 830-837
Montesano, F.; Zaccone, D.; Battaglia, E.; Genco, F.; Mellace, V. 2010: Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre. Clinical Drug Investigation 30(Suppl 1): 13-19
Takebayashi, T.; Amano, S.; Hanada, K.; Umeji, A.; Takahashi, K.; Koyama, T.; Domen, K. 2014: Therapeutic synergism in the treatment of post-stroke arm paresis utilizing botulinum toxin, robotic therapy, and constraint-induced movement therapy. Pm and R: the Journal of Injury Function and Rehabilitation 6(11): 1054-1058
Nishimura, M.; Jung, E.-J.; Shah, M.Y.; Lu, C.; Spizzo, R.; Shimizu, M.; Han, H.D.; Ivan, C.; Rossi, S.; Zhang, X.; Nicoloso, M.S.; Wu, S.Y.; Almeida, M.I.; Bottsford-Miller, J.; Pecot, C.V.; Zand, B.; Matsuo, K.; Shahzad, M.M.; Jennings, N.B.; Rodriguez-Aguayo, C.; Lopez-Berestein, G.; Sood, A.K.; Calin, G.A. 2013: Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discovery 3(11): 1302-1315
Suzuki, M. 2007: Therapeutic system for eating disorders in England and the United States. Seishin Shinkeigaku Zasshi 109(12): 1140-1145
Kharitonova, L.A. 2011: Therapeutic tactics in cholelithiasis in children. Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 72-77
Davis, C. 2009: Therapeutic tales. Nursing Standard: 1987) 24(5): 20-22
Kang, A.Y.; Park, S.K.; Park, S.Y.; Lee, H.J.; Han, Y.; Lee, S.R.; Suh, S.H.; Kim, D.K.; Park, M.K. 2011: Therapeutic target achievement in type 2 diabetic patients after hyperglycemia, hypertension, dyslipidemia management. Diabetes and Metabolism Journal 35(3): 264-272
Ren, H. 2012: Therapeutic target and termination for chronic hepatitis B: reforcing on persistent immune control. Zhonghua Gan Zang Bing Za Zhi 20(10): 721-722
Zhu, F.; Shi, Z.; Qin, C.; Tao, L.; Liu, X.; Xu, F.; Zhang, L.; Song, Y.; Liu, X.; Zhang, J.; Han, B.; Zhang, P.; Chen, Y. 2012: Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Research 40(Database Issue): D1128-D1136
Qin, C.; Zhang, C.; Zhu, F.; Xu, F.; Chen, S.Ying.; Zhang, P.; Li, Y.Hong.; Yang, S.Yong.; Wei, Y.Quan.; Tao, L.; Chen, Y.Zong. 2014: Therapeutic target database update 2014: a resource for targeted therapeutics. Nucleic Acids Research 42(Database Issue): D1118-D1123
Matsumoto, T. 2010: Therapeutic target for endothelium-derived hyperpolarizing factor signaling in diabetic vascular complication. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 130(6): 777-784
Fukusumi, Y.; Miyauchi, N.; Hashimoto, T.; Saito, A.; Kawachi, H. 2014: Therapeutic target for nephrotic syndrome: Identification of novel slit diaphragm associated molecules. World Journal of Nephrology 3(3): 77-84
Karle, H.; Hansen, N.E. 2007: Therapeutic target for the use of erythropoietin (EPO): is subnormal better than normal?. Ugeskrift for Laeger 169(19): 1782-1783
Gabellieri, C.; Reynolds, S.; Lavie, A.; Payne, G.S.; Leach, M.O.; Eykyn, T.R. 2008: Therapeutic target metabolism observed using hyperpolarized 15N choline. Journal of the American Chemical Society 130(14): 4598-4599
Do, J.-S.; Park, K.-S.; Seo, H.-J.; Kim, J.-H.; Hwang, J.-K.; Song, E.-J.; Nam, S.-Y. 2009: Therapeutic target validation of protein kinase C(PKC)-zeta for asthma using a mouse model. International Journal of Molecular Medicine 23(4): 561-566
Patschull, A.O.M.; Segu, L.; Nyon, M.P.; Lomas, D.A.; Nobeli, I.; Barrett, T.E.; Gooptu, B. 2011: Therapeutic target-site variability in α1-antitrypsin characterized at high resolution. Acta Crystallographica. Section F Structural Biology and Crystallization Communications 67(Part 12): 1492-1497
Ferrand, F.-R.; Pavic, M. 2014: Therapeutic targeted approaches on androgen receptors in prostate cancer. La Revue de Medecine Interne 35(10): 670-675
Peruzzi, P.P.; Lonser, R.R. 2014: Therapeutic targeting based on gene-expression profiling in vestibular schwannomas. Journal of Neurosurgery 121(6): 1432-1433
Penault-Llorca, F.éd.ér. 2009: Therapeutic targeting in breast cancer. Annales de Pathologie 29(Special Issue 1): S71-S73
Guo, J.; Fisher, K.A.; Darcy, R.; Cryan, J.F.; O'Driscoll, C. 2010: Therapeutic targeting in the silent era: advances in non-viral siRNA delivery. Molecular Biosystems 6(7): 1143-1161
Cherian, C.; Kugel Desmoulin, S.; Wang, L.; Polin, L.; White, K.; Kushner, J.; Stout, M.; Hou, Z.; Gangjee, A.; Matherly, L.H. 2013: Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter. Cancer ChemoTherapy and Pharmacology 71(4): 999-1011
Chatenoud, L. 2013: Therapeutic targeting of B cells and T cells in autoimmune diabetes: is it a solution?. Diabetes 62(8): 2659-2661
Engel, P.; Gómez-Puerta, J.é A.; Ramos-Casals, M.; Lozano, F.; Bosch, X. 2011: Therapeutic targeting of B cells for rheumatic autoimmune diseases. Pharmacological Reviews 63(1): 127-156
Hasan, A.; Ghebeh, H.; Lehe, C.; Ahmad, R.; Dermime, S. 2011: Therapeutic targeting of B7-H1 in breast cancer. Expert Opinion on Therapeutic Targets 15(10): 1211-1225
Yeung, D.T.; Hughes, T.P. 2012: Therapeutic targeting of BCR-ABL: prognostic markers of response and resistance mechanism in chronic myeloid leukaemia. Critical Reviews in Oncogenesis 17(1): 17-30
Alli, E.; Solow-Cordero, D.; Casey, S.C.; Ford, J.M. 2014: Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repair. Cancer Research 74(21): 6205-6215
Reisman, D. 2007: Therapeutic targeting of Brahma by HDAC inhibitors. Cancer Biology and Therapy 6(7): 997-998
Straza, M.W.; Paliwal, S.; Kovi, R.C.; Rajeshkumar, B.; Trenh, P.; Parker, D.; Whalen, G.F.; Lyle, S.; Schiffer, C.A.; Grossman, S.R. 2010: Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle 9(18): 3740-3750
Katz, B.-Z.; Herishanu, Y. 2014: Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond. Leukemia and Lymphoma 55(5): 999-1006
Ye, F.; Gao, Q.; Cai, M.-J. 2010: Therapeutic targeting of EGFR in malignant gliomas. Expert Opinion on Therapeutic Targets 14(3): 303-316
Gao, Q.; Lei, T.; Ye, F. 2013: Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma. Expert Opinion on Investigational Drugs 22(8): 1023-1040
Fabi, A.; Mottolese, M.; Segatto, O. 2014: Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic. Journal of Molecular Medicine 92(7): 681-695
Banham, A.H.; Pulford, K. 2009: Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581. Expert Opinion on Therapeutic Patents 19(7): 1023-1028
Jiang, Y.; Bao, H.; Ge, Y.; Tang, W.; Cheng, D.; Luo, K.; Gong, G.; Gong, R. 2015: Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C. Gut 64(1): 168-179
Davis, D.R.; Seth, P.P. 2011: Therapeutic targeting of HCV internal ribosomal entry site RNA. Antiviral Chemistry and ChemoTherapy 21(3): 117-128
Nowell, M.A.; Williams, A.S.; Carty, S.A.; Scheller, J.ür.; Hayes, A.J.; Jones, G.W.; Richards, P.J.; Slinn, S.; Ernst, M.; Jenkins, B.J.; Topley, N.; Rose-John, S.; Jones, S.A. 2009: Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. Journal of Immunology 182(1): 613-622
Pesu, M.; Laurence, A.; Kishore, N.; Zwillich, S.H.; Chan, G.; O'Shea, J.J. 2008: Therapeutic targeting of Janus kinases. Immunological Reviews 223: 132-142
Kaushik, D.Kumar.; Mukhopadhyay, R.; Kumawat, K.Lal.; Gupta, M.; Basu, A. 2012: Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation. Journal of Neuroinflammation 9: 57
Noble, P.; Spendlove, I.; Harding, S.; Parsons, T.; Durrant, L.G. 2013: Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29. Plos one 8(2): E54892
Liedtke, M.; Cleary, M.L. 2009: Therapeutic targeting of MLL. Blood 113(24): 6061-6068
Dang, C.V. 2011: Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. Cold Spring Harbor Symposia on Quantitative Biology 76: 369-374
Bruserud, Øy.; Reikvam, H.åk. 2010: Therapeutic targeting of NF-κB in myelodysplastic syndromes and acute myeloid leukaemia - the biological heterogeneity. Expert Opinion on Therapeutic Targets 14(11): 1139-1142
Palomero, T.; Ferrando, A. 2009: Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia. Clinical Lymphoma and Myeloma 9(Suppl 3): S205-S210
O'Shea, L.K.; Abdulkhalek, S.; Allison, S.; Neufeld, R.J.; Szewczuk, M.R. 2014: Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance. Oncotargets and Therapy 7: 117-134
Chakravarty, D.; Roy, S.Saha.; Babu, C.Ram.; Dandamudi, R.; Curiel, T.J.; Vivas-Mejia, P.; Lopez-Berestein, G.; Sood, A.K.; Vadlamudi, R.K. 2011: Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(8): 2250-2259
Spartà, A.M.; Bressanin, D.; Chiarini, F.; Lonetti, A.; Cappellini, A.; Evangelisti, C.; Evangelisti, C.; Melchionda, F.; Pession, A.; Bertaina, A.; Locatelli, F.; McCubrey, J.A.; Martelli, A.M. 2014: Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia. Cell Cycle 13(14): 2237-2247
Ateeq, B.; Tomlins, S.A.; Laxman, B.; Asangani, I.A.; Cao, Q.; Cao, X.; Li, Y.; Wang, X.; Feng, F.Y.; Pienta, K.J.; Varambally, S.; Chinnaiyan, A.M. 2011: Therapeutic targeting of SPINK1-positive prostate cancer. Science Translational Medicine 3(72): 72ra17
Hu, M.; Che, P.; Han, X.; Cai, G.-Q.; Liu, G.; Antony, V.; Luckhardt, T.; Siegal, G.P.; Zhou, Y.; Liu, R.-m.; Desai, L.P.; O'Reilly, P.J.; Thannickal, V.J.; Ding, Q. 2014: Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis. Journal of Pharmacology and Experimental Therapeutics 351(1): 87-95
Egwuagu, C.E.; Larkin Iii, J. 2013: Therapeutic targeting of STAT pathways in CNS autoimmune diseases. Jak-Stat 2(1): E24134
Yu, C.-R.; Lee, Y.S.; Mahdi, R.M.; Surendran, N.; Egwuagu, C.E. 2012: Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis. Plos one 7(1): E29742
Colonna, L.; Catalano, G.; Chew, C.; D'Agati, V.; Thomas, J.W.; Wong, F.S.; Schmitz, J.; Masuda, E.S.; Reizis, B.; Tarakhovsky, A.; Clynes, R. 2010: Therapeutic targeting of Syk in autoimmune diabetes. Journal of Immunology 185(3): 1532-1543
Brignole, C.; Marimpietri, D.; Di Paolo, D.; Perri, P.; Morandi, F.; Pastorino, F.; Zorzoli, A.; Pagnan, G.; Loi, M.; Caffa, I.; Erminio, G.; Haupt, R.; Gambini, C.; Pistoia, V.; Ponzoni, M. 2010: Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma. Cancer Research 70(23): 9816-9826
Michaelson, J.S.; Burkly, L.C. 2009: Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway. Results and Problems in Cell Differentiation 49: 145-160
O'Neill, L.A.J.; Bryant, C.E.; Doyle, S.L. 2009: Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacological Reviews 61(2): 177-197
Robles Irizarry, L.; Hambardzumyan, D.; Nakano, I.; Gladson, C.L.; Ahluwalia, M.S. 2012: Therapeutic targeting of VEGF in the treatment of glioblastoma. Expert Opinion on Therapeutic Targets 16(10): 973-984
Kugel Desmoulin, S.; Wang, L.; Hales, E.; Polin, L.; White, K.; Kushner, J.; Stout, M.; Hou, Z.; Cherian, C.; Gangjee, A.; Matherly, L.H. 2011: Therapeutic targeting of a novel 6-substituted pyrrolo [2,3-d]pyrimidine thienoyl antifolate to human solid tumors based on selective uptake by the proton-coupled folate transporter. Molecular Pharmacology 80(6): 1096-1107
Wang, H.; Yang, Z.; Gu, J. 2014: Therapeutic targeting of angiogenesis with a recombinant CTT peptide-endostatin mimic-kringle 5 protein. Molecular Cancer Therapeutics 13(11): 2674-2687
Neesse, A.; Gress, T.M.; Michl, P. 2012: Therapeutic targeting of apoptotic pathways: novel aspects in pancreatic cancer. Current Pharmaceutical Biotechnology 13(11): 2273-2282
Nagelkerke, A.; Sweep, F.C.G.J.; Geurts-Moespot, A.; Bussink, J.; Span, P.N. 2015: Therapeutic targeting of autophagy in cancer. Part I: molecular pathways controlling autophagy. Seminars in Cancer Biology 31: 89-98
Nagelkerke, A.; Bussink, J.; Geurts-Moespot, A.; Sweep, F.C.G.J.; Span, P.N. 2015: Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy. Seminars in Cancer Biology 31: 99-105
Cheng, Y.; Ren, X.; Hait, W.N.; Yang, J.-M. 2013: Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacological Reviews 65(4): 1162-1197
Ashman, L.K.; Griffith, R. 2013: Therapeutic targeting of c-KIT in cancer. Expert Opinion on Investigational Drugs 22(1): 103-115
Loosveld, M.; Castellano, R.ém.; Gon, S.ép.; Goubard, A.; Crouzet, T.; Pouyet, L.; Prebet, T.; Vey, N.; Nadel, B.; Collette, Y.; Payet-Bornet, D. 2014: Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL. Oncotarget 5(10): 3168-3172
Dang, C.V.; Hamaker, M.; Sun, P.; Le, A.; Gao, P. 2011: Therapeutic targeting of cancer cell metabolism. Journal of Molecular Medicine 89(3): 205-212
Maugeri-Saccà, M.; Zeuner, A.; De Maria, R. 2011: Therapeutic targeting of cancer stem cells. Frontiers in Oncology 1: 10
Dillon, L.M.; Miller, T.W. 2014: Therapeutic targeting of cancers with loss of PTEN function. Current Drug Targets 15(1): 65-79
Medvetz, D.; Priolo, C.; Henske, E.P. 2015: Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift. Molecular Cancer Research: Mcr 13(1): 3-8
Hamann, I.; Zipp, F.; Infante-Duarte, C. 2008: Therapeutic targeting of chemokine signaling in Multiple Sclerosis. Journal of the Neurological Sciences 274(1-2): 31-38
Kwon, O.-J.; Kang, E.; Choi, J.-W.; Kim, S.W.; Yun, C.-O. 2013: Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy. Journal of Controlled Release: Official Journal of the Controlled Release Society 169(3): 257-265
Shi, Z.; Zhang, Y.; Yin, Z. 2014: Therapeutic targeting of circulating tumor cells--a new strategy in treatment of liver cancer recurrence and metastasis after hepatectomy. Zhonghua Zhong Liu Za Zhi 36(6): 401-404
Castellano, G.; Melchiorre, R.; Loverre, A.; Ditonno, P.; Montinaro, V.; Rossini, M.; Divella, C.; Battaglia, M.; Lucarelli, G.; Annunziata, G.; Palazzo, S.; Selvaggi, F.Paolo.; Staffieri, F.; Crovace, A.; Daha, M.R.; Mannesse, M.; van Wetering, S.; Paolo Schena, F.; Grandaliano, G. 2010: Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. American Journal of Pathology 176(4): 1648-1659
Tan, T.-T.; White, E. 2008: Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. Advances in Experimental Medicine and Biology 615: 81-104
Baiula, M.; Bedini, A.; Carbonari, G.; Dattoli, S.D.; Spampinato, S. 2012: Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis. Frontiers in Pharmacology 3: 203
Wykosky, J.; Fenton, T.; Furnari, F.; Cavenee, W.K. 2011: Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations. Chinese Journal of Cancer 30(1): 5-12
Lee, J.; Ryu, H.; Keum, G.; Yoon, Y.J.; Kowall, N.W.; Ryu, H. 2014: Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS). Current Medicinal Chemistry 21(31): 3576-3582
Wang, S.; Huang, J.; Lyu, H.; Cai, B.; Yang, X.; Li, F.; Tan, J.; Edgerton, S.M.; Thor, A.D.; Lee, C.-K.; Liu, B. 2013: Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer. Breast Cancer Research: Bcr 15(5): R101
Paolillo, M.; Schinelli, S. 2008: Therapeutic targeting of g-protein coupled receptor-mediated epidermal growth factor receptor transactivation in human glioma brain tumors. Mini Reviews in Medicinal Chemistry 8(13): 1418-1428
Koldehoff, M.; Elmaagacli, A.H. 2009: Therapeutic targeting of gene expression by si RNAs directed against BCR-ABL transcripts in a patient with imatinib-resistant chronic myeloid leukemia. Methods in Molecular Biology 487: 451-466
Stabile, L.P.; Rothstein, M.E.; Keohavong, P.; Jin, J.; Yin, J.; Land, S.R.; Dacic, S.; Luong, T.M.; Kim, K.J.; Dulak, A.M.; Siegfried, J.M. 2008: Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis. Molecular Cancer Therapeutics 7(7): 1913-1922
Kultti, A.; Li, X.; Jiang, P.; Thompson, C.B.; Frost, G.I.; Shepard, H.M. 2012: Therapeutic targeting of hyaluronan in the tumor stroma. Cancers 4(3): 873-903
Verma, S.; Gupta, M.; Ridker, P.M. 2012: Therapeutic targeting of inflammation in atherosclerosis: we are getting closer. Canadian Journal of Cardiology 28(6): 619-622
Topkara, V.K.; Evans, S.; Zhang, W.; Epelman, S.; Staloch, L.; Barger, P.M.; Mann, D.L. 2011: Therapeutic targeting of innate immunity in the failing heart. Journal of Molecular and Cellular Cardiology 51(4): 594-599
Peri, F.; Piazza, M. 2012: Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Biotechnology Advances 30(1): 251-260
Moore, K.M.; Thomas, G.J.; Duffy, S.W.; Warwick, J.; Gabe, R.; Chou, P.; Ellis, I.O.; Green, A.R.; Haider, S.; Brouilette, K.; Saha, A.; Vallath, S.; Bowen, R.; Chelala, C.; Eccles, D.; Tapper, W.J.; Thompson, A.M.; Quinlan, P.; Jordan, L.; Gillett, C.; Brentnall, A.; Violette, S.; Weinreb, P.H.; Kendrew, J.; Barry, S.T.; Hart, I.R.; Jones, J.L.; Marshall, J.F. 2014: Therapeutic targeting of integrin αvβ6 in breast cancer. Journal of the National Cancer Institute 106(8)
Coisne, C.; Lyck, R.; Engelhardt, B. 2007: Therapeutic targeting of leukocyte trafficking across the blood-brain barrier. Inflammation and Allergy Drug Targets 6(4): 210-222
Sampson, J.R. 2009: Therapeutic targeting of mTOR in tuberous sclerosis. Biochemical Society Transactions 37(Part 1): 259-264
Alexandru-Abrams, D.; Jadus, M.R.; Hsu, F.P.; Stathopoulos, A.; Bota, D.A. 2014: Therapeutic targeting of malignant glioma. Anti-Cancer Agents in Medicinal Chemistry 14(8): 1075-1084
Stallings, R.L.; Foley, N.H.; Bryan, K.; Buckley, P.G.; Bray, I. 2010: Therapeutic targeting of mi RNAs in neuroblastoma. Expert Opinion on Therapeutic Targets 14(9): 951-962
Konopleva, M.; Tabe, Y.; Zeng, Z.; Andreeff, M. 2009: Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer ChemoTherapy 12(4-5): 103-113
Nyon, M.P.; Gooptu, B. 2014: Therapeutic targeting of misfolding and conformational change in α1-antitrypsin deficiency. Future Medicinal Chemistry 6(9): 1047-1065
Dikalova, A.E.; Bikineyeva, A.T.; Budzyn, K.; Nazarewicz, R.R.; McCann, L.; Lewis, W.; Harrison, D.G.; Dikalov, S.I. 2010: Therapeutic targeting of mitochondrial superoxide in hypertension. Circulation Research 107(1): 106-116
Ugel, S.; Delpozzo, F.; Desantis, G.; Papalini, F.; Simonato, F.; Sonda, N.; Zilio, S.; Bronte, V. 2009: Therapeutic targeting of myeloid-derived suppressor cells. Current Opinion in Pharmacology 9(4): 470-481
Roberts, T.C.; Wood, M.J.A. 2013: Therapeutic targeting of non-coding RNAs. Essays in Biochemistry 54: 127-145
Chahine, M.N.; Pierce, G.N. 2009: Therapeutic targeting of nuclear protein import in pathological cell conditions. Pharmacological Reviews 61(3): 358-372
Lim, S.M.; Westover, K.D.; Ficarro, S.B.; Harrison, R.A.; Choi, H.G.; Pacold, M.E.; Carrasco, M.; Hunter, J.; Kim, N.D.; Xie, T.; Sim, T.; Jänne, P.A.; Meyerson, M.; Marto, J.A.; Engen, J.R.; Gray, N.S. 2014: Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor. Angewandte Chemie 53(1): 199-204
Kim, S.-G.; Song, J.-Y. 2012: Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma. Oncology Reports 28(2): 539-544
Broadhead, M.L.; Clark, J.C.M.; Dass, C.R.; Choong, P.F.M.; Myers, D.E. 2011: Therapeutic targeting of osteoclast function and pathways. Expert Opinion on Therapeutic Targets 15(2): 169-181
Selivanova, G. 2010: Therapeutic targeting of p53 by small molecules. Seminars in Cancer Biology 20(1): 46-56
Ehnman, M.; Östman, A. 2014: Therapeutic targeting of platelet-derived growth factor receptors in solid tumors. Expert Opinion on Investigational Drugs 23(2): 211-226
Sampson, N.; Berger, P.; Zenzmaier, C. 2012: Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease. Oxidative Medicine and Cellular Longevity 2012: 458276
Fogg, M.; Murphy, J.R.; Lorch, J.; Posner, M.; Wang, F. 2013: Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma. Virology 441(2): 107-113
Kauvar, L.M.; Harcourt, J.L.; Haynes, L.M.; Tripp, R.A. 2010: Therapeutic targeting of respiratory syncytial virus G-protein. ImmunoTherapy 2(5): 655-661
Bhatnagar, S.; Kumar, A. 2010: Therapeutic targeting of signaling pathways in muscular dystrophy. Journal of Molecular Medicine 88(2): 155-166
Stohl, W. 2014: Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 18(4): 473-489
Parekh, S.; Privé, G.; Melnick, A. 2008: Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas. Leukemia and Lymphoma 49(5): 874-882
Jahn, L.; Hombrink, P.; Hassan, C.; Kester, M.G.D.; van der Steen, D.M.; Hagedoorn, R.S.; Falkenburg, J.H.F.; van Veelen, P.A.; Heemskerk, M.H.M. 2015: Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b. Blood 125(6): 949-958
Martin, S.A.; Lord, C.J.; Ashworth, A. 2010: Therapeutic targeting of the DNA mismatch repair pathway. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(21): 5107-5113
Aittomäki, S.; Pesu, M. 2014: Therapeutic targeting of the Jak/STAT pathway. Basic and Clinical Pharmacology and Toxicology 114(1): 18-23
Zhang, C.; Saunders, A.J. 2007: Therapeutic targeting of the alpha-secretase pathway to treat Alzheimer's disease. Discovery Medicine 7(39): 113-117
Ferreira, A.J.; Bader, M.; Santos, R.A.S. 2012: Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review. Expert Opinion on Therapeutic Patents 22(5): 567-574
Miyauchi, T.; Wei, E.P.; Povlishock, J.T. 2013: Therapeutic targeting of the axonal and microvascular change associated with repetitive mild traumatic brain injury. Journal of Neurotrauma 30(19): 1664-1671
Dhomen, N.S.; Mariadason, J.; Tebbutt, N.; Scott, A.M. 2012: Therapeutic targeting of the epidermal growth factor receptor in human cancer. Critical Reviews in Oncogenesis 17(1): 31-50
Wendt, M.K.; Schiemann, W.P. 2009: Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Breast Cancer Research: Bcr 11(5): R68
Wright, K.T.; Giardina, C.; Vella, A.T. 2014: Therapeutic targeting of the inflammome. Biochemical Pharmacology 92(2): 184-191
Coffey, T.J.; Werling, D. 2011: Therapeutic targeting of the innate immune system in domestic animals. Cell and Tissue Research 343(1): 251-261
Tanaka, T.; Narazaki, M.; Kishimoto, T. 2012: Therapeutic targeting of the interleukin-6 receptor. Annual Review of Pharmacology and Toxicology 52: 199-219
Moschetta, M.; Reale, A.; Marasco, C.; Vacca, A.; Carratù, M.R. 2014: Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations. British Journal of Pharmacology 171(16): 3801-3813
Parikh, S.M. 2013: Therapeutic targeting of the mitochondrial dysfunction in septic acute kidney injury. Current Opinion in Critical Care 19(6): 554-559
Kaestner, P.; Aigner, A.; Bastians, H. 2011: Therapeutic targeting of the mitotic spindle checkpoint through nanoparticle-mediated siRNA delivery inhibits tumor growth in vivo. Cancer Letters 304(2): 128-136
Pöling, J.; Gajawada, P.; Richter, M.; Lörchner, H.; Polyakova, V.; Kostin, S.; Shin, J.; Boettger, T.; Walther, T.; Rees, W.; Wietelmann, A.; Warnecke, H.; Kubin, T.; Braun, T. 2014: Therapeutic targeting of the oncostatin M receptor-β prevents inflammatory heart failure. Basic Research in Cardiology 109(1): 396
Prabhu, V.V.; Allen, J.E.; Hong, B.; Zhang, S.; Cheng, H.; El-Deiry, W.S. 2012: Therapeutic targeting of the p53 pathway in cancer stem cells. Expert Opinion on Therapeutic Targets 16(12): 1161-1174
Hernández, J.L.; Padilla, L.; Dakhel, S.; Coll, T.; Hervas, R.; Adan, J.; Masa, M.; Mitjans, F.; Martinez, J.M.; Coma, S.; Rodríguez, L.; Noé, V.ér.; Ciudad, C.J.; Blasco, F.; Messeguer, R. 2013: Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody. Plos one 8(9): E72480
Bowman, R.L.; Joyce, J.A. 2014: Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma. ImmunoTherapy 6(6): 663-666
Hiscox, S.; Barrett-Lee, P.; Nicholson, R.I. 2011: Therapeutic targeting of tumor-stroma interactions. Expert Opinion on Therapeutic Targets 15(5): 609-621
Mahajan, S.D.; Aalinkeel, R.; Reynolds, J.L.; Nair, B.B.; Sykes, D.E.; Hu, Z.; Bonoiu, A.; Ding, H.; Prasad, P.N.; Schwartz, S.A. 2009: Therapeutic targeting of "DARPP-32": a key signaling molecule in the dopiminergic pathway for the treatment of opiate addiction. International Review of Neurobiology 88: 199-222
Brenner, A.K.; Reikvam, Håkon.; Lavecchia, A.; Bruserud, Øystein. 2014: Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms. Molecules 19(11): 18414-18447
Lu, X.; Wei, W.; Fenton, J.; Nahorski, M.S.; Rabai, E.; Reiman, A.; Seabra, L.; Nagy, Z.; Latif, F.; Maher, E.R. 2011: Therapeutic targeting the loss of the birt-hogg-dube suppressor gene. Molecular Cancer Therapeutics 10(1): 80-89
Bueno, L. 2009: Therapeutic targets. Gastroenterologie Clinique et Biologique 33(Suppl 1): S59-S67
Matsukawa, N.; Yasuhara, T.; Hara, K.; Xu, L.; Maki, M.; Yu, G.; Kaneko, Y.; Ojika, K.; Hess, D.C.; Borlongan, C.V. 2009: Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. Bmc Neuroscience 10: 126
Uehara, Y. 2010: Therapeutic targets and molecular mechanisms. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(10): 1772-1776
Carneiro, P.íc.; Figueiredo, J.; Bordeira-Carriço, R.; Fernandes, M.S.; Carvalho, J.; Oliveira, C.; Seruca, R. 2013: Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opinion on Therapeutic Targets 17(10): 1187-1201
Tarditi, A.; Caricasole, A.; Terstappen, G. 2009: Therapeutic targets for Alzheimer's disease. Expert Opinion on Therapeutic Targets 13(5): 551-567
Clézardin, P. 2011: Therapeutic targets for bone metastases in breast cancer. Breast Cancer Research: Bcr 13(2): 207
Maiese, K. 2013: Therapeutic targets for cancer: current concepts with Pi 3-K, Akt, and mTOR. Indian Journal of Medical Research 137(2): 243-246
Iwatsubo, K.; Ishikawa, Y. 2008: Therapeutic targets for heart failure: beyond beta-adrenergic and renin-angiotensin system blockade. Recent Patents on Cardiovascular Drug Discovery 3(1): 37-44
Alonzi, D.S.; Butters, T.D. 2011: Therapeutic targets for inhibitors of glycosylation. Chimia 65(1-2): 35-39
Wlodarski, P.K.; Jozwiak, J. 2008: Therapeutic targets for medulloblastoma. Expert Opinion on Therapeutic Targets 12(4): 449-461
Brodeur, G.M.; Iyer, R.; Croucher, J.L.; Zhuang, T.; Higashi, M.; Kolla, V. 2014: Therapeutic targets for neuroblastomas. Expert Opinion on Therapeutic Targets 18(3): 277-292
Kelso, M.L.; Pauly, J.R. 2011: Therapeutic targets for neuroprotection and/or enhancement of functional recovery following traumatic brain injury. Progress in Molecular Biology and Translational Science 98: 85-131
Stankowski, J.N.; Gupta, R. 2011: Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?. Antioxidants and Redox Signaling 14(10): 1841-1851
Ito, K.; Mercado, N. 2009: Therapeutic targets for new therapy for corticosteroid refractory asthma. Expert Opinion on Therapeutic Targets 13(9): 1053-1067
Edmonds, S. 2009: Therapeutic targets for osteoarthritis. Maturitas 63(3): 191-194
Murphy, P.; Hillman, T.; Rajakulasingam, K. 2010: Therapeutic targets for persistent airway inflammation in refractory asthma. Biomedicine and PharmacoTherapy 64(2): 140-145
Keystone, E.C.; Haraoui, B. 2009: Therapeutic targets for rheumatoid arthritis. Journal of Rheumatology. Suppl 82: 1
Alghasham, A.; Rasheed, Z. 2014: Therapeutic targets for rheumatoid arthritis: Progress and promises. Autoimmunity 47(2): 77-94
Jaggi, A.S.; Singh, N. 2011: Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. Cns and Neurological Disorders Drug Targets 10(5): 589-609
Lee, S.-Y.; Kim, S.I.; Choi, M.E. 2015: Therapeutic targets for treating fibrotic kidney diseases. Translational Research: the Journal of Laboratory and Clinical Medicine 165(4): 512-530
Corbo, C.P.; Alonso, A.d.C. 2011: Therapeutic targets in Alzheimer's disease and related tauopathies. Progress in Molecular Biology and Translational Science 98: 47-83
Giraldo, P.; Roca, M. 2011: Therapeutic targets in Gaucher's disease. Medicina Clinica 137(Suppl 1): 46-49
Bird, A.C. 2010: Therapeutic targets in age-related macular disease. Journal of Clinical Investigation 120(9): 3033-3041
Chatzikyrkou, C.; Haller, H.; Menne, J. 2012: Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?. Der Internist 53(7): 882-892
Peral, A.; Domínguez-Godínez, C.O.; Carracedo, G.; Pintor, J.ús. 2008: Therapeutic targets in dry eye syndrome. Drug News and Perspectives 21(3): 166-176
Lavin, P.J.; Gbadegesin, R.; Damodaran, T.V.; Winn, M.P. 2008: Therapeutic targets in focal and segmental glomerulosclerosis. Current Opinion in Nephrology and Hypertension 17(4): 386-392
Wardelmann, E.; Schildhaus, H.-U.; Merkelbach-Bruse, S.; Büttner, R. 2006: Therapeutic targets in gastrointestinal stromal tumors. Verhandlungen der Deutschen Gesellschaft für Pathologie 90: 73-79
Schelbert, E.B.; Fonarow, G.C.; Bonow, R.O.; Butler, J.; Gheorghiade, M. 2014: Therapeutic targets in heart failure: refocusing on the myocardial interstitium. Journal of the American College of Cardiology 63(21): 2188-2198
Giachini, F.R.C.; Callera, G.E.; Carneiro, F.S.; Tostes, R.C.; Webb, R.C. 2008: Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?. Expert Opinion on Therapeutic Targets 12(3): 327-339
Alfany-Fernandez, I.; Casillas-Ramirez, A.; Bintanel-Morcillo, M.; Brosnihan, K.B.; Ferrario, C.M.; Serafin, A.; Rimola, A.; Rodés, J.; Roselló-Catafau, J.; Peralta, C. 2009: Therapeutic targets in liver transplantation: angiotensin Ii in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 9(3): 439-451
Schmitt, A.; Falkai, P. 2013: Therapeutic targets in major psychiatric disorders revisited. European Archives of Psychiatry and Clinical Neuroscience 263(8): 619-620
Barcellos-Hoff, M.H.; Newcomb, E.W.; Zagzag, D.; Narayana, A. 2009: Therapeutic targets in malignant glioblastoma microenvironment. Seminars in Radiation Oncology 19(3): 163-170
Van der Horst, I.W.J.M.; Reiss, I.; Tibboel, D. 2008: Therapeutic targets in neonatal pulmonary hypertension: linking pathophysiology to clinical medicine. Expert Review of Respiratory Medicine 2(1): 85-96
Rhodes, C.J.; Davidson, A.; Gibbs, J.S.R.; Wharton, J.; Wilkins, M.R. 2009: Therapeutic targets in pulmonary arterial hypertension. Pharmacology and Therapeutics 121(1): 69-88
Dayer, J.-M.; Choy, E. 2010: Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology 49(1): 15-24
Lund, V.J. 2008: Therapeutic targets in rhinosinusitis: infection or inflammation?. Medscape Journal of Medicine 10(4): 105
Denton, C.P. 2007: Therapeutic targets in systemic sclerosis. Arthritis Research and Therapy 9(Suppl 2): S6
Hayakawa, R.; Hayakawa, T.; Takeda, K.; Ichijo, H. 2012: Therapeutic targets in the ASK1-dependent stress signaling pathways. Proceedings of the Japan Academy. Series B Physical and Biological Sciences 88(8): 434-453
Häcker, G.; Paschen, S.A. 2007: Therapeutic targets in the mitochondrial apoptotic pathway. Expert Opinion on Therapeutic Targets 11(4): 515-526
Kawachi, H.; Han, G.D.; Miyauchi, N.; Hashimoto, T.; Suzuki, K.; Shimizu, F. 2009: Therapeutic targets in the podocyte: findings in anti-slit diaphragm antibody-induced nephropathy. Journal of Nephrology 22(4): 450-456
Brea Hernando, Án.J.án. 2014: Therapeutic targets in the treatment of dyslipidemia: HDL and non-HDL cholesterol. Clinica e Investigacion en Arteriosclerosis: Publicacion Oficial de la Sociedad Espanola de Arteriosclerosis 26(Suppl 1): 3-6
Teng, Y.H.-F.; Thike, A.-A.; Wong, N.-S.; Tan, P.-H. 2011: Therapeutic targets in triple negative breast cancer - where are we now?. Recent Patents on Anti-Cancer Drug Discovery 6(2): 196-209
De la Monte, S.M. 2012: Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. Frontiers in Bioscience 4(4): 1582-1605
Cao, Y.; Liu, Q. 2007: Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. Advances in Cancer Research 97: 203-224
Ezama, E.; Alonso, Y.; González, S.; Galván, S.; Fontanil, Y. 2011: Therapeutic tasks: what kind of help is sought in psychotherapeutic sessions?. Psicothema 23(4): 566-572
Katarzyna, B.; Marcin, T.; Michał, N. 2008: Therapeutic team--a standard for peritoneal dialysis patent care--assumptions and reality. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(Suppl 4): 12-14
Garbi, S.L.; Touris, M.ía.C.; Epele, M.ía. 2012: Therapeutic techniques and subjectivation in treatment with drug users. Ciencia and Saude Coletiva 17(7): 1865-1874
Wearden, A.; Peters, S. 2008: Therapeutic techniques for interventions based on Leventhal's common sense model. British Journal of Health Psychology 13(Pt 2): 189-193
Angres, E. 1946: Therapeutic techniques used with a special group of disturbed children. Illinois Medical Journal 89: 133-136
Stockmann, H.; Krannich, A.; Schroeder, T.; Storm, C. 2014: Therapeutic temperature management after cardiac arrest and the risk of bleeding: systematic review and meta-analysis. Resuscitation 85(11): 1494-1503
Herr, D.L.; Badjatia, N. 2009: Therapeutic temperature management: why, who, when, where, and how. Critical Care Medicine 37(7 Suppl): S185
Lord, A.S.; Karinja, S.; Lantigua, H.; Carpenter, A.; Schmidt, J.M.; Claassen, J.; Agarwal, S.; Connolly, E.S.; Mayer, S.A.; Badjatia, N. 2014: Therapeutic temperature modulation for fever after intracerebral hemorrhage. Neurocritical Care 21(2): 200-206
Wald, M.; Makhlouf, A.A.; Niederberger, C.S. 2007: Therapeutic testis biopsy for sperm retrieval. Current Opinion in Urology 17(6): 431-438
Ziehn, M.O.; Avedisian, A.A.; Dervin, S.M.; Umeda, E.A.; O'Dell, T.J.; Voskuhl, R.R. 2012: Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(36): 12312-12324
Dutt, N. 2013: Therapeutic thoracentesis in tuberculous pleural effusion: Needs more ammunition to prove. Annals of Thoracic Medicine 8(1): 65
Feller-Kopman, D. 2007: Therapeutic thoracentesis: the role of ultrasound and pleural manometry. Current Opinion in Pulmonary Medicine 13(4): 312-318
Rioux, E.; Decker, A.; Deffrennes, D. 2012: Therapeutic thoughts on the treatment of sequellae of labial-alveolar-palatal clefts in adult patients - Part 1. International Orthodontics 10(3): 241-260
Rioux, E.; Decker, A.; Deffrennes, D. 2012: Therapeutic thoughts on the treatment of sequellae of labial-alveolar-palatal clefts in adult patients-part 2. International Orthodontics 10(4): 404-421
Frøisland, D.H. 2010: Therapeutic thresholds for extremely premature neonates. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 130(11): 1120
Peng, T.; Britton, G.L.; Kim, H.; Cattano, D.; Aronowski, J.; Grotta, J.; McPherson, D.D.; Huang, S.-L. 2013: Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke. Cns Neuroscience and Therapeutics 19(10): 773-784
Yang, B.; Strong, R.; Sharma, S.; Brenneman, M.; Mallikarjunarao, K.; Xi, X.; Grotta, J.C.; Aronowski, J.; Savitz, S.I. 2011: Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. Journal of Neuroscience Research 89(6): 833-839
Zhu, X.-L.; Xiong, L.-Z.; Wang, Q.; Liu, Z.-G.; Ma, X.; Zhu, Z.-H.; Hu, S.; Gong, G.; Chen, S.-Y. 2009: Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats. Neuroscience Letters 449(1): 24-27
Guo, C.; Zhu, Y.; Weng, Y.; Wang, S.; Guan, Y.; Wei, G.; Yin, Y.; Xi, M.; Wen, A. 2014: Therapeutic time window and underlying therapeutic mechanism of breviscapine injection against cerebral ischemia/reperfusion injury in rats. Journal of Ethnopharmacology 151(1): 660-666